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ABSTRACT 
  
Since the first successful liver transplant in 1968 the surgery has become very 
common and 6,291 patients received liver transplants in 2010 in the United States. 
However, the monitoring methods used post-surgery, in the recovery phase, are still very 
basic and rely mainly on blood tests and looking for unusual symptoms. Complications 
are usually detected after the organ is substantially damaged which poses a risk to the 
patients’ life. This dissertation presents the development and testing of an implantable 
sensor that can potentially be used to monitor the transplant continuously and transmit 
the information wirelessly to the medical staff for timely intervention. Such a sensor 
could have a great effect on survival and reduction of retransplantation rates.  
The presented sensor employs near infrared spectroscopy to measure perfusion 
changes, arterial oxygenation and venous oxygenation in the parenchyma of the liver 
tissue and the supplying vessels. Light at three different wavelengths (735-, 805- and 
940-nm) is shined on the tissue and the diffuse reflectance is collected via a 
photodetector.  The collected signals can be transmitted wirelessly to an external unit for 
processing and display. In this dissertation, different perfusion and oxygenation 
monitoring techniques are reviewed and the instrumentation of an NIRS based wireless 
sensor is introduced. A phantom that mimics the anatomy of the liver and its optical and 
mechanical properties is presented. The processing methods to extract the information of 
interest from the diffuse reflectance are described in details. Finally, results from in vitro 
phantom experiments, ex vivo perfused livers and in vivo porcine studies are presented.  
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The first in vivo wireless monitoring of hepatic perfusion and oxygenation levels 
is reported. The studies show that the sensor can track perfusion changes with a 
resolution of 0.1 mL/min/g of tissue. The possibility of tracking oxygen saturation 
changes is also shown as well as the ability to separate them from perfusion changes. 
Combining results from the pulsatile wave and DC levels, venous and arterial oxygen 
saturation changes were tracked with a resolution of 1.39% and 2.19% respectively. In 
conclusion, optical spectroscopy is shown to track perfusion, and arterial and venous 
oxygenation in tissue. In particular, the method was tested on hepatic and intestinal 
tissue.  
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NOMENCLATURE 
 
AC Alternating Current 
BPM Beat Per Minute 
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IR Infrared 
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NIRS Near-Infrared Spectroscopy 
  
viii 
 
PDMS Polydimethylsiloxane 
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RF Radio Frequency 
SaO2 Arterial oxygen saturation 
SO2 Oxygen Saturation 
SpO2 Peripheral Oxygen Saturation 
SvO2 Venous oxygen saturation 
UV Ultraviolet 
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YM Young’s Modulus 
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CHAPTER I 
INTRODUCTION 
 
Liver Transplant: Past, Present, and Future 
The liver is the largest internal organ in the human body (2% of the total body 
weight) and has many essential functions to the human life [1]. Terminal liver failure is 
life threatening and currently the only treatment for end stage liver disease (ESLD) is 
transplant. ESLD can be inherited or caused by a wide variety of factors including viral 
infections, drugs, and alcohol abuse. The first successful liver transplant was performed 
by Dr. Thomas Starzl in 1967 [2]. Since then, this operation has become a standard of 
care for patients with ESLD. A timeline of the progress of liver transplantation has been 
recently reviewed by Zarrinpar et al. [3].  The increase in the number of performed liver 
transplants has been exponential in the 1980s and 1990s and it plateaued in the early 
2000s, due to the shortage of organs [4]. Currently, around 6,400  and 4,200 liver 
transplants are performed yearly in the United States [5] and Europe [4]. The 1-, 3-, and 
5-year survival rates in the United States (1997-2004) for liver transplant recipients are 
86, 78, and 72% respectively [5]. 
Liver transplant is a complex procedure and often patients suffer from life 
threatening early acute graft failure (EAGF) complications such as hepatic artery 
thrombosis, portal vein thrombosis, primary graft non-function, hemorrhage, and others 
[6]. The majority of complications take place in the first two weeks following the 
surgery [7]. The current standard of care relies on biweekly blood work and needle 
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biopsies for suspicious cases [8]. These procedures are expensive, time consuming, and 
do not provide real-time assessment of the graft leading to delayed detection in many 
cases increasing the risk on the patient’s life and reducing the success rate of the 
intervention. Our group is working on developing an implantable sensor to monitor graft 
health in real-time and provide the care providers with frequent quantitative 
measurements to help detect any acute complications in the first two weeks post-
transplant in a timely manner [9, 10]. Figure 1 shows a schematic of the envisioned 
system. 
 
 
Fig. 1. Schematic of the envisioned system [9].  
   
Most EAGFs are associated with a disturbance in the hepatic perfusion pattern or 
tissue oxygenation. Vascular complications are typically associated with a decrease in 
hepatic tissue perfusion levels due to a decrease in supply (HA and PV complications) or 
a downstream blockage (Hepatic Vein complications). Klar et al. found in two different 
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clinical studies that liver transplant failures were associated with decreased perfusion 
levels under 60 mL/min/100 g of tissue during [11] or after transplant [12]. These 
perfusion changes are accompanied with changes in the tissue oxygen supply and 
consumption. Normal perfusion levels vary between subjects and to assess the adequacy 
of perfusion, measurements should be coupled with an oxygen consumption measure. 
Takaya et al. found in a clinical study (88 patients) that oxygen consumption can be used 
as a “predictive indicator for liver allograft function after transplantation” [13]. A sensor 
tracking perfusion and oxygenation changes in real-time can detect graft failures at an 
early stage and allow for timely medical intervention. 
Perfusion and Flow Monitoring Techniques 
There is a wide variety of blood flow and perfusion monitoring techniques. 
Perhaps the most common techniques used clinically are Doppler based techniques [14]. 
The Doppler principle relies on measuring the change in the frequency of a wave after 
bouncing off a scatterer, in this case red blood cell. This change, namely Doppler shift, is 
proportional to the velocity of the moving scatterers. Doppler measurements are not 
quantitative and track patterns of flow changes. This principle is used in Laser Doppler 
Flowmetry (LDF) that employs optical waves to measure the Doppler shift caused by 
blood flow. This measure of flow is often related to perfusion by assuming the probed 
blood volume (vessels and capillaries) is constant. If the volume of the blood vessels or 
capillaries is constant, this quantity can be related to tissue perfusion. This assumption 
should be used very carefully since many physiologic conditions can trigger changes in 
the probed blood volume such as vasoconstriction. 
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Another widely used technique is Transit-Time Ultrasound (US) flowmetry [15]. 
In this technique, the time it takes for an US wave to propagate across a blood vessel and 
back is measured and is proportional to the flow in that vessel. The main advantage of 
that technique over LDF is the quantitative measurements it provides. However, a major 
drawback is the inability to use the technique for tissue perfusion measurements since it 
requires an US reflector placed at a known distance from the source. 
Blood perfusion controls the tissue thermal properties. Bowman et al. showed 
that by using thermistor probes to measure the thermal properties of tissue, one can 
monitor its perfusion levels [16]. Since then, this technique became widely used for 
numerous applications ranging from skin grafts to brain tissue [17, 18]. This technique 
has shown success in monitoring hepatic microcirculation [12, 19]. The probes used in 
these monitors employ two thermistors. The proximal thermistor is passive and is used 
to measure the baseline temperature of the surrounding tissue. The second thermistor is 
active and is placed on the distal side of the probe. When this thermistor is powered, it 
causes an increase of about 2C in the local temperature. The power needed to cause that 
change is used to measure perfusion levels. 
Another technique that is widely used in hemodynamics research is laser speckle 
flowmetry. When coherent light is shined on tissue, the reflected light forms an 
interference pattern known as speckle. This pattern is blurred when the scatterers in the 
medium start moving. Many variations of this principle have been developed to study 
tissue perfusion in a variety of biomedical applications [20]. In its current form, laser 
  
5 
 
speckle perfusion monitoring does not provide quantitative measurements which is one 
of the main drawbacks of this technique [21]. 
A technique that has emerged recently in blood flow monitoring is Diffuse 
Correlation Spectroscopy (DCS) [22, 23]. This technique typically employs NIR 
coherent light sources and operates in reflectance mode using long source to detector 
separations which gives the technique the advantage of probing deeper tissue compared 
to LDF [24]. This technique can be combined with Near Infrared Spectroscopy (NIRS) 
to get oxygenation information [25, 26].  
These techniques are the most used in the clinic and research for flow and/or 
perfusion monitoring. There are other imaging techniques that are mainly used in 
diagnostic and are not suitable for long term monitoring mainly due to their cost and size 
and in some cases the use of ionizing radiation [27, 28]. 
A common problem with these techniques is the difficulty to miniaturize the 
instrumentation to a level where the sensor can be implanted with the organ and monitor 
the perfusion in the first two weeks post-surgery. In addition, all these techniques except 
the combined DCS-NIRS systems, do not provide any oxygenation information which is 
essential to assess the adequacy of perfusion and the oxidative stress levels on tissue. 
Oxygenation Monitoring Techniques 
Oxygen is not very soluble in water and hemoglobin is used as the carrier of 
oxygen in our blood to transport it from our lungs to the different organs of the body. 
Each hemoglobin molecule has four oxygen binding sites. When one of the binding sites 
is bound to oxygen, it increases the affinity of the other binding sites to oxygen so the 
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free oxygen will preferably bind to the hemoglobin molecule that has more binding sites 
occupied by oxygen. This leads to having the majority of hemoglobin molecules in one 
of two states: oxygenated (HbO2) or reduced (Hb). The ratio of HbO2 to the total amount 
of hemoglobin (HbT) is known as the hemoglobin oxygen saturation (SO2). 
Optical techniques are still the gold standard for non-invasive blood oxygen 
monitoring. Hemoglobin’s extinction coefficient depends on its oxygenation state [29-
31] and this property has been used in multiple optical techniques to quantify 
oxygenation levels [32-35]. Figure 2 shows hemoglobin’s extinction coefficient in its 
two oxygenation states. 
Oximetry using light first started in the 1930s-1940s [36, 37]. However, the idea 
of employing the pulsatile signal to isolate the contribution of the arterial blood to the 
collected signal wasn’t discovered until the 1970s by Takuo Aoyagi [34, 36]. This 
marked the first realization of pulse oximetry in its current basic form. Today, pulse 
oximetry is the standard for monitoring peripheral oxygen saturation (SpO2) and is used 
in nearly every surgical procedure that involves anesthetia or sedation in the developed 
world. Its concept relies on comparing the absorbance of light by the arterial blood on 
two different wavelengths. The details of the theory will be described later in this thesis. 
Since its invention, there have been many variations on pulse oximetry to enhance its 
signal and optimize it for use in different applications but the principle remains the same 
[38-40]. The instrumentation used in this technique is simple and multiple groups have 
shown the possibility to miniaturize it to the level of implantable and/or wearable 
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sensors [9, 10, 41, 42]. In addition, multiple reports have shown the possibility of using 
the photoplethysmogram (the pulsatile signal) to track perfusion changes [35, 42-45]. 
 
 
Fig. 2. Hemoglobin extinction coefficient in the VIS-NIR range (data from [31]) [43].  
 
Another technique that has shown a success in monitoring oxygenation changes 
is Near Infrared Spectroscopy (NIRS) [46]. Similar to pulse oximetry, NIRS uses two or 
more wavelengths of light in the red to NIR range and the difference in absorbance at the 
two wavelengths can be used to track changes in the concentration of HbO2 and Hb. An 
absolute measure of these concentrations is dependent on the optical pathlength. 
Different techniques have been used to accomplish that such as NIRS in frequency 
domain (FD-NIRS) and in time domain (TD-NIRS) [33, 47]. FD-NIRS employs 
modulated light sources and uses the phase of the collected wave to measure the optical 
pathlength. In TD-NIRS, pulses of light are used to illuminate the tissue and the delay 
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and shape of the collected pulse is used to determine the optical pathlength. The 
information in pulse oximetry is contained mainly in the pulsatile signal that constitutes 
around 0.2 to 5.2 % of the collected signal [48]. NIRS uses the full signal which allows 
it to use long source to detector separations with NIR wavelengths to probe deeper in 
tissue. That gave NIRS an advantage in some applications such as functional brain 
imaging (fNIRS) [33]. Note that NIRS measures tissue oxygenation levels which include 
arterial, capillary, and venous contribution. Pulse oximetry measures pulsatile oxygen 
saturation which, in most cases, follows the arterial oxygenation closely. 
Pulse oximetry and NIRS are very similar. The main difference is the method 
each of the techniques uses to separate the contribution of blood from that of tissue. In 
the sensor described herein, both of these techniques were used as complementary 
measurements to get arterial and tissue oxygenation measurements. 
Proposed Approach 
The sensor described herein is based on photoplethysmography (PPG). That type 
of sensors can operate in reflectance and transmittance modes [41, 42, 44, 45]. In 
transmittance mode, the photodetector is on the opposite side of the light source and 
light goes through the full thickness of tissue before it is collected. This mode is used in 
applications such as finger and ear pulse oximeters [49]. However, it can not be used on 
large organs due to the limited penetration depth of light. The sensor presented in this 
thesis operates in reflectance mode where the light source and photodetector are on the 
same side. This mode can be used to monitor hemodynamics in thick organs [9, 10, 42, 
45]. To obtain perfusion and oxygenation information, we employ three Light Emitting 
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Diodes (LEDs) emitting in the Red-NIR region (735, 805, and 940 nm). Figure 3 shows 
a schematic of the sensor probe with the three LEDs and the photodetector. 
 
 
Fig. 3. Probe schematic : (top) face view and (bottom) side view when placed on tissue. 
The different lines (1, 2, and 3) refer to different wavelengths of light [9]. 
 
 When light is shined on tissue, part of it is absorbed by various chromophores in 
tissue (hemoglobin, melanin, water, etc.). The remainder of the light exits the tissue 
scattered in various directions and locations. A photodetector placed on the surface of 
the tissue detects any fluctuations in the signals due to changes in the 
concentration/volume of the chromophores. The collected signal has multiple frequency 
components caused by different periodic processes (respiration, blood flow/pressure, 
vasomotion, etc.). Changes at the heart rate are due to the arterial pulsatile blood flow 
and can be used to separate the blood signal from the tissue contribution. This signal is 
measured as an alternating current (AC) signal and is referred to as the 
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photoplethysmogram (PPG). PPG can be used to monitor heart rate and perfusion levels 
[35, 44]. The amplitude of the PPG is a function of wavelengths. By using two or more 
wavelengths, blood oxygen saturation can be quantified and separated from perfusion 
changes [50]. The photodetector also measures a direct current (DC) that maps the 
absorbance of chromophores that are not time variant during the collection/integration 
period. These chromophores include non-pulsatile arterial blood, venous blood, and 
surrounding tissue (Figure 4). Although this part constitutes the majority of the 
reflectance and is rich in information about the hemodynamics of the tissue, PPG sensors 
commonly employ the DC level for the sole purpose of normalizing the AC signal to 
account for tissue absorbance, light-source intensity and coupling, and other undesired 
background signals. In our system, the DC levels are used to measure venous 
oxygenation changes.  
 
 
Fig. 4. Diagram of the different parts of the collected light signal (left) and a typical 
frequency spectrum of the collected intensity (right) prior to any amplification. Note that 
the signals are not to scale in the diagram and the DC signal is omitted from the 
spectrum to be able to visualize the pulsatile signal peaks.  
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Traditional PPG systems use hemoglobin as the chromophore of interest to detect 
blood pulsation. However, some variations of PPG systems are used to monitor 
exogenous chromophores such as Indocyanine Green (ICG) [51] and gold nanoshells 
[52] in the blood stream. These systems are typically used to study the clearance of 
introduced exogenous chromophores from the blood stream for a variety of applications 
ranging from studying liver function [51] to measuring cardiac output [53]. 
Although PPG is most known for the aforementioned applications, there are 
many variations of this technique that are currently being explored to suit various 
biomedical applications. One of the growing areas of interest with PPG is contactless 
monitoring [54-57]. Similar to regular PPG, these systems have the potential to be used 
to monitor heart rate [54] perfusion [56] and oxygenation [57]; however, more studies 
are needed to validate and assess their performance. 
As mentioned earlier, the PPG signal is relatively weak and the instrumentation 
design requires optimization of multiple parameters (probe geometry, filtration and 
amplification, wavelength selection, etc.) to maximize the collected signal. These 
parameters have been studied by various groups and have shown to have substantial 
effect on the performance of the PPG sensors [39, 40, 58-61]. Most of these parameters 
depend on the application of interest. In the following chapter, the optimization of the 
instrumentation is discussed for an implantable PPG sensor for continuous monitoring of 
perfusion and oxygenation changes in liver tissue. 
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CHAPTER II 
INSTRUMENTATION DESIGN
*
 
 
Instrumentation Overview 
The essential parts of a typical multiwavelength PPG sensor are: light sources 
multiplexed to avoid cross-talk between the channels, one or multiple photodetectors, 
and filters and amplifiers to extract and amplify the weak pulsatile signal (Figure 5). The 
system described herein utilizes three wavelengths to measure and separate perfusion 
and oxygenation signals and correct for motion artifacts [50, 62]. The three light sources 
are multiplexed which allows the use of a single photodetector. In our system we use 
time-division multiplexing (TDM) which reduces power consumption in comparison 
with frequency-division multiplexing (FDM) [10]. Figure 5 shows a block diagram of 
the sensor. The left side shows the three light sources with the corresponding drive units. 
Light Emitting Diodes (LEDs) were used as light sources because of their availability in 
small sizes, low prices, and low power consumption. The signal detection and separation 
diagram is shown in the right part of figure 5. The light measured by the photodetector is 
first amplified by a low noise preamplifier. The signal is then demultiplexed into four 
channels: one for each wavelength and one that is measured when all LEDs are off to 
quantify the dark current. The signal then goes through a differential amplifier for dark 
                                                 
*
 Part of this chapter is reprinted from T. J. Akl, R. Long, M. J. McShane et al., “Optimizing 
probe design for an implantable perfusion and oxygenation sensor,” Biomed Opt Express, 2(8), 
2096-109 (2011)., with kind permission of OSA, Copyright 2013 by The Optical Society.  
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current subtraction. The resultant signal on each of the wavelength channels is split into 
a DC channel with a low pass filter and an AC channel with a bandpass filter and a 
variable gain amplifier (VGA) that is set by the user to amplify the AC signal [9, 10, 63]. 
Each sensor results in 6 channels (AC and DC channels for each of the 3 wavelengths) 
which are digitized and saved into a data acquisition computer. 
 
 
Fig. 5. Block diagram of illumination and signal processing electronics for a 3 
wavelengths sensor.  
 
The PPG sensor performance depends on multiple parameters that will be 
discussed in details in this chapter. These parameters include the probe geometry, 
illumination wavelength(s), filter cutoff frequencies, and amplification. First we discuss 
the probe design and fabrication (source to detector separation, illumination 
wavelengths, etc.) followed by a description of the filtering and amplification 
parameters. 
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Probe Design 
The separation of the illumination and collection points in a reflectance based 
sensor is essential in determining the probing volume and probing depth which are 
directly related to the signal to background ratio [64, 65]. In addition, by varying the 
probing volume, the optical pathlength is altered leading to a change in absorbance and 
the collected light intensity. For these reasons, the source to detector separation should 
be optimized, especially in the case of an implantable sensor where power is limited and 
artifacts are relatively high. Similarly, the optical properties of chromophores are 
wavelength dependent and the performance of an optical sensor depends largely on the 
wavelengths used. In this section, we investigate the effect of source to detector 
separation and other source-detector characteristics to optimize the sensor’s signal to 
background ratio using Monte Carlo (MC) based simulations and in vitro phantom 
studies. In summary, separations in the range 0.45 to 1.25 mm were found to be optimal 
in the case of a point source. The numerical aperture (NA) of the source had no effect on 
the collected signal while the widening of the source spatial profile caused a shift in the 
optimal source-detector separation. Specifically, for a 4.5 mm flat beam and a 2.4 mm × 
2.5 mm photodetector, the optimal performance was found to be when the source and 
detector are adjacent to each other. These modeling results were confirmed by data 
collected from in vitro experiments on a liver phantom perfused with dye solutions 
mimicking the absorption properties of hemoglobin for different oxygenation states. 
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Materials and Methods 
Monte Carlo Simulations 
A multilayer photon propagation Monte Carlo simulation program based on the 
algorithm developed by Wang et al. [66] was developed in MATLAB (Appendix A). 
The placement of the sensor on the portal vein, the main blood supplier to the liver [67], 
and the hepatic artery were modeled as three layer structures (Fig. 6). The first and third 
layer have the optical properties of liver tissue [68] and the middle layer has the optical 
properties of whole blood and the dimensions of the vessel under investigation (Table 1). 
The optical properties of blood were changed to mimic different oxygenation states [30, 
31]. Table 2 shows the optical properties of the two oxygenation states of blood at three 
wavelengths of interest [29, 31]. 
 
Table 1. Diameter and wall thickness of the portal vein and hepatic artery ([69, 
70] & [69, 71] ) 
 
 Portal Vein (PV) 
 
Hepatic Artery (HA) 
 
Vessel wall 
thickness (mm) 
 
0.61 0.49 
Vessel lumen 
diameter (mm) 
 
7.8 3.8 
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Fig. 6. Schematic of the multilayer MC model mimicking a blood vessel.  
 
For each run, 1 million photon packets were launched in different directions, 
with equal probability, within the Numerical Aperture (NA) of the source. The program 
recorded the collected intensity at the tissue surface and the corresponding penetration 
depth of each photon collected, producing a photon distribution map indicating at every 
point of the surface how many photons were collected and the penetration depth of each 
photon. This feature was used to find the probing depth for every source to detector 
separation and to separate the background intensity collected from photons that are 
probing the blood.  
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Table 2. Blood optical properties for two oxygenation states[29, 31] 
 Oxygenated 
 
 Deoxygenated 
 (nm) µa 
(1/mm) 
 
µs 
(1/mm) 
g  µa 
(1/mm) 
µs 
(1/mm) 
g 
735 nm 
 
0.2408 80.5 0.9790  0.6025 80.5 0.9790 
805 nm 
 
0.4557 76.7 0.9786  0.3943 76.7 0.9786 
940 nm 
 
0.6555 67.7 0.9760  0.3744 67.7 0.9760 
 
 
To study the effect of the source spatial distribution, the collected intensity was 
convoluted with the source spatial profile as discussed by Wang et al. [72]. All the 
modeling results were verified by comparison to MCML and CONV developed by 
Wang et al. [66, 72]. 
The performance of various wavelengths was studied by changing the optical 
properties of the layers to match those of the corresponding chromophore (tissue or 
blood) for that specific wavelength. 
In Vitro Setup 
To verify the modeling results, an in vitro system was constructed to measure 
perfusion and oxygenation in a liver phantom at different source - detector separations. 
Polydimethylsiloxane (PDMS) based phantoms were designed and fabricated to mimic 
the optical properties of liver tissue as described in details in Chapter IV. In summary, a 
mixture of PDMS, Al2O3 powder, Black India Ink, and blue food coloring was poured 
into a petri-dish containing a plastic tube (8 mm in outer diameter for the PV or 3 mm 
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for HA) fixed at 1 mm above the petri-dish bottom surface and cured at 65°C to 
completely crosslink the PDMS. The plastic tube was removed, and the resulting 
phantom is a slab with the optical properties of liver tissue containing a hollow 
cylindrical structure with similar dimensions to the vessel under investigation (PV or 
HA). Slabs of the same material were also fabricated for use in case extra-thickness 
above or below the initial design is needed.  Fig. 7 shows a schematic of the phantom 
with the optical probe placed on top of it. 
 
 
 
 
Fig. 7. Schematic of the PDMS based portal vein phantom showing the placement of the 
probe on top. The Light Emitting Diode is protruding out of the probe surface to provide 
better light coupling to the interrogation medium. The source to detector separation is 
referred to as d.  
 
The phantoms used in this study mimicked the case where the sensor is placed on 
a blood vessel (PV or HA) at the entrance of the liver to monitor the blood supply. The 
phantoms were perfused with dye mixtures that simulate the optical properties of blood 
in its different oxygenation states. These mixtures are described in details and 
characterized in Chapter IV.   
Two peristaltic pumps (Gilson, Minipuls 3) driven using LabVIEW via a data 
acquisition board (National Instruments, USB 6009) were used to pump the dye 
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solutions through the phantom. Extra care was taken to ensure no air bubbles were 
circulated. The driver signal used to control the pumps was a square wave.  The 
frequency and the pulse width were set to the desired values that mimic the cardiac 
pulsatile flow pattern. Each pump can be used to pump a different dye solution 
corresponding to different oxygenation states and the mixture can mimic any 
oxygenation state by changing the ratio of the pump speeds. 
The probes used are circular (1 inch in diameter) and contain a single can 
package with four light emitting diodes (epitex, L660/735/805/940-40B42-C-I) and a 
silicon photodetector (Hamamatsu, S2833-01). Five different LED to photodetector 
spacings were used ranging from 2 mm to 10 mm (edge to edge separation) with a step 
of 2 mm. A mechanical arm was used to fix the probe on the surface of the phantom 
above the hollow cylinder (Fig. 7) with the LED and photodetector aligned along the 
tube. Fig. 8 shows the complete setup with the LabVIEW interface used for data 
collection and visualization. 
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Fig. 8. In vitro setup showing the two peristaltic pumps pushing a dye solution through 
the PV phantom with the optical probe held on top with a mechanical arm. Note the 
phantom appears light bluish in color to the eye but has the optical properties, in the 
735-940 nm wavelength range, of liver.  
 
Results 
Monte Carlo Modeling Results 
The diffuse reflection intensity at the surface decayed rapidly with increasing 
source-detector separation for all three wavelengths, for both simulated oxygenated and 
de-oxygenated signals. However, these intensities (the case of oxygenated blood is 
shown in Fig. 9a) carry signal from the blood volume as well as background intensity 
from the surrounding tissue. To separate the signal from background intensity, we 
looked at the difference between the collected intensity in the cases of oxygenated and 
deoxygenated blood. This difference eliminates the constant background intensity and is 
a better indicator of the optimal spacing to collect the highest signal probing the blood 
volume. The difference showed a plateau phase followed by a quick decay for the 735 
and 940 nm wavelengths. This plateau extends to 0.55 and 0.45 mm for the 735 and 940 
nm wavelengths respectively (Fig. 9b). However, the 805 nm wavelength, since it is near 
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the isobestic point, carried little information about the oxygenation state. Note that the 
805 nm wavelength does have a bias to the 940 nm side, since in our model 805 nm is on 
the IR side of the isobestic point. After the peak, the difference signal decayed rapidly to 
reach 10% of its maximal value at 2.4 and 2.2 mm for the 735 and 940 nm wavelengths 
respectively. Despite the rapid decay, there was still a relatively long range where the 
signal is strong enough to have a dynamic difference between the two oxygenation 
states.  
In Fig. 9 the signal is presented in terms of its total reflectance at a specific 
distance (Fig. 9a for oxygenated simulation) and difference between oxygenated and de-
oxygenated reflectance (Fig. 9b). However, the overall intensity decays with increasing 
separation. This implies that, although signal (S) is decaying, the signal to background 
ratio (SBR) might be constant or even increasing. To validate this hypothesis, we looked 
at the normalized intensity that we defined as the ratio of signal difference (S) to the total 
average intensity (It). Equation (II.1) shows the defined SBR ratio where Roxy and RDeoxy 
are the photon fluence at the surface in the oxygenated and deoxygenated state 
respectively. 
0.5 ( )
Oxy Deoxy
Oxy Deoxy t
R R S
SBR
R R I

 
 
    (II.1) 
S is the signal defined as the difference between the collected intensities in the 
oxygenated and deoxygenated states: 
Oxy DeoxyS R R   
It is the average total intensity in the oxygenated and deoxygenated states: 
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2
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t
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I

  
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Note that It is the average total intensity, thus it comprises both signal and background 
and the defined SBR is the ratio of the difference signal to the total collected intensity 
which gives an idea about the signal to background ratio. 
 
 
Fig. 9. Light fluence & oxygenation signal as a function of source to detector separation. 
(Left) Fluence decay curves for all three wavelengths as a function source to detector 
separation. These curves correspond to the case of oxygenated blood. The curves 
indicate a rapid decay in total collected fluence with increasing separation. (Right) The 
difference (S=ROXY – RDEOXY) as a function of source to detector separation. The signal S 
shows a plateau phase with a maximal value followed by a rapid decay for the 735 and 
940 nm wavelengths. The 805 nm wavelength carries a low oxygenation signal since it 
was slightly on the IR side of the isobestic point. The arrows indicate the end of the 
plateau phase and the start of the rapid decay.  
 
Fig. 10 shows the SBR calculated using (II.1) as a function of source-detector 
separation. In the source-detector separation range shown (0.05 to 10 mm) the absolute 
value of the SBR is monotonically increasing. Past this range, this ratio is very noisy due 
to the weakness of the collected intensity. 
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Fig. 10. SBR as a function of source to detector separation. SBR starts from 0 and 
absolute value increases monotonically (Note by definition this means at 735 nm the 
SBR is positively increasing and at 940 nm the SBR is negatively increasing with 
separation indicating a decrease in the background to signal ratio. For the 805 nm 
wavelength, SBR is close to zero with a little bias to the negatively increasing 940 nm 
side, since in our model 805 nm is on the IR side of the isobestic point.  
 
To better understand this phenomenon, we added to our MC algorithm a feature 
to record the penetration depth of the collected photons on the tissue surface. As shown 
in Fig. 11(a) below, although the total intensity decreased, the ratio of photons collected 
from the vessel lumen (deeper than 0.5 mm which is the vessel upper limit) increased 
relatively to the photons probing the shallow tissue as we increased the source to 
detector separation. However, the total number of collected photons probing the blood 
layer decreased. This supports the data presented in Figures 9 and 10 and indicates that 
the total intensity and signal decrease with increasing source to detector separations but 
the signal to background ratio increases. These findings are very important to know 
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when designing probes for this type of sensor in order to optimize the use of the dynamic 
range of the photodetector as discussed in further details in the Discussion section. 
 
 
Fig. 11. The distribution of the collected photon fluence on the penetration depth for the 
735 nm wavelength. Photons with a penetration depth higher than 0.5 mm are 
considered as signal while those that have a shallower penetration depth are considered 
as background since they do not probe the blood volume. Panel (a) shows the data for 5 
selected source-detector separations. Panel (b) is a 3D representation of the data.  
 
  
25 
 
Fig. 11(b) shows the collected photon fluence as a function of separation and 
penetration depth of each photon. This figure shows two peaks before and after the 
vessel lumen boundary at 0.5 mm. The shallower peak corresponds to the background 
intensity and, although higher in intensity, decays (as a function of source to detector 
separation) faster than the second peak that corresponds to the signal collected from the 
vessel lumen. The axes on this graph start at 0.2 mm (depth) and 0.1 mm (source to 
detector separation) because before these points there is a high background peak (at 0.1 
mm depth and 0.1 mm source to detector separation) that is difficult to visualize with the 
signal peak on the same scale. 
One way to maximize both quantities, SBR and S, if weighted equally is to 
maximize their product (equation II.2). Fig. 12 shows the product as a function of 
source-detector separation.  
 
2
*
0.5*( )
Oxy Deoxy
Oxy Deoxy
R R
S SBR
R R



                 (II.2) 
As expected, the 805 nm wavelength carries almost no oxygenation information 
and the product is stable at nearly zero for all spacings. However, for both the 735 and 
940 nm wavelengths, the product starts as an increasing function with source to detector 
separation and plateaus at 0.35 and 0.45 mm respectively. This plateau ends and a rapid 
decay starts around 1.25 and 1.35 mm respectively.  
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Fig. 12. The product of signal (S) and SBR as a function of source to detector 
separation. The product shows a plateau phase with maximal S*SBR product for the 735 
and 940 nm wavelengths. The 805 nm wavelength carries almost no oxygenation signal 
and the product is stable at nearly zero.  
 
All the previous results were based on a collimated point source. Other probe 
characteristics such as the source NA and spatial profile might have a significant 
influence on these findings. The NA effect was studied by launching the photons in 
different directions, with equal probability, within a cone corresponding to a numerical 
aperture specified by the user. As expected, the numerical aperture of the source had no 
significant effect on the results because of the highly scattering nature of tissue. 
To investigate the effect of the source spatial profile, we compared the results of 
the point source to those of a 4.5 mm cylindrical flat beam mimicking the light emitting 
diodes used in our probes (Epitex, L660/735/805/940-40B42-C-I) and a photodetector 
with an active area of 2.4 mm x 2.5 mm (Hamamatsu, S2833-01). Fig. 13 shows the 
corresponding results. 
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Fig. 13. MC modeling results for a 4.5 mm source and a 2.4 mm x 2.5 mm photodetector. 
The diffuse reflectance for all three wavelengths was normalized to the reflectance at the 
closest separation for the 735 nm wavelength. The signal S was normalized similarly.  
 
Similar to the point source case, Fig. 13 shows a rapid decay in the intensity and 
signal as the detector is moved away from the source. The SBR ratio shows also a similar 
profile to the previous case with the main difference being the start point that is not 
equal to zero in that case. This is expected since the broad source can be considered as 
an assembly of point sources and even when the detector is placed right next to the 
source there will still be a point source at the other end that is far from the detector and is 
probing deep in the tissue collecting signal from the blood vessel lumen. Note that the 
results from the circular flat beam appear less noisy due to the convolution process, used 
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to account for the source spatial profile, which eliminates high frequency noise. This can 
be thought of as having multiple point sources, instead of one, launching photons leading 
to a less noisy diffuse reflectance signal. Table 3 summarizes these results. 
 
Table 3. Summary of the MC modeling results
a
 
  Point Source  4.5 mm beam 
  Maximum Plateau 
Phase 
 Maximum Plateau 
Phase 
735 nm 
S 0 0 – 0.55 mm  0 x 
SBR ↗ > 3.05 mm  ↗ x 
S*SBR 0.55 0.35 – 1.25 mm  0 x 
940 nm 
S 0 0 – 0.45 mm  0 x 
SBR ↗ > 2.55mm  ↗ x 
S*SBR 0.85 0.45 – 1.35 mm  0 x 
a↗ refers to a monotonically increasing function with increasing source-detector separation. The 
plateau phase refers to ranges of source-detector separations where the corresponding function is 
changing relatively slow compared to the rest of the source-detector separations. 
 
In Vitro Results 
To verify the modeling results and apply them to our system, we used the setup 
described in the in vitro setup section. Five source-detector spacings were used and 
compared to the model. For each run, one of the two dye solutions corresponding to the 
two oxygenation states of blood, was passed through the phantom using the flow system 
previously described. We alternated between the dye solutions to calculate the quantities 
defined in the previous section (MC results) and the phantom was washed in between 
runs by flowing deionized (DI) water through the fluidics system. This experiment was 
repeated three times. For each set of experiments, data was collected with the shortest 
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spacing probe first and its position on the phantom was marked to guaranty similar 
coupling between all probes. Fig. 14 shows the signal S, previously defined in equation 
II.1, for the in vitro phantom studies compared to the MC modeling results. The data 
from 3 sets of experiments was averaged. In terms of calibration, the average of the 
shortest spacing probe was normalized to the model to account for the probe 
characteristics such as detector sensitivity and LED power, the same calibration factor 
was applied to the rest of the probes. Since the 805 nm wavelength carries minimal 
information about changes in the dye solution (i.e. simulated oxygenation), it was used 
as a baseline to account for any changes not related to varying the dye solution as shown 
in equation II.3. In the ideal case, where there are no changes in the background, the 
intensity on the 805 nm wavelength is the same for both dye solutions and equation II.3 
reduces to (IOxy - IDeoxy). In this case, IOxy and IDeoxy are the collected intensity at the 
wavelength of interest when the phantom is perfused with the dye solution mimicking 
oxygenated and deoxygenated blood respectively. 
805 805
805
( ) ( )
( )
Oxy Oxy Deoxy Deoxy
Oxy Deoxy
S I I I I
I I I
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                   (II.3) 
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Fig. 14. In vitro data collected from the PDMS based phantom perfused with the dye 
solutions. The solid lines show the data from the MC model while the squares and 
circles represent the average of the collected data from the phantom at the 735 and 940 
nm wavelengths respectively. The error bars correspond to (+/-) one standard deviation.  
 
Wavelength Selection 
Wavelength selection is an essential part in designing any optical system and in 
particular spectroscopy based sensors. The first step in selecting suitable wavelengths for 
a spectroscopy sensor is determining what wavelengths are sensitive to the analyte or 
property of interest. In the case of an oxygenation and perfusion sensor, the wavelengths 
have to be sensitive to the hemoglobin oxygenation state. To study that we looked at the 
change in the extinction coefficient with the oxygenation state (equation II.4). Figure 15 
shows the normalized oxygenation signal as a function of wavelength. The highest 
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change in hemoglobin’s extinction coefficient is around 660 nm which is commonly 
used in pulse oximeters. Note that the zero crossings correspond to isobestic points 
where the optical properties are independent of the oxygenation state. 
  ,, 2HbOHbS   (II.4) 
Figure 15 shows that there are various wavelengths bands that are sensitive to 
hemoglobin oxygenation state. However, many of these wavelengths have a limited 
penetration depth and are not suitable for sensing in tissue. Equation II.5 shows the 
theoretical mean penetration depth in a homogeneous medium as a function of its optical 
properties. 
  4
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Fig. 15. Normalized oxygenation signal vs wavelength. 
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This equation was derived by Weiss et al. based on a random walk model [73]. It 
defines the mean penetration depth (Z) as a function of the source to detector separation 
(r), the absorption coefficient (µa), and the reduced scattering coefficient of the medium 
(µ’s). The mean penetration depth vs. wavelength is shown in figure 16 for various 
source-to-detector separations. The mean penetration depth increases significantly for 
NIR wavelengths (700-1000nm) compared to their visible counterparts. That is why this 
region is referred to as the therapeutic window (also known as optical window) and most 
optical sensors and imaging systems operate in this wavelength range. In addition, since 
the measurements of the described sensor require the use of multiple wavelengths, and to 
avoid probing different tissue volumes on the different wavelength which can lead to 
erroneous reading, we wanted all three wavelengths to have a similar penetration depth 
and that is why we selected all three wavelengths in the 700-950nm band where the 
penetration depth is similar. Although this range is less sensitive to oxygenation changes 
compared to the 660 nm wavelength, but it does carry oxygenation information in wide 
bands that are suitable to use with LEDs.  
The sensor requires the use of one isobestic point and in this range there is one 
isobestic point around 800 nm and LEDs are commercially available with emission 
wavelength in that range. In all the following studies, unless otherwise specified, 805 nm 
LEDs were used as one of the three wavelengths. It is preferable to have the other two 
wavelength on opposite sides of the isobestic point. This allows to have one wavelength 
more sensitive to HbO2 and another more sensitive to Hb. We selected the 735 nm and 
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940 nm wavelengths. These wavelengths are commercially available, sensitive to 
oxygenation changes, and have similar penetration depth.   
 
 
Fig. 16. Mean penetration depth in liver tissue perfused with oxygenated blood as a 
function of wavelength for various source to detector separations.  
 
Another problem with the 660 nm wavelength that led us to avoid its use is the 
high extinction coefficient of deoxy-hemoglobin on that wavelength (figure 2). This 
leads to a limited penetration depth on this wavelength for low oxygen saturation states 
[58]. Using equation II.5 and assuming that the liver tissue is perfused with 
deoxygenated blood (SO2=0%), we can calculate the mean penetration depth shown in 
figure 17. It can be seen that for low oxygenation states, the 660 nm is highly attenuated 
and has a lower penetration depth compared to the selected wavelengths (735, 805, and 
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940 nm). This is important to account for since the liver gets 75% of its blood supply 
from the portal vein which carries blood with low oxygen saturation levels [1]. 
 
 
Fig. 17. Mean penetration depth in liver tissue perfused with deoxygenated blood as a 
function of wavelength for various source to detector separations.  
 
Filter Design 
The main signal in a PPG sensor is the cardiac modulation of the optical signal. 
As discussed earlier, this signal is relatively weak [48] and is typically filtered and 
amplified before any digitization. If not filtered and amplified, the signal will be buried 
by electronic and digitization noise. One of the main challenges in accomplishing that 
goal is the relatively high amplitude noise surrounding the cardiac cycle component. The 
normal resting heart rate for human adults ranges between 60 and 80 bpm (1 and 1.33 
Hz) [74]. As discussed earlier, prior to filtering the PPG signal has many other 
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components one of which is the respiratory rate due to the pulsation of veins and motion 
artifacts in the measuring site. The normal resting respiratory rate ranges from 12 to 20 
respirations per minute (0.2 – 0.33 Hz). The collected cardiac cycle component is much 
weaker than most other variables in the PPG, including the respiratory component, and 
requires high amplification. A successful filtering scheme has to separate these two 
components and attenuate the respiratory component on the AC channel to avoid 
saturating the high gain amplifiers.   
 
 
Fig. 18. Block diagram of the signal processing electronics in the bench-top system [63].  
 
The first bench-top system that was used in the in vitro, ex vivo, and early in vivo 
studies used a 4
th
 order Low Pass Filter (LPF) with Butterworth response characteristics 
and a 3 dB cutoff frequency of 0.15 Hz on each of the DC channels. The AC channel 
had a 4
th
 order High Pass Filter (HPF) and a 4
th
 order LPF both with Butterworth 
response characteristics and a 3 dB cutoff frequency of 0.15 and 15 Hz respectively. 
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Figure 18 shows the diagram of the signal processing electronics for the bench-top 
system [63]. All filters were partitioned using a cascade of 2
nd
 order filters implemented 
using Sallen-Key active filter topologies. The VGA allows the user for selecting the AC 
gain from a range of 1 V/V to 440 V/V using DIP switches. 
The bench-top system was used for testing and optimizing the hardware design. 
The filters used in that system were not capable of blocking the low-frequency noise 
adequately and the AC channels were often saturated by the respiratory artifacts during 
in vivo porcine studies. The filters were modeled in custom LabVIEW software that was 
built to model the performance of various filters and their ability to block low-frequency 
noise. The simulation assumed a low frequency sinusoidal respiratory signal that has a 
ten times higher amplitude than the cardiac cycle signal. Its frequency was varied 
between 0.1 and 0.33 Hz to model the different rates of respiration. The frequency of the 
cardiac signal was changed between 1 Hz, mimicking the case of a human adult at rest, 
and 2.1 Hz, mimicking the case of porcine to assess the performance for animal studies. 
Figure 19 shows a snapshot of the simulated signal and its corresponding power 
spectrum as seen on the LABVIEW interface. 
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Fig. 19. The simulated signal used to test the performance of the designed filters 
showing the cardiac cycle component and a motion artifact at the respiratory rate.  
 
 To quantify the performance of the filters we looked at the power spectrum of 
the input and output signals and defined the following quantities: 
  Background : Amplitude of the low-frequency peak 
  Signal  : Amplitude of the cardiac cycle peak 
  SBR  : Signal to background ratio 
When using the filter described above, the input SBR was calculated to be 1/100 
(Signal = (1/√2)2 = 0.5 and background = (10/√2)2 =50) and the output SBR was 
approximately 1/17 (5.8 folds enhancement) which means the background signal is still 
more than 4 times larger in amplitude than the output signal.  Figure 20 shows the 
characteristics of the filter and the output signal after filtering. 
Cardiac cycle 
Motion artifact 
  
38 
 
 
 
Fig. 20. Filter characteristics (upper panel) and response to the simulated signal (lower 
panel) of the bench-top system.  
 
To enhance that, we tried various filters limiting them to the 4
th
 order to limit the 
filters to a simple two stage implementation. We found that the LPF on the AC channel 
does not have a substantial effect since the majority of the background and noise are low 
frequency signals (respiration, motion artifact, etc.). For the high pass filter, we decided 
to use a 4
th
 order Butterworth filter with a 3dB cutoff at 0.55 Hz. This filter leads to an 
output SBR of  1111 indicating that the background was highly attenuated (5 orders of 
magnitude) and the signal amplitude is more than 33 times higher than the background 
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on the output. Figure 21 shows the described results and the characteristics of the 
proposed filter. 
 
 
 
Fig. 21. Filter characteristics (upper panel) and response to the simulated signal (lower 
panel) of the redesigned band-pass filter.  
 
Next we tested the worst case scenario when the heart rate is at 60 bpm (1 Hz) 
and the respiratory rate is at 20 breaths per minute (0.33 Hz). The cardiac signal used in 
this case simulated the shape of the pulse as reported by Millasseau et al. [75]. In this 
case the proposed filter resulted in a SBR of 0.625 (signal amplitude 1.26 times weaker 
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than background) which was a 2 orders of magnitude improvement over the filters in the 
original bench-top system (SBR of 1/100). Figure 22 shows the results of the proposed 
filter. 
 
 
Fig. 22. The output signal of the redesigned band-pass filter in response to a cardiac 
signal at 1 Hz (60 bpm) and a respiratory signal at a rate of 0.33 Hz (20 bpm).  
 
Discussion 
The probing depth in diffuse reflection is highly dependent on the source to 
detector separation. Large separations lead to deeper probing which increases the blood 
signal carrying portion of the total intensity. However, this increases the optical path 
length and attenuates the total intensity causing lower levels of light to be collected 
which leads to higher system error. Photodetectors and electronic amplifiers have a 
limited dynamic range, and optimizing the separation is critical to increase the levels of 
the signal without saturating the detection electronics with background intensity. Using 
higher separations lead to better signal to background ratios (less sample noise) but at 
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the same time it decreases the intensity of the collected light leading to a decrease in the 
system signal to noise ratio assuming fixed electronics noise. A compromise has to be 
made between the signal to background ratio and the absolute values of the collected 
intensity and signal. Our model showed that, for a point source, there is an optimal range 
with high signal levels and high signal to background ratio for both wavelengths (735 
and 940 nm) extending from 0.45 to 1.25 mm. These values change with the spatial 
profile of the source. For the case of a 4.5 mm LED, most of this plateau phase 
overlapped with the source and only a peak was seen right next to the source followed 
by a signal decay. Despite this decay, the collected signal is high enough to be detected 
millimeters away from the source. This was shown in our in vitro data (Fig. 14) where 
changes in oxygenation were still detected 10 mm away from the edge of the source. The 
previously defined SBR ratio showed a similar increasing trend for the in vitro data. 
However, past 6-8 mm edge to edge separation the ratio showed a decreasing trend that 
is due to the system noise since the total intensity at this point is close to the detection 
limit of our hardware. Note that the same amplification level was used for all separations 
to provide a fair comparison. The numbers for the SBR ratio from the in vitro data are 
much lower than those calculated by the model due to multiple reasons. The main reason 
for this discrepancy results from the use of a simplified 2D layered model with the blood 
vessel represented as a layer of blood. In the real case, the blood vessel is surrounded by 
tissue that contributes to the background intensity and not the oxygenation signal. Also, 
the dynamic range between the optical properties of the two dye mixtures mimicking the 
two oxygenation states is less than that of whole blood which causes a reduction in the 
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signal (S) intensity. However, this second factor is not as significant as the first since the 
optical properties of the dye mixtures at the 940 nm wavelength match those of whole 
blood very closely and the reduction in the SBR ratio can still be seen. As expected, 
similar to the modeling results, the product S*SBR also showed a decreasing trend for 
the in vitro data. This shows that the optimal performance of this source-detector pair is 
at the closest separation. 
To better understand this tradeoff between signal levels and the signal to 
background ratio, we ran simulations for different oxygenation levels and observed the 
correlation between the photon fluence values and the oxygenation levels as shown in 
Fig. 23 (a-c). For very short separations, the coefficient of determination, R
2
, started as 
an increasing function and peaked at 0.45 mm separation with a peak value of 0.9941. 
Past this point, R
2
 showed a decreasing trend and reached 0.9795 (0.7022) at 1.05 mm 
(10.05 mm) separation. As for the slope of the linear fit, it showed a similar trend with 
increasing source-detector separation as the signal S which was expected (Fig. 23-d). 
The coefficient R
2
 shows that, although the slope representing the signal level is 
highest for the shortest separation (Fig. 23-d), the optimal spacing where the signal 
correlates best with changes in the vessel lumen is at 0.45 mm. This is shown in Fig. 
23(a-c) where the slope and intensity values are the highest in panel (a) (d = 0.15 mm) 
while the photon fluence doesn’t correlate with oxygenation as closely as in the top right 
panel (d = 0.45 mm). 
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Fig. 23. Photon fluence vs. oxygenation level. The three panels (a-c) correspond to three 
different source-detector spacings indicated in the inset legends. At 0.45 mm separation, 
the change in diffuse reflection correlates well with the oxygenation changes (R
2 
= 
0.994) and the slope of the linear fit is high (0.00844) indicating a good sensitivity to 
oxygenation changes. Panel d shows the changes of the R
2
 factor and the slope as a 
function of the source to detector separation.  
 
 Although the principle we used in optimizing the source-detector separation 
relies on changing the oxygen saturation of the blood and monitoring its effect on the 
collected diffuse reflectance, the results stand true for any change in the optical 
properties of the blood whether they were due to oxygenation, perfusion or hematocrit 
variations. 
As mentioned earlier in the introduction, this sensor can be used to monitor 
perfusion and oxygenation in many other visceral organs. Since the optimal source-
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detector separation is a function of the optical properties and the dimensions of the 
vessel under investigation, the results presented in this paper stand true only for the case 
of the portal vein. However, the same methods employed in this chapter can be used to 
define the optimal source-detector separation for similar applications. 
Chapter Conclusions 
Source to detector separation is a major factor in optimizing the performance of 
any diffuse reflectance based optical sensor. This becomes more important in the case of 
implantable biosensors where power consumption is of significant concern. In this work, 
we modeled the performance of an implantable perfusion and oxygenation sensor and 
found a source-detector separation of around 0.5 mm to be optimal in the case of a point 
source. Closer placement of the detector yields very high background intensity while 
moving the detector further than 1.2 mm shows a rapid decay in total intensity and signal 
levels. For the more realistic case of a 4.5 mm diameter LED package and a 2.4 mm x 
2.5 mm photodetector, it was shown that the highest signal is collected with the source 
and detector placed right next to each other. However, similar to the point source case, it 
was shown that larger separations lead to higher SBR.  
The results were compared to data collected from in vitro phantom studies. We 
reported a dye solution mimicking the absorption properties of the two oxygenation 
states of blood. These mixtures can be useful in characterizing and testing any optical 
sensor that probes blood. We used these mixtures to perfuse a phantom mimicking the 
optical and anatomical properties of the portal vein and the results were used to verify 
our modeling data. The in vitro data showed similar trends to those of the MC model 
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with some contribution from the system/hardware noise that caused the SBR ratio to 
show a decreasing trend past 6-8 mm source-detector separation. In the remainder of this 
dissertation, a 2 mm (edge to edge) separation was used in all experiment unless 
otherwise indicated. 
In addition, the filter design for the high amplification AC channel was 
discussed. The results show that a 4
th
 order filter with a 3 dB cut-off frequency of 0.5 Hz 
enhances the signal to background ratio on the AC channel substantially. These findings 
were later tested in vivo as shown in Chapter V and lead to a significant enhancement in 
the performance of the system by avoiding amplifier saturation from background signals. 
Finally, the wavelength effects on the penetration depth and oxygenation signal were 
investigated and the penetration depth was found to be relatively constant throughout the 
700 – 1000 nm range which has several bands that can be potentially used for oxygen 
saturation measurements. 
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CHAPTER III 
THEORY AND SIGNAL PROCESSING 
 
Light Propagation in Tissue 
One of the challenges in the proposed sensor is the ability to separate the venous 
and arterial oxygenation signals. As described earlier in chapter I the collected light 
intensity from an NIRS sensor contains information about both arterial and venous 
oxygenation. The signal also contains very valuable information about the biomechanics 
of the tissue that is commonly ignored. In this chapter, we review some of the theory 
behind pulse oximetry and near infrared spectroscopy, the two main techniques used in 
this sensor. 
When light is shined on tissue, it is scattered and absorbed by the various 
chromophores present in the medium. This process is described by the Beer-Lambert 
Law highlighted in equation III.1. 
 lcII ..exp.0    (III.1) 
This equation explains that the collected light intensity (I) is a function of: the 
source intensity (I0), the extinction coefficient of the chromophore (), the chromophore 
concentration (c), and the optical pathlength (l). Any change in these parameters is 
reflected as a variation in the collected light intensity. 
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In tissue, there are many chromophores and equation III.1 is expanded to include 
the contribution of all chromophores. The resulting absorbance is the sum of all 
individual absorbances as shown in equation III.2.  






 
i
iii lcII ..exp.0   (III.2) 
The source intensity term is usually known and kept constant. The extinction 
coefficients of chromophores of interest are known and do not change. The pathlength 
term can be estimated using theoretical formulas [76], or measured [33, 47]. This leaves 
the chromophores concentration unknown. Measuring the collected light intensity at 
multiple wavelengths can be used to quantify each chromophore concentration. The 
number of wavelengths needed depends on the number of chromophores of interest. An 
oximetry sensor has to measure two chromophores at least, oxygenated hemoglobin and 
deoxygenated (reduced) hemoglobin. This requires a minimum of two wavelengths. 
Temporal Frequency Analysis 
Because of changes in the propagation medium, the optical pathlength, described 
above, is a function of time (equation III.3). Different phenomena cause this factor to 
change which results in a modulation of the chromophore concentration signal. This 
property can be used to isolate different components of the signal. This concept is the 
basis of pulse oximetry [36, 77]. The absorbance signal has many frequency components 
that correspond to a variety of physiologic processes, noise, and background changes. 
Some of these frequencies are: heart rate, respiratory rate, low frequency vascular 
autoregulation, and motion artifacts as shown in equation III.4. 
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          tAItlCtItI LED
i
iiiLEDPD ,exp...exp.,,  





   (III.3) 
  
The first two components shown in equation III.4 are the AC signal while the last 
one is the DC level. Notice that the DC component is not a function of time. The 
chromophores in the DC component include: arterial blood, venous blood, and 
surrounding tissue. Changes in the signal at the heart rate (component 1 in equation 
III.4) are due to changes in the arterial blood volume between the systolic and diastolic 
phase. This component is isolated and used to extract information about arterial blood.  
The system described in this thesis utilizes the first and third component of 
equation III.4. The first component is extracted from the AC signal to measure arterial 
changes. The DC component is used to measure tissue oxygenation levels. Knowing the 
arterial oxygenation, the venous component can be extracted from the tissue oxygenation 
levels. The AC and DC components are also used to measure the perfusion index (PI), 
that tracks the pulse volume, and the tissue total hemoglobin concentration respectively. 
The following sections in this chapter describe the origins of the AC and DC signals and 
the flow of the signal processing used in the described sensor. 
 
 
                
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i
iii lCtlCtlCtlCtA ........,   (III.4) 
Heart rate Other frequencies    DC component 
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AC Signal 
The assumption used in pulse oximetry is that the signal at the heart rate is solely 
due to changes in arterial blood. When other frequencies are filtered out, the only 
chromophores contributing to the resulting signal are those present in the blood, which 
are dominated by the various forms of hemoglobin. Assuming that the only forms of 
hemoglobin present are oxygenated and deoxygenated hemoglobin for simplicity, the 
heart rate component of equation III.4 can be reduced to the form below: 
           lCClClCtA HbHbHbOHbOHbHbHbOHbO  ......., 2222   (III.5) 
The change in optical pathlength between systole and diastole is represented by 
l. This change is due to the varying blood volume in the interrogated tissue during the 
cardiac pulse and can be used to track pulsatile perfusion changes. 
As mentioned earlier, multiple wavelengths are needed to obtain oxygenation 
information. Using a pair of wavelengths (R and IR), and taking the ratio of the two as 
shown below (equation III.6), we get the modulation ratio (R) that is used in pulse 
oximetry to track arterial oxygenation changes.  
 
 
    
     lCC
lCC
tA
tA
R
HbIRHbHbOIRHbO
HbRHbHbORHbO
IR
R



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,
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



 (III.6) 
Rearranging the equation above, R can be written as a function of arterial oxygen 
saturation (SaO2): 
      
       22
22
.
.
SaO
SaO
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
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

  (III.7) 
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DC Signal 
In addition to the background, the DC signal carries information about 
hemoglobin oxygenation changes that is typically not used in pulse oximetry. Figure 24 
shows the change in the DC levels on three wavelengths (735, 805, and 940 nm) 
collected in vivo during a breath hold that causes the oxygenation levels to drop. Note 
that the 805 nm wavelength is at an isobestic point and does not change significantly 
during oxygenation changes. Although the absolute change in the DC levels are small 
(left panel), the normalized signals show a significant change over a 50 seconds period. 
The processing methods used with the AC signal do not need to quantify the 
optical pathlength to get a measure of oxygenation changes. However, to get quantitative 
oxygenation measurements using the DC component, the optical pathlength has to be 
measured or estimated. The optical pathlength is a function of the optical properties of 
the propagation medium and the optodes separation. The Beer-Lambert law is typically 
modified when studying highly scattering media [78]. The modified Beer-Lambert law 
(MBLL) incorporates an additive term describing the scattering losses and a multiplier to 
account for the increase in optical pathlength caused by scattering of light. The 
pathlength correction factor is referred to as the Differential Pathlength Factor (DPF). 
MBLL can be written as: 
GDPFdC
I
I
A 





 ...log 010    (III.8) 
Where d is the optode separation (source to detector separation) and G is the 
additive term describing scattering losses. Although G is unknown, it does not change 
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over time and by measuring the change in attenuation (A) between two different time 
points, we can rewrite equation III.8 to eliminate the additive term. The change in 
attenuation is commonly referred to as differential attenuation. 
 
 
Fig. 24. Absolute (a) and relative (b) DC changes during a breath hold porcine 
experiment.  
 
DPFdCA ...    (III.9) 
This equation can be expanded to account for the two chromophores of interest 
(i.e. oxygenated and reduced hemoglobin): 
DPFdCA
i
ii ...
2
1
, 





 

   (III.10) 
Combining measurements from two wavelengths, we get a system of two 
equations with two unknowns that can be written in matrix form as shown in equation 
III.11. Solving these equations gives the relative changes in oxygenated and 
deoxygenated hemoglobin concentrations (HbO2 and Hb respectively). The sum of 
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the two is the relative change in total hemoglobin concentration (III.11-a) while the 
difference is the hemoglobin oxygenation index (III.11-b) commonly used to track tissue 
oxygenation changes [79]. 

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 (III.11) 
 HbHbOHbT  2  (III.11-a) & HbHbOHbD  2   (III.11-b) 
Processing Flow 
The pulsatile signal tracks arterial changes and can be used, as described earlier, 
to track pulsatile perfusion and the arterial oxygen saturation (SaO2). The trends in 
pulsatile perfusion are tracked using the perfusion index (PI=AC/DC). The arterial 
saturation can be computed using the modulation ratio (equation III.7) and a calibration 
algorithm. The hemoglobin oxygenation index described earlier is a function of arterial 
and venous oxygenation as shown in equation III.12. Knowing SaO2 and having the 
calibration factors, we can compute SvO2 from the measured HbD. In addition, the 
total hemoglobin concentration can be measured as shown earlier to track perfusion 
changes. Figure 25 shows a flow diagram of the processing method. 
cSvOvSaOaHbHbOHbD  222 ..  (III.12) 
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Fig. 25. Signal processing flow diagram  
 
Chapter Conclusions 
When light is shined on tissue, the collected optical signal has an AC and a DC 
component. Both components carry information about the tissue hemodynamics and can 
be used to assess perfusion and oxygenation changes. The AC signal carries information 
about the pulsatile blood which is typically the arterial blood. Note that in the case of 
hepatic tissue, the pulsatile blood is not completely arterial and it has a venous 
component since this tissue is supplied by an artery (hepatic artery) and a vein (portal 
vein). However, this pulsatile signal is still considered the supply blood and it carries 
information about oxygen supply to the tissue. This issue will be discussed in further 
details in chapter V.  
To get oxygenation information, a minimum of two wavelengths is needed since 
oxygenation is controlled by the concentration of two chromophores (oxygenated and 
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deoxygenated hemoglobin). In addition, at least one of the two wavelengths has to be 
sensitive to hemoglobin oxygenation changes. Figure 26 shows an example on how the 
signal changes during hypoxia and decreased perfusion on three wavelengths that have 
different sensitivity to hemoglobin oxygenation. The 805 nm is an isobestic wavelength 
and is not affected by oxygenation changes. The 735 nm has a higher absorption 
coefficient for deoxygenated hemoglobin while the 940 nm is absorbed more by 
oxygenated hemoglobin. Note how during hypoxia the amplitude of the 735 and 940 nm 
signals are flipped relative to the unchanged 805nm signal (relative to baseline). 
 
 
Fig. 26. Changes in the AC signal during vascular occlusions (red) and hypoxia (blue) 
at three different wavelengths (735, 805, and 940 nm).  
 
In the following chapter, we will test the performance of the sensor and the 
processing techniques described in this chapter in a series of ex vivo and in vitro studies. 
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CHAPTER IV 
IN VITRO AND EX VIVO TESTING
*
 
 
Introduction 
To minimize the need for animal studies during the optimization and testing of 
the sensor, phantoms mimicking the optical, mechanical, and anatomical properties of 
hepatic tissue were developed and tested. This is a common practice used to evaluate and 
optimize optical techniques, and compare performance of various systems [80]. There 
are numerous liver phantoms for non-optical techniques such as CT and MRI [81-90]. In 
addition, some optical phantoms have been reported to mimic optical properties of 
hepatic tissue for specific wavelengths and most of them are in the aqueous phase which 
is not suitable for perfusion studies required to evaluate a perfusion sensor [91, 92]. 
However, no functional fluidic phantoms have been reported in the literature to mimic 
optical, anatomical, and mechanical properties of liver tissue. In this chapter, we will 
describe a new set of phantoms that mimic these properties along with the fluidic circuit 
                                                 
*
 Part of this chapter is reprinted from T. J. Akl, R. Long, M. J. McShane et al., “Optimizing 
probe design for an implantable perfusion and oxygenation sensor,” Biomed Opt Express, 2(8), 
2096-109 (2011), with kind permission of OSA, Copyright 2013 by The Optical Society; and 
from R. Long, T. King, T. Akl et al., “Optofluidic phantom mimicking optical properties of 
porcine livers,” Biomed Opt Express, 2(7), 1877-92 (2011), with kind permission of OSA, 
Copyright 2013 by The Optical Society; and from T. J. Akl, T. J. King, R. Long et al., 
“Performance assessment of an opto-fluidic phantom mimicking porcine liver parenchyma,” J 
Biomed Opt, 17(7), 077008 (2012), with kind permission of SPIE, Copyright 2012 by Society of 
Photo Optical Instrumentation Engineers; and from T. J. Akl, T. J. King, R. Long et al., “In vitro 
performance of a perfusion and oxygenation optical sensor using a unique liver phantom,” Proc. 
SPIE, 8229, (2012), with kind permission of SPIE, Copyright 2012 by Society of Photo Optical 
Instrumentation Engineers. 
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used to mimic blood perfusion and the dye mixtures used to mimic the different 
oxygenation states of blood. These phantoms and dye mixtures were used in a series of 
in vitro and ex vivo studies to assess the performance of the reported sensor. But first, we 
start by describing the anatomy of the liver and the properties that the phantoms were 
designed to mimic. 
Liver Anatomy 
The liver is a highly vascularized organ. It stores around 450 milliliters of blood 
(almost 10% of the total blood volume) and around 1450 mL of blood flow into the liver 
every minute which amounts to 29% of the resting cardiac output [1]. It is supplied with 
blood by two major vessels: the hepatic artery (HA), and the portal vein (PV). The HA 
supplies around 25% of the total hepatic blood flow (350 mL/min) while the PV is 
responsible for the remainder 75% (1100 mL/min). Although the PV is supplying blood 
and takes the role of an artery, it is a vein and the blood it carries has been deoxygenated 
in the spleen and gastrointestinal tract. The PV supplies around 25% of the total hepatic 
oxygen while the rest is supplied by the HA. The dimensions of the HA and PV are 
shown in Table 1 (Chapter II). The hepatic parenchyma is made of hexagonal structures 
known as lobules. Each lobule is several millimeters in length and 0.8 to 2 millimeters in 
diameter. The lobule is constructed of small microchannels, known as sinusoids, 
transporting blood from the corners of the hexagon to the center point where a central 
vein is located that transports blood into the hepatic vein and thence into the vena cava. 
Each corner of the hexagon has an arrangement named the portal triad. This arrangement 
consists of a portal vein, a hepatic artery, a common bile duct, lymphatic vessels, and a 
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branch of the vagus nerve.  The diameter of the sinusoids connecting the portal triad to 
the central vein is around 8.8 µm [93]. Figure 27 shows a schematic of a hepatic lobule 
[94]. The liver is made of 50,000 to 100,000 lobules stacked next to each other to form 
the parenchyma [1].  
 
 
Fig. 27. Schematic of liver lobules showing the structure of the sinusoids, the portal 
triad, and the central vein [94].  
 
Three types of phantoms are desired for the testing of the perfusion and 
oxygenation sensor: PV & HA phantoms for testing of vascular sensors and a 
parenchymal phantom mimicking a slab of 10 mm x 10 mm x 2 mm of liver tissue for 
testing of parenchymal sensors. All phantoms had to meet the following criteria: 1) 
match the optical properties of hepatic tissue in the range that covers all the wavelengths 
of interest (630 – 1000 nm); 2) mimic the anatomical properties of the HA, PV, and the 
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hepatic parenchyma; 3) allow for adjustment of flow/perfusion state in the physiological 
ranges of the liver; 4) provide good thermal stability and low chemical reactivity for 
possible use with blood and other perfusate at various temperatures; and 5) possess 
elastic properties that allows the phantoms to deform and regain native shape when 
perfused with low frequency (0.5-5 Hz) pulsatile flow. 
Soft lithography was used to produce silicone-based phantoms with various 
geometries to match the hepatic vasculature. Dyes and scatterers were added to the 
mixture to match the desired optical properties. The curing parameters were adjusted to 
control the mechanical properties. In the following sections of this chapter, the materials 
and methods used to fabricate these phantoms are explained in details followed by 
testing results to verify compliance of the phantoms with the aforementioned criteria. 
Materials and Methods 
Phantoms Materials and Recipe 
Polydimethylsiloxane (PDMS) was chosen as the main constituent in the 
designed phantoms (SYLGARD® USA). PDMS is easy to handle, stable once cured, 
chemically inert, and has a low viscosity making it suitable for surface preparation and 
soft lithography applications [95]. In addition, its optical properties are suitable for soft 
tissue phantoms. It is optically clear and has a refractive index (~1.4) similar to that of 
soft tissue (1.33-1.50) [96]. To mimic the optical properties of tissue, a combination of 
various scatterers and absorbers were mixed with PDMS. This recipe was developed and 
tested by Long et al.[97]. The recipe was prepared by mixing 437.4 mg of 0.5-1 μm 
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Al2O3 powder (99.99% purity, average particle size: 0.5-1μm, Inframat
®
 Advanced 
MaterialsTM), 120 mg of 100 nm Al2O3 powder, 4.02μL of black India ink (Higgins, 
Black India 4415), 120 μL of blue food coloring (Wilton®), and 60mL PDMS resin. 
Long et al. showed that this formula has similar optical properties to liver tissue [97]. 
Figure 28 shows the effective attenuation coefficient of hepatic tissue and the PDMS 
recipe [97]. The mixture was sonicated and stirred until homogeneously distributed. 
Then, curing agent was added to the mixture and stirred until uniform. The amount of 
curing agent added was differs depending on the desired mechanical properties as 
described later in this chapter. Vacuum was applied to degas bubbles in the mixture. 
Finally, the mixture was cast into a petri-dish containing a mold that mirrors the anatomy 
of either the HA, PV, or hepatic parenchyma and placed in an oven for curing. The 
following section presents the details of the various molds used and the curing process. 
 
 
Fig. 28. Effective attenuation coefficient of the prepared liver phantom compared to 
hepatic tissue [97].  
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Molds & Phantoms Fabrication Process 
Vascular Phantoms 
To mirror the anatomy of a blood vessel embedded in tissue, a plastic tube (8 mm 
in outer diameter for the PV or 3 mm for the HA) was fixed in a petri-dish (40 mm in 
diameter) at 1 mm above the bottom surface as shown in Figure 29-a. The PDMS was 
poured into the petri-dish until the tube is completely covered and then placed in the 
oven to corss-link the PDMS. Different curing parameters (temperature and time) were 
used depending on the desired mechanical properties as described in the following 
section. Once the PDMS was completely cross-linked, the phantom was left at room 
temperature for a minimum of 2-3 hours before being removed from the petri-dish and 
the tube taken out of the PDMS. Two small tubes were placed on the sides of the hollow 
structure and were sealed with silicone to make the connection to a flow circuit simple. 
This resulted in a hollow structure that resembles a vessel embedded in tissue as seen in 
Figure 29-b. Slabs from the same recipe were also fabricated for use in case extra 
thickness above or below the initial design is needed.   
 
 
Fig. 29. Drawings of the portal vein phantom (b) and the mold used to prepare it (a).  
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Parenchymal Phantoms 
Blood flow in the hepatic parenchyma goes through the sinusoids that range in 
diameter between 5.9 and 7.1 µm [98]. SU-8 molds were fabricated to mirror a cross-
section of an arrangement of lobules.  
A pattern of a cross-section of lobules was designed with computer aided design 
(CAD) software (Rhinoceros 4.0). The pattern consists of adjacent hexagons with 0.5 
mm vertices. At each intercept of vertices, a cylinder of 0.06 mm diameter was placed to 
mimic the hepatic artery and portal vein branches in the portal triad. In the center of the 
hexagon lies a cylinder of 0.1 mm diameter mimicking the central vein. A series of 10 
µm wide micro-channels radiate outward from the center of the hexagon to the sides as 
shown in Figure 30 mimicking the liver sinusoids. All these structures are 50 µm high. 
To supply all channels with flow, the sides of adjacent hexagons were 
interconnected. The design included two inlets that can be connected to a flow circuit 
mimicking the portal vein and hepatic artery supplying the liver and one outlet that takes 
the function of the hepatic vein draining the effluent solution from the microchannels. A 
pattern of 20x20 hexagons was printed onto a transparent film with a black background 
and clear features to be used as the mask for photolithography.  
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Fig. 30. Designed microfluidic pattern to mimic the parenchymal microcirculation.  
 
These masks were used to create the molds of the parecnchymal microcirculation 
on silicon wafers. The silicon wafers (4 inch in diameter) were cleaned first in 
hydrochloric acid at 80˚C for 20 min and then rinsed with acetone, isopropyl alcohol 
(IPA) and deionized (DI) water. The wafers were then dried on a hot plate set at 130˚C 
for 30 minutes. The wafers were left at room temperature to cool down and then 4 mL of 
degassed SU8-50 photo-resist (MicroChem) were dispensed on the center of the wafer 
placed in a spin coater. The wafer was spun at 500 RPM (acceleration rate of 100 
RPM/s). Once that speed was reached, it was held constant for 10 seconds which 
allowed the photo-resist to cover the full surface of the wafer. The speed was then 
increased to 2000 RPM with an acceleration rate of 300 RPM/s and held constant at that 
level for 30 seconds. This results in a 50 µm thick layer of SU8-50 on top of the wafer. 
The photo-resist was then placed on a hot plate and baked on two steps: 1) 65˚C for 10 
min (pre-bake); 2) 95˚C for 20 min (soft bake). After the wafer cooled down, the mask 
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described above was placed on top of the photo-resist in a closed collimated UV lamp 
for 32 seconds. This was followed by another two step bake: 1min at 65˚C followed by 
5min at 95˚C. After cooling down, the wafer was placed in a 7 inch glass dish containing 
the SU8 developer solution and left there for 6 min. The dish was shaken gently multiple 
times during the development process to ensure that the uncross-linked portion of the 
photoresist was dissolved completely. The wafer was then removed from the solution 
and rinsed with IPA then dried with a gentle stream of air. Finally the wafer was baked 
at 135˚C for 2 hours to ensure complete crosslinking of the SU-8 mold. 
Similar to the vascular phantoms, degassed PDMS was poured onto the 
micropatterned mold and left on a level surface till it stabilize and covers the entire 
wafer. The volume of the PDMS used for each layer was calculated according to the 
desired thickness of the layer (~0.5 mm). The PDMS on the micropatterned mold was 
degassed again to remove any air bubbles trapped between channels. Depending on the 
number of the desired layers of microfluidics, multiple of these molds were used. In 
addition, an empty petri-dish without any mold in it was used to make the base layer (~5 
mm thick) that is required to seal the other side of the microchannels. The PDMS 
covered molds and the petri-dish were placed in a preheated oven at 65˚C for 50 min to 
pre-cure the PDMS. Holes that align with the inlets and outlet of the microfluidic pattern 
were made in the base layer using 20-gauge needles. The PDMS layer was then carefully 
peeled from the micropatterned mold. The microfluidic PDMS layer and the base layer 
were corona treated and attached to one another making sure that the access ports align 
with the holes in the base layer. Flat tipped needles were inserted in the holes to allow 
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for connecting the channels to the flow circuit when needed. When extra layers of 
microfluidic channels were desired, the bonding process was repeated by using the 
obtained phantom (base layer + channels) as the base layer for the following layer and 
making sure that the access ports on the following layer do not overlap with any 
channels in the previous layer(s). Finally, the bonded PDMS layers were baked at 65˚C 
for an extra 70 min to completely cure the PDMS. In the studies described in this 
dissertation, two types of parenchymal phantoms were used: 1) Single layer phantoms 
consisting of one layer of microfluidic channels and 2) Multilayer phantoms consisting 
of three layers of microfluidic channels. Figure 31 shows a schematic of the multilayer 
phantom. Note that the different layers of the phantom are not interconnected in the 
phantom. However, the flow circuit can be adjusted to get the same supply to all layers. 
 
 
Fig. 31. Schematic of a three-layer phantom showing the various layers and the 
corresponding access ports with different colors.  
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The phantoms were left a room temperature over night with the layers 
compressed before being connected to the flow circuit. In addition, prior to any flow 
studies, the phantoms were perfused with either DI water or a dye solution to test for 
leakage. Figure 32 shows pictures of clear phantoms (PDMS without the dyes and 
scatterers) perfused with a red dye to highlight the channels. 
 
 
Fig. 32. Images of clear phantoms perfused with a red dye to visualize the channels: (a) 
single layer phantom, (b) close up look at the microchannels in a single layer phantom, 
and (c) three layers phantom.  
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Phantoms’ Mechanical Properties 
The PDMS curing process determines its mechanical properties. Various 
parameters can be adjusted to vary the elasticity of the PDMS phantoms including the 
concentration of the curing agent, the curing temperature, and the curing time [99]. 
These parameters were varied to build phantoms with different mechanical properties 
that mimic those of normal liver tissue and different disease states that lead to loss of 
tissue elasticity [70, 95, 100]. For most perfusion and oxygenation studies described in 
this dissertation, the PDMS was mixed with the curing agent at a volumetric ratio of 
10:1 and cured at 65ºC for 120 min, unless otherwise indicated. 
When preparing the phantoms, a portion of the recipe used in each phantom was 
put in a separate petri-dish (40 mm in diameter) and cured with the phantom (same oven, 
curing time, and curing temperature). This slab (1-3 mm in thickness) provided 2-3 
specimens of PDMS for testing the mechanical properties of the phantom. Tensile tests 
were performed on the specimens using an Instron 3345 Universal tester configured for 
tensile testing as shown in Figure 33. MATLAB (Mathworks, Inc., MA, USA) software 
was implemented to quantify the Young’s Modulus of each specimen from the collected 
data (Appendix D).  
 
 
  
67 
 
 
Fig. 33. Image of the Instron 3345 system used for testing the YM of the phantoms’ 
PDMS recipe. 
 
Hemoglobin Mimicking Dye Solutions 
To avoid handling whole blood that needs to be in a pH and temperature 
controlled medium, and requires oxygenators and blood analyzers to change and test 
oxygen levels, we formulated two dye solutions that have optical properties similar to 
circulating blood in its oxygenated and deoxygenated states [29, 31]. To mimic the 
absorption spectrum of whole blood in its deoxygenated state, we used a mixture of 
0.226% v/v India ink (Speedball Art, product number 3338) and 4.17% v/v inkjet photo 
cyan (Macro Enter, cat.# FPB085) dissolved in Phosphate Buffered Solution (PBS 0.1M, 
pH 7.4). The India ink has an extinction coefficient that covers all the wavelength bands 
of interest [101, 102] and it was used to create a baseline in the extinction coefficient 
  
68 
 
spectrum that matches the absorption in the near infrared wavelength range. The inkjet 
photo cyan was used to increase the absorption on the red side of the spectrum, a 
characteristic of the deoxygenated state of blood. On the other hand, the oxygenated 
state has a higher absorption in the NIR region and 358.8 mg/L of Epolight 2735 
(Epolin, Inc.) was used to increase the absorption in the NIR region along with 0.068% 
v/v of India ink in a PBS (0.01M, pH 7.4). The extinction coefficient of the two dye 
solutions compared to that of whole blood is shown in Figure 34. The absorption of the 
NIR dye (Epolight 2717) was found to be pH sensitive. Because the Inkjet Photo Cyan is 
highly acidic (low pH), when the HbO2 mimicking dye was mixed with the Hb 
mimicking mixture to mimic various oxygenation levels the HbO2 dye mixture changed 
its absorption profile (See data in Appendix B). In addition, the mixture was not very 
stable, changed its profile over time, and formed large aggregates that fell out of solution 
(Appendix B). To overcome that problem, a stronger buffer (PBS 0.1 M pH 7.4) was 
used with the Hb dye mixture to maintain its pH at 7.4 which resolved the problem. 
The dyes that were used with the microfluidic phantoms went through additional 
steps to make sure that they don’t contain any large aggregates that can clog the 
channels. First, the India Ink dye that was used was first diluted in PBS to 10 times the 
concentration needed for the final mixture. The diluted mixture was then filtered through 
0.45 µm syringe filters (VWR, cat. # 28145-481). The filter was changed multiple times 
during the filtration depending on the volume filtered solution due to clogging. The 
extinction coefficient of the filtered dye was measured to estimate the dye concentration 
in the filtered solution. The dye was then diluted to the desired concentration and mixed 
  
69 
 
with the other components as described above. Once the mixture was made, the final 
solution was sonicated and filtered through a 0.45 µm syringe filter. The sonication was 
performed prior to every phantom study if the dyes have not been sonicated on that day. 
Mixtures of the two dye solutions in various proportions were made to mimic 
different oxygenation states. The right panel of Figure 34 shows the extinction 
coefficient of these mixtures at the three wavelengths of interest. All extinction spectra 
were measured using a spectrometer (Ocean Optics USB-2000), a UV-VIS fiber coupled 
light source (Hamamatsu, part # L10290) and a fiber coupled cuvette holder. Mixtures 
were placed in a 1 mm glass cuvette (Starna cells, part # 1/G/1) for spectrum 
measurements. 
The extinction coefficient of the dye solutions matches closely to that of whole 
blood at the three wavelengths of interest (735, 805 and 940 nm). The isobestic point is 
red shifted when compared to the data reported by Prahl [31], however, there are 
inconsistencies in the reported isobestic point between different groups and it ranges 
between 797 nm [31] and 815 nm [103]. Our dye mixtures have an isobestic point, at 
807 nm, in between these two extremes. At 735 nm the extinction coefficient of the dye 
solution M1 does not match exactly that of the oxygenated state of circulating blood. 
This causes the dynamic range between the two dye solutions at 735 nm to decrease 
causing the resolution in detecting oxygenation changes to decrease. For the purpose of 
this paper, this is not problematic since the main goal is to determine the optimal probe 
design and the same dye solution will be used to compare all of the different designs. At 
940 nm, the two solutions match the desired extinction coefficients exactly. 
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Fig. 34. Absorption spectra of whole blood and the two dye solutions used in the in vitro 
setup. (Left panel) Extinction spectra of the dye mixtures (M1: HbO2 mixture, M2: Hb 
mixture) compared to hemoglobin’s spectra [31]. The LEDs emission spectra (shown in 
black) were scaled to match the scale of the extinction spectra. (Right panel) Extinction 
coefficient at the three wavelength of interest as a function of the simulated oxygen 
saturation [104].  
 
Flow System Setup 
To create the desired flow patterns, the phantoms were connected to two 
peristaltic pumps (MINIPULS 3, Gilson) driven by a LabVIEW virtual instrument (VI) 
via a data acquisition board (USB-6009, National Instruments). Two pumps were used 
only with the PV phantom to be able to reach the high levels of flow that mimic the 
normal physiologic flow (1100 mL/min). In the case of the microfluidic phantoms one 
pump was sufficient to get the desired flow levels; however the phantoms had to be 
preloaded with the desired dye solution prior to starting the pulsatile flow, as described 
in the following paragraph,  to avoid bursting the connections at the input and output 
ports. The VI used generated a square wave with a variable amplitude, frequency and 
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duty cycle (Appendix C). The VI allows the user to adjust the flow level, the pulse 
frequency to mimic the heart rate, and the pulse width. In addition, the VI also read data 
from a thermistor that was used to give the user feedback on the fluid temperature. This 
last feature was added for the ex vivo studies described later in this chapter. The tubing 
size was varied depending on the phantom used, the type of the experiment, and the 
desired flow rates. Prior to any data collection, the phantoms were perfused with the 
desired dye solution until no air bubbles were seen in the circuit. Figure 35 shows a 
schematic of the pumping circuit along with the electronics of the bench-top system (left 
panel) and a picture of the flow circuit with the single layer parenchymal phantom.  
The microfluidic phantoms were preloaded with the desired dye solution prior to 
the start of the pulsatile flow experiments to avoid bursting the phantom inlets and 
outlets due to the high levels of flow and the resistance of the microfluidic channels. 
Two syringe pumps were used to accomplish that: the first syringe pump (cat. # 70-
2208, Harvard Apparatus) was connected to the input ports and set to pump at a 
volumetric flow rate of 0.3 mL/min and 0.9 mL/min for the single and multilayer 
phantom, respectively, and the second syringe pump (New Era Pump Systems, Inc., NE-
4000) was connected to the output ports and set to withdraw at a rate of 0.35 mL/min 
and 0.95 mL/min for the single and multilayer phantom, respectively, creating a negative 
pressure gradient to help perfuse the phantoms without bursting the connections at the 
input and output ports [105]. 
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Fig. 35. Schematic (top) and image (bottom) of the in vitro pumping system, phantom, 
and bench-top sensor electronics [104] and [97].  
 
Ex Vivo Liver Perfusion 
The phantom experiments were designed to minimize the use of animal studies 
and ex vivo tissue studies. However, these studies were still performed in much smaller 
numbers to test verify the in vitro results. The ex vivo studies were performed by 
perfusing freshly harvested livers (rats and rabbits) with the aforementioned dye 
mixtures. Blood perfusion was tested first but many complications were encountered 
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especially with blood clotting and getting enough blood for the perfusion circuit. The 
following sections describe the organ harvesting procedure and the perfusion circuit used 
in these studies. 
Harvesting of the Liver 
Male Sprague-Dawley rats (250 – 300 g) were anesthetized by Isoflurane (3%) 
induction via a vaporizer in an anesthesia chamber. The animal was then placed on a 
water circulated heating pad, abdominal fur was clipped and chlorhexidine (an antiseptic 
antibacterial agent) was applied to the abdomen. After confirming adequate depth of 
anesthesia, a right subcostal incision was made to get access to the liver. The portal vein 
was dissected and ligated on the proximal side to avoid excessive bleeding. Tubing (PE 
200) was inserted into the portal vein and 1 mL of heparinized saline (20 units/mL) was 
injected. Next, the hepatic artery was ligated and dissected. The inferior vena cava was 
ligated and cut on the proximal side of the ligation. The liver was re-irrigated with 
heparinized saline until the effluent became clear. The liver was removed to an iced 
buffer container and moved to the perfusion system. The portal vein cannula was 
connected to the pump output in the perfusion chamber. Figure 36 shows a liver placed 
in the perfusion chamber prior to the start of the experiment. The animal was then 
euthanized via administration of pentobarbital intracardially. These experiments were 
performed at the University of Pittsburgh, Pennsylvania, and all procedures followed the 
local animal regulations.  
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Fig. 36.  Ex vivo perfusion chamber.  
 
Perfusion System 
After the liver was harvested, it was weighted and then placed in a flow circuit 
that allowed the adjustment of flow/perfusion levels. All flow levels were normalized by 
the tissue weight to get an average perfusion level. The main component of the flow 
circuit consisted of a Harvard apparatus perfusion system (Harvard Apparatus, Item # 
739909) that allowed for temperature control of the tissue and the solution used to 
perfuse it. In addition, it controlled the pressure levels at the input of the liver. The 
harvested liver was placed in the perfusion chamber and the cannula in the portal vein 
was connected to a pulsatile blood pump (Harvard Apparatus, Item # 529552). Flow 
levels were recorded using a Transit Time Flowmeter (Transonic systems). In these 
studies, the bench-top system was used with one probe placed on the hepatic tissue and 
another placed on the tubing upstream from the organ. Figure 37 shows the ex vivo flow 
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circuit. Note that the flow circuit was ran for a minimum of 1 hour prior to the placement 
of the organ to make sure that the temperature of the chamber and the fluid are stable at 
the desired levels (37-38ºC). Once the organ was ready to be connected to the circuit, the 
flow was paused and the cannula was connected then flow was initiated at 0.25 ml/min/g 
of liver tissue with a “pulse rate” of 100 cycles per minute. Flow was then maintained at 
this level for 10 minutes to get to assure stable temperature and flow rate. Data was then 
collected with the bench-top system and the flow was increased to 5-6 levels in the range 
of 0.1 – 1.5 mL/min/g tissue. Each level was maintained for a duration of 5 minutes or 
more during which data was collected for 2 min intervals. 
 
 
 
 
 
 
 
 
Fig. 37. Schematic (left) and image (right) of the ex vivo flow circuit.  
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Results 
In Vitro Phantom Studies 
Perfusion Studies 
The performance of the sensor in detecting changes in flow/perfusion was 
assessed in three types of phantoms: Portal Vein (PV) phantoms, Single Layer (SL) 
parenchymal phantoms, and Multi-Layer (ML) parenchymal phantoms. The PV phantom 
studies model the case of a sensor placed above a major vessel buried in hepatic tissue. 
For these studies, flow levels in the range of 0-500 mL/min were used. This range is 
lower than physiologic flow levels seen in the PV (~1100 mL/min). Our pumping 
system does not have the capability of covering the full range of flow with fine 
resolution; therefore the flow circuit was designed to get flow levels that mimic low 
physiologic levels that are seen during liver transplant complications and are more 
challenging for the sensor to pick up. During these studies, each flow level was 
maintained constant for at least 1 minute to let everything in the circuit stabilize then 
data was collected using the bench-top system described in Chapter II for a duration of 1 
to 2 minutes. The collected data was processed using an automated processing software 
implemented in MATLAB (Mathworks, Inc.) shown in Appendix E. The software 
computes the FFT spectrum on each of the wavelengths and detects the peak of the 
pulsatile flow which is then normalized by the DC level to calculate the perfusion index 
(PI) commonly used in PPG sensors to track pulsatile perfusion/flow [106]. 
PI=AC/DC 
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Figure 38 (left panel) shows a typical waveform collected with the bench-top 
system from one of the PV phantom studies. The right panel shows the FFT spectra 
corresponding to three flow levels (50, 150, and 250 mL/min). The flow pulse rate in 
this experiment was set to 70 bpm (1.167 Hz). The frequency peak corresponding to the 
pulsatile flow and multiple harmonics can be seen at all three flow levels. The amplitude 
of the peak, which was used to measure the AC amplitude, changes with the flow level. 
Note that the DC levels are not shown in this graph. 
 
 
Fig. 38. A typical waveform measured from the portal vein phantom and the 
corresponding FFT spectrum for multiple flow levels (left and right panel respectively) 
[104]. Note the change in the FFT peak amplitude with flow and the multiple harmonics 
measured.  
 
Figure 39 below shows the perfusion index (PI) as a function of the flow level on 
three separate experiments. The error bars represent the standard deviation. The flow 
was changed in different directions for the separate runs (increased, decreased, and then 
increased again). During these studies the phantoms were perfused with the same dye 
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mixture, mimicking oxy-hemoglobin, for all flow levels. The perfusion index shows a 
non-linear trend with flow. This is due to the mechanical properties of the phantom and 
is similar to the non-linearity seen in the stress-strain curves. If we limit the data to flow 
levels between 0 and 250 mL/min, the root mean squared error for predicting flow using 
a linear model is 13.48, 16.55, and 19.19 for the 940, 805, and 735 wavelengths 
respectively. 
 
 
Fig. 39. Perfusion index as a function of flow measured from the portal vein phantom 
experiments.  
 
Similar experiments were used to assess the performance of the bench-top system 
in detecting perfusion levels in the microfluidic phantoms. Prior to starting the pulsatile 
flow, the phantoms were preloaded with the desired dye solution using two peristaltic 
pumps as described earlier in the “Materials and Methods” section of this chapter. A 
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similar setup was used to perfuse the phantoms with the dye mixtures. In these 
experiments, a single peristaltic pump was used with smaller tubing sizes compared to 
the PV experiments. The pump frequency was set at 100 bpm (1.67 Hz) to approximate 
the cardiac pulsatile rate seen during the in vivo porcine data. Figure 40 shows 10 second 
intervals of the pulsatile wave measured from the SL phantom, ML phantom, and in vivo 
porcine studies and the corresponding FFT spectra. The FFT spectra show that the 
pulsatile flow peak can be seen in the FFT spectra of the microfluidic phantoms and 
multiple harmonics can be seen as well. In addition there are some low frequency 
components that we will discuss later in this section. 
The average physiologic flow to the liver is 1450 mL/min [1]; however, this flow 
is divided to between the approximately 1 million lobules that constitute the 1.5 Kg of 
liver tissue (~0.967 mL/min/g tissue) [1]. Our phantoms mimic a small section of the 
liver that contains 20*20 lobules in each layer. This means that each layer of the 
phantoms should receive around 0.58 mL/min (1450*400/1,000,000) to mimic the 
physiologic rate of 0.967mL/min/g of tissue.  In these studies, each layer was perfused 
with 0.6 mL/min when mimicking the physiologic conditions. This corresponds to 1 
mL/min/g of tissue. All other flow levels are reported in terms of hepatic perfusion 
levels in mL/min/g of tissue using this same reasoning. 
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Fig. 40. Pulsatile wave (left) and the corresponding FFT spectrum (right) from the 
single layer phantom, multilayer phantom, and in vivo porcine studies (top to bottom 
respectively).  
 
For the SL phantom, the flow was varied between 0.2 and 0.6 mL/min in 0.1 
mL/min steps which is equivalent to perfusion levels in the range of 0.33 to 1 mL/min/g. 
The FFT peak changed linearly with perfusion changes. The root mean squared error of 
prediction   (RMSE) is 0.077, 0.078 and 0.071 mL/min/g of tissue for the 735, 805, and 
940 nm wavelengths respectively. Figure 41 shows the average FFT peak of 4 
experiments on each of the wavelengths as a function of perfusion level. The error bars 
correspond to the standard deviation. 
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Fig. 41. Results of the single layer phantom perfusion experiments [105].  
 
For the ML phantom, the flow was varied between 0.76 and 1.8 mL/min which 
corresponds to perfusion levels in the range 0.42 to 1 mL/min/g of tissue. Using the 
normalized FFT peak, we were able to predict the perfusion level with an RMSE of 
0.0718, 0.066, and 0.062 mL/min/g for the 735, 805, and 940 nm wavelengths 
respectively. Note that in both SL and ML phantom studies, the results were normalized 
to the FFT peak at the 1 mL/min/g perfusion level. This is required because this method 
is not quantitative and monitors trends in perfusion. Figure 42 summarizes the results of 
the ML phantom studies. 
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Fig. 42. Results of the three layers phantom perfusion experiments [105].  
 
The measured signal from the microfluidic phantoms had a low frequency 
component (around 0.833 Hz). We believe this frequency component corresponds to 
back flow due to pressure build up in the circulation system. To verify this hypothesis, 
since our measurements are not sensitive to flow direction, air bubbles were introduced 
in the circulation and the flow pattern monitored visually.   In this experiment, back flow 
was depicted at the corresponding frequency. To better understand this phenomenon, the 
flow levels were varied in the SL phantom experiment which resulted in a linear shift of 
the peak (R
2
=0.9997) as shown in Figure 43. This was expected since for higher flow 
levels the pressure builds up faster and the frequency of the back flow was higher. 
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Further, the amplitude of the peak did not correlate to the changes in flow level. This 
peak could be varied by adjusting the mechanical properties of the fluidic system either 
by changing the curing method of the PDMS as described earlier, or modifying the 
tubing (material or size) used in the system. Preliminary studies were conducted to 
verify this hypothesis and we were able to shift the low frequency peak from 0.833 Hz to 
0.55 Hz at a constant perfusion level of 1 ml/min/g by using a more compliant phantom. 
This peak can be adjusted to mimic different noise artifacts seen in vivo such as the back 
pressure seen in vivo in the venous system due to respiration. 
 
 
Fig. 43. Back pressure peak frequency as a function of perfusion levels for the single 
layer phantom. Note that the plot has 16 data points at three different flow levels but 
most of these points are overlapping.  
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Oxygenation Studies 
After preparing the two dye mixtures mimicking oxy- and deoxy-hemoglobin, 
the two solutions were mixed in different ratios to model oxygen saturations between 50 
and 100% in steps of 5% as shown previously in Figure 34. The PV phantom was 
perfused with these mixtures at a rate of 500 mL/min and the collected data was used to 
measure the modulation ratio (R) used in pulse oximetry to measure oxygen saturation. 
The modulation ratio as a function of oxygen saturation is shown in Figure 44. The error 
bars correspond to +/- one standard deviation that was computed from three runs. After 
collecting data for 1-2 minutes on every oxygenation level in every run, the dye solution 
was pumped out of the dye and collected for later studies. The phantom was then 
perfused with the new dye solution and the mixture was left to circulate through the 
circuit for 1-2 minutes prior to collecting any data. This allowed time to eliminate air 
bubbles from the circuit and make sure there are no residues of the previous mixture in 
the circuit. The optical probes were not moved during this experiment to minimize 
changes in light coupling. 
940
940
735
735
DC
AC
DC
AC
R   
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Fig. 44. Modulation ratio measured from the PV as a function of oxygen saturation. The 
error bars correspond to the standard deviation on three runs. Note that every SO2 
value corresponds to a dye mixture that mimics the optical properties of hemoglobin for 
that saturation level.  
 
The error of prediction of oxygen saturation using the modulation ratio shown 
above was around 1.3 % when using data from a single run and 4.6% when using the 
averages shown in the figure above. This is on the order of the prediction error using the 
extinction coefficient of the prepared dye mixtures which is 3.7% and 2.4% for the 735 
and the 940 nm wavelength respectively. 
Waveform Analysis 
The PPG contains information in its amplitude, frequency, phase, and waveform 
[35]. Most common PPG sensors utilize only the amplitude and frequency of one or 
multiple wavelengths to measure perfusion [42, 45, 106], oxygenation [41, 107],  and 
heart and respiratory rates [54, 108]. The phase and waveform of the measured pulse 
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contain information about blood pressure [109], and cardiovascular health and 
mechanical properties [35, 75, 110-112]. In this section, we will present some 
preliminary results on analyzing the pulse shape to get information about hepatic tissue 
and assess the origin of vascular complications when they take place.  
The measured pulse in PPG is affected by the mechanical properties of the 
cardiovascular system. In this chapter, we start by studying the effect of tissue 
compliance on the measured PPG signal. A device that can quantify the mechanical 
properties of hepatic tissue non-invasively would be of interest for many applications 
including staging liver fibrosis. As liver fibrosis progresses, the elastin to collagen ratio 
increases [113] and the crosslinking is increased [114]. These changes lead to an 
increase in tissue stiffness [95] which affects the response of tissue to flow and governs 
the shape of the pulse. To mimic these changes, we used different curing methods in 
building the vascular PDMS phantoms as described earlier. The Young’s Modulus (YM) 
was varied between 15 KPa and 61 KPa which mimics the change seen from normal 
hepatic tissue (stage F0) to fibrotic tissue (stage F4) [95]. Figure 45 shows the tensile 
test data from two different curing methods of the PDMS phantoms. Note that the YM of 
the PDMS phantom mixture differ from that of PDMS alone. 
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Fig. 45. Tensile test data of the PDMS phantoms’ mixture with two different sets of 
curing parameters.  
 
Multiple parameters were computed and compared between the two cases. One 
of these parameters is the emptying time for each pulse. The emptying time correspond 
to the time it takes for the fluid to exit the vasculature during diastole. During this period 
the PPG is increasing in amplitude due to the decrease in absorbance. To quantify that, 
an algorithm was developed that automatically detects the point that is 10% above the 
valley of the PPG pulse (start of diastole) and the point that is at 90% of the peak of the 
PPG pulse (end of diastole). The time between these two points was defined as the 
emptying time. The algorithm was implemented in MATLAB (Mathworks, Inc.) and is 
shown in Appendix F. The emptying time decreased from 305 ms for phantoms with 
YM of 15 KPa to 195 ms for phantoms with YM of 100 KPa. As shown in Figure 46. 
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Fig. 46. Vessel emptying time for a Young’s modulus of 100 and 15 KPa.  
 
Note that these absolute numbers depend on the flow circuit as well as the 
phantom’s mechanical properties. This means that, when applied in vivo, these 
measurements will be affected by systemic changes as well and a reference measurement 
should be made to account for systemic variables. This can be done by analyzing the 
peripheral pulse. This experiment was repeated with another flow circuit and this time 
using three different phantoms with Young’s moduli of 11.7, 15.1, and 61 KPa. The 
same trend was observed as shown in Figure 47. Note that 11.7 and 15.1 are both in the 
normal range. The change in the absolute numbers is due to the change in the flow 
circuit as discussed earlier. 
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Fig. 47. Vessel emptying time as a function of YM (11.7 – 61 KPa).  
 
In addition, when a vascular complication is detected from the perfusion data, 
PPG waveform analysis can provide insight into the type of complication. More 
specifically, a reduced level of perfusion can be caused by an obstruction of flow either 
downstream or upstream from the organ (measurement site). Downstream occlusion are 
expected to increase downstream pressure which would increase the resistance in the 
diastole phase leading to longer emptying times which are expressed as rise times in the 
PPG signal. To test that theory, a flow circuit was built with a peristaltic pump and the 
vascular phantom. Clamps were placed downstream and upstream from the phantom as 
shown in Figure 48.  
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Fig. 48. Schematic of the in vitro clamping study showing the change in the PPG 
waveform in the case of upstream and downstream occlusions.  
 
Baseline data were collected and then one of the clamps was tightened while 
recording the PPG waveform. As seen in Figure 48, the downstream occlusions show a 
decrease in the slope of the diastole phase which is not seen in the upstream occlusions. 
This was quantified by measuring the vessel emptying time as described earlier. Figure 
49 shows the PPG rise time changes during an upstream and a downstream occlusion. 
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Fig. 49. Changes in PPG rise time during upstream (a) and downstream (b) occlusions. 
The shaded areas correspond to the occlusion time.  
 
These experiments were repeated three times and the averages and standard 
deviations are shown in Figure 50. 
 
 
Fig. 50. Changes in PPG rise time during occlusions for the 15 KPa (a) and 100 KPa 
(b) phantoms.  
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Ex Vivo Studies 
To verify the results obtained in vitro, we conducted a limited number of ex vivo 
rat liver perfusion studies. During these studies, only perfusion changes were monitored. 
Figure 51 shows the perfusion data measured from one of the livers. Note that the 
Transit-Time flow monitoring system was measuring flow in the supplying tube of the 
flow circuit and not the tissue microcirculation which could have added error to our 
measurements in the case of any perfusion inhomogeneity in the liver microcirculation. 
The collected pulsatile signal was processed in the time domain by measuring the 
amplitude of each pulse (difference between local maxima and minima) using the 
automated MATLAB code (Appendix F). The perfusion index (PI=AC/DC) was used to 
track perfusion changes. The DC level was computed for each pulse by taking the 
average of the DC channel between two consecutive pulses. All three wavelengths 
tracked perfusion changes with similar accuracy. Perfusion levels were varied between 
0.01 and 1 mL/min/g of tissue. The PI was averaged for 5 seconds intervals to eliminate 
pulse to pulse variation. The root mean squared error (RMSE) in the study shown below 
was 0.0874 mL/min/g of tissue. 
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Fig. 51. Perfusion index as a function of liver perfusion measured from excised rat livers 
perfused with hemoglobin mimicking dyes mixture.  
 
Chapter Conclusions 
In this chapter, a phantom that simulates the optical, mechanical, and anatomical 
properties of the liver and its vasculature was presented. This phantom can be used to 
evaluate the performance of a variety of optical sensing and imaging systems that 
operate in the 650 to 1000 nm wavelength range. The designed phantoms were used with 
different dye mixtures that mimic the optical properties of blood in its various 
oxygenation states in a flow system to test the performance of the perfusion and 
oxygenation sensor. The sensor tracked perfusion changes with an RMSE of 0.077 
mL/min/g for the single layer phantoms and 0.071 mL/min/g for the three layers 
phantom. These results were verified in ex vivo rat liver perfusion studies and perfusion 
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was tracked with an RMSE of 0.0874 mL/min/g of tissue. This resolution is similar to 
that of thermal diffusion perfusion monitoring systems that have an error of around 10% 
caused by the tissue temperature variation (0.025C). The 10% error translates to a 
variation of 0.0367 mL/min/g of tissue in the perfusion range used in the ex vivo studies 
reported in this chapter. The sensor was also tested for sensitivity to oxygenation 
changes in vitro. The sensor was able to track oxygenation changes with a prediction 
error of 1.3% within a study and 4.6% across studies. These numbers are on the same 
order as the prediction error on the extinction coefficients of the dye mixtures due to 
preparation errors. 
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CHAPTER V 
IN VIVO TESTING 
 
Introduction 
While the studies presented in the previous chapters show the ability of the 
sensor to track perfusion and oxygenation changes, in vivo studies present additional 
sources of noise and challenges that are not present in the controlled environment of in 
vitro and ex vivo testing. In order to evaluate the performance of the sensor in a more 
realistic environment, we conducted a series of in vivo porcine studies. Various 
techniques have been validated in vivo for monitoring liver perfusion and/or oxygenation 
such as NIRS [115], thermal diffusion [12, 19], Laser Doppler Flowmetry [116], and 
others. Several animal models have been used in these studies; however, since the 
ultimate goal of the sensor presented herein is to be implanted, we chose the porcine 
model due to the body size and since  the mechanical properties of porcine livers have 
been shown to be similar to those of human livers [70, 100]. In this chapter, we will 
describe the porcine studies and the data collected using the bench-top and the telemetry 
system. The data show the ability of the proposed system to measure and separate 
perfusion, arterial oxygenation, and venous oxygenation. In addition, we investigate the 
homogeneity of perfusion across the liver. 
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Materials and Methods 
Animal Study Protocol 
The studies were performed on eight swine. Four studies were performed with 
each of the systems (bench-top and telemetry). The animal body weights from the early 
bench-top experiments were not recorded. The animal body weights form the telemetry 
studies ranged between 21 and 29.5 kg. Prior to anesthesia, the animals were 
premedicated with Telazol (5-10 mg/kg) and the analgesic Buprenorphine (0.01-0.05 
mg/kg). Both drugs were introduced via intramuscular injections. To induce anesthesia, 
the animals were given 3-4% Isoflurane in Oxygen at 3 L/min via a face mask. An 
endotracheal tube was inserted into the trachea, secured in place and connected to a 
mechanical ventilator (8-12 BPM and tidal volume of 5-10 mL/lb). Isoflurane (0.5-4%) 
was introduced in Oxygen to maintain anesthesia. A laparotomy was performed to 
expose the liver. Transit-Time Ultrasound probes were placed on the Hepatic Artery 
(Transonic Systems, cat# MA4PSB) and the Portal Vein (Transonic Systems, cat# 
MA10PSB) to monitor flow changes. During the last two hypoxia studies with the 
telemetry system two oxygenation catheters were used to monitor oxygen saturation 
changes. The first oxygenation catheter was placed in the aorta via the iliac artery 
(Edwards Lifesciences, cat# XA3820HKCDC) and connected to a Vigilance Monitor 
(Edwards Lifesciences). Another oxygenation catheter was placed in the inferior vena 
cava at the level of the hepatic veins to monitor venous oxygenation changes. Two laser 
Doppler flowmeter probes were placed on the parenchyma to monitor tissue perfusion 
changes. A catheter was placed in the femoral artery to monitor arterial pressure. 
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Throughout the experiments, the vital signs (body temperature, SpO2, heart rate, blood 
pressure, etc.) were monitored closely and recorded. All reference equipment were 
connected to a custom built data acquisition system and saved for further processing. 
The probes from the sensing system were placed on the HA, PV, and the liver 
parenchyma. For the studies with the bench-top system, at least two parenchymal probes 
were used to verify that there are no significant heterogeneities in the hepatic tissue 
perfusion. This resulted in four total probes (1 HA, 1 PV, and 2 parenchymal) compared 
to only three used with the telemetry system. All probes were secured using 5/0 Prolene 
sutures. Note that the HA and PV probes were placed for reference; however, no 
vascular probes will be used in the final application. Vascular occluders were placed on 
the HA and PV to be able to alter hepatic flow and perfusion. Hypoxia was induced by 
inhalation of low oxygen content mixtures. The electronic unit was placed outside the 
body next to the animal on the surgical table and tethered to the probes. The relay unit 
was connected to a laptop placed around 4 feet from the surgical table. Data were 
collected intermittently prior, during, and after any flow or oxygenation perturbation. At 
the end of the experiment, while still anesthetized, the animal was euthanized with a 
barbiturate derivative solution administered intravenously (80-120 mg/kg). Finally, 
livers were extracted and weighted (465 and 525 g for the 21 and 27 kg animals 
respectively) to convert the flow measurements (mL/min) into an average tissue 
perfusion measure (mL/min/g of tissue). All studies were performed under an animal use 
protocol (AUP #2010-257) approved by the Institutional Animal Care and Use 
Committee at Texas A&M University. 
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Instrumentation 
The initial studies were conducted using a bench-top system. The system 
consisted of four sensor interface boards driving four different probes. The AC channels 
on this system have band-pass filters with cut-off frequencies (f3dB) at 0.15 and 15 Hz for 
the high- and low-pass filters respectively. These filters were originally designed to 
block the DC light from the high gain AC channel to avoid saturation. Because of this 
design, the bench-top system allows part of the respiratory signal to pass through the 
high amplification AC channels. This signal is usually much higher than the measured 
cardiac cycle and causes saturation of the channel. For that reason, the animals’ breath 
was held for short durations to collect data with this system and avoid saturation. The 
left panel of Figure 52 shows a pulsatile signal collected in vivo using the bench-top 
system while the animal is on a mechanical ventilator. The supply voltages for the 
amplifiers in this system are -10 V and 10 V and the figure below shows the saturation 
periods when the gains are adjusted to get an AC amplitude of around 10 V (half of the 
dynamic range of the system). 
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Fig. 52. Pulsatile waveform collected in vivo from the hepatic parenchyma using the 
bench-top system (left) and the telemetry system (right) during respiration. The bench-
top system’s AC signal saturates due to respiration which is not seen with the telemetry 
signal.  
 
As discussed in chapter II, these filters were redesigned for the telemetry system 
to avoid that problem. The redesigned filters block the majority of the respiratory signal 
and do not show any saturation problems. The right panel of Figure 52 shows a pulsatile 
waveform collected with the telemetry system in vivo from the hepatic parenchyma 
while the animal was on a mechanical ventilator. Note that the dynamic range of the 
amplifiers in the telemetry system is 0-5 V and that is why the gain on this system is 
adjusted to get an AC amplitude around 2 V. Both systems are shown in the figure 
below. 
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Fig. 53. (a) Picture of the telemetry system showing the sensors, probes, relay unit, and 
computer interface.  (b) Bench-top and telemetry system next to each other.  
 
Data Processing 
Each of the sensors extracts an AC signal from the collected diffuse reflectance 
and amplifies it by a gain specified by the user (1 to 96 X for the telemetry system and 1 
to 470 X for the bench-top). Both the DC and AC signals are transmitted to a data 
acquisition and saved on a computer for further processing. 
AC Processing 
Fourier processing was used to measure the amplitude of the pulsatile wave. The 
Fast Fourier Transform (FFT) was calculated for 25 s data intervals using software 
developed in MATLAB (MathWorks, Inc.). The software detects the peak that 
corresponds to the cardiac cycle and uses it as the amplitude of the AC signal. The 
frequency of that peak was used to measure the heart rate in beats per minute (60*fpeak). 
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Using the AC amplitude at the 735 and 940 nm wavelengths, we calculated the 
modulation ratio R that is typically used in pulse oximeters to assess oxygen saturation. 
This quantity requires a calibration curve to produce quantitative oxygen saturation 
results. To calibrate our sensor we fit the data to a calibration model in the form shown 
in equation V.1-b. Although the fitting parameters (a, b, c, and d) can be estimated 
theoretically, previous work has shown that the practical calibration curve is different 
from the theory that is simplified and does not account for the effects of scattering [117]. 
However, the general form of the equation still holds. 
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The quantity (R) is a measure of the ratio of absorbance at the red and NIR 
wavelengths of the pulsatile perfusion. Due to the compliance of the tissue, blood flow 
loses its pulsation on the venous side. Thus R is used to follow the changes in the 
oxygen supply (i.e. arteries and the arterial side of the capillary network). 
DC Processing 
The DC signals were processed using the typical equations employed for NIRS 
signals described in details in Chapter 3 [76]. The pathlength factor was estimated using 
the theoretical equation reported by Boas et al. [76].  These equations are used to derive 
the change in concentration of oxyhemoglobin, deoxyhemoglobin, and total hemoglobin 
  
102 
 
(HbO2, Hb, and HbT respectively). The change in total hemoglobin concentration 
(HbT) tracks perfusion. To obtain a measure of the change in oxygenation, we used the 
hemoglobin oxygenation index (HbD = HbO2 - Hb) [79]. During perfusion changes, 
HbO2 and Hb vary similarly and the difference (HbD) remains unaltered. However, 
for oxygenation changes, HbO2 and Hb vary in opposite directions leading to a 
change in the hemoglobin oxygenation index (HbD). 
The values calculated using the DC levels as described above represent tissue 
oxygenation which may be affected by either changes in oxygen supply (arterial side) or 
in oxygen consumption (venous side). It is of paramount importance to separate the two 
contributions to be able to possibly diagnose the cause of complications when they 
occur. Most previous reports employing NIRS measured, or assumed a constant percent 
contribution of, venous and arterial components to the collected signal [118, 119]. This 
ratio is different for various types of tissue and probe geometries. If this ratio is 
determined it can be used to extract the venous signal contribution to the DC levels. To 
accomplish that we used Multiple Linear Regression (MLR), and the measured venous 
oxygenation was fit to the linear combination of the DC measured changes (HbD) and 
the oxygen saturation of the supply (equation V.2). 
SvO2= a.DC + b.SO2 + c        (V.2) 
Reference Measurements 
The liver has a complex vasculature that is supplied by two different vessels: the 
hepatic artery (HA) and the portal vein (PV). The HA supplies approximately 25% of 
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nutrient and total blood flow but it is rich in oxygen and delivers approximately 75% of 
the total liver oxygen supply. The PV is part of the venous system but supplies blood to 
the liver. The portal venous blood is rich in nutrients but relatively poor in oxygen, and it 
supplies roughly 75% of liver nutrients along with 25% of its oxygen. Thus, the supply 
oxygenation in the liver tissue is not that of the artery alone, but it is the addition of the 
contribution of the PV and the HA. In the remainder of this chapter we will refer to this 
quantity as the mixed oxygen saturation (MOS) as defined in equation 3. Due to the 
limited exposed space on the PV (few centimeters) and the required flow probes and 
vascular occluders placed on that vessel, we could not insert a catheter into the PV to 
monitor its oxygenation. We assumed it to be equal to the non-hepatic venous 
oxygenation for the purpose of our calculations. 
total
PVHA
Flow
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In addition to the Laser Doppler Perfusion monitor, we used the total flow as 
measured by two Transit-Time vascular flow monitors to track tissue perfusion as 
described by equation (V.4) below: 
PerfusionTissueFlowFlowFlow PVHAtotal   (V.4) 
Results 
Figure 54 shows a typical pulsatile waveform collected using the bench-top 
system during in vivo porcine studies. The corresponding FFT spectrum shows multiple 
harmonics of the cardiac cycle peak that can be measured with this system. 
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 Fig. 54. Pulsatile waveform (left) collected in vivo from the hepatic artery using the 
bench-top system and its corresponding FFT spectrum [63].© 2011 IEEE.  
 
Similarly, AC waveforms collected with the telemetry system and their 
corresponding FFT spectra are shown in Figure 55 below. 
 
 
Fig. 55. Pulsatile waveform (left) collected in vivo from the hepatic parenchyma using 
the telemetry system and its corresponding FFT spectrum.  
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Bench-Top System 
Perfusion 
In the early studies conducted with the bench-top system, we were not able to get 
readings from the reference equipment used to monitor hepatic flow and perfusion. This 
prevented us from performing a quantitative analysis of the performance of our sensor in 
monitoring perfusion in vivo. Figure 56 shows the measured perfusion index 
(PI=AC/DC) from a parenchymal probe on all three wavelengths from data collected 
during an occlusion study to the hepatic artery. Each data point represents the average of 
60 seconds of data. Note that after a duration of occluding the HA, the perfusion index 
goes back up on the parenchymal tissue which is likely due to an increase in portal vein 
flow as a response to the decreased HA flow. 
 
 
Fig. 56. Perfusion index changes during an HA occlusion. The blue shaded area 
represent the full HA occlusion while the red area corresponds to a 50% HA occlusion. 
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 The perfusion index measures the pulse volume (pressure) which tracks pulsatile 
perfusion changes. However, there are many other confounding factors that affect the PI 
such as pressure. Thereby, the total hemoglobin concentration changes (HbT) was used 
to track perfusion changes. This quantity measures changes in tissue hemoglobin content 
by using the DC levels on two or more wavelengths. In our case, three wavelengths were 
used. Figure 57 shows the changes in total hemoglobin concentration during an HA 
occlusion and the corresponding signal measured by a Hemedex thermal diffusion 
perfusion monitor. 
 
 
Fig. 57. Perfusion changes during an HA occlusion as measured by the total hemoglobin 
concentration and the Hemedex perfusion monitor.  
 
Heterogeneity of Liver Perfusion 
All sensors discussed herein measure local tissue perfusion. Often, it is assumed 
that hepatic perfusion is homogeneous and these point measurements are used as 
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indicators of total hepatic perfusion. To study this assumption, we used two bench-top 
systems (8 probes total) and placed the probes on various locations of the liver. Two 
probes were placed on the HA and PV. The remaining 6 were placed on different parts 
of the liver. Different source to detector separations were used to probe different depths 
in tissue. The separations ranged between 2 and 6 mm edge to edge separation which 
corresponds to 7 to 11 mm center to center separation.  The signal on one of the 
parenchymal probes was lost after the start of the study and data from that probe were 
not used in the analysis. Figure 58 shows the data from the 5 parenchymal probes during 
two consecutive occlusions of both the HA and PV. This should result in a complete 
blockage of hepatic flow if the occlusions are successful.  Each data point in the graph 
corresponds to a 5 s average of the change in total hemoglobin concentration.  
 
 
Fig. 58. Change in total hemoglobin concentration during HA and PV occlusions 
measured on 5 different sites of the liver.  
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The data show that all 5 parenchymal probes detected a decrease in perfusion 
during the HA occlusions. The changes in perfusion seem to be independent of the 
location on the liver. However, differences in the trends can be seen for the various 
optodes’ separations. This indicates that the perfusion trends, when hepatic flow is 
restricted, vary with depth in the tissue. Figure 59 shows various scatter plots of the 
detected hemoglobin concentration changes measured by various probes with different 
optodes’ separation. The scatter plots show that the low optodes’ separation probes reach 
the minimum perfusion levels prior to their long separation counterparts. The left panel 
shows data from all probes plotted against the 4 mm separation probe placed on the right 
lobe. Note how all lower separations (2 mm) show a horizontal asymptotic behavior for 
low perfusion levels while higher separations (6 mm) shows a vertical asymptotic 
behavior. This suggests that for low perfusion levels, low separation probes stop 
detecting changes while the higher separation probes are still detecting perfusion 
changes. Similarly, the right panel of Figure 59 shows all probes data plotted against the 
6 mm probe (highest optode separation). Note that this was only seen during very low 
perfusion levels when both HA and PV were occluded. This indicates that ischemia 
affects shallow tissue first. This can also be seen in Figure 58 above during the first 
occlusion. The short separation probes reach a minimum first and the signal flattens at 
one low level until reperfusion. 
Despite the differences for very low perfusion levels, data from all probes 
correlated with each other with coefficients of determination (R
2
) mostly above 0.9 (6 
combinations above 0.9 and 4 above 0.8). This suggests that there are no significant 
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differences in the perfusion levels observed among different sites of the liver. Note that 
this might be different in the case of a transplant and this study only investigated normal, 
healthy livers. 
 
 
Fig. 59. Scatter plots showing the performance of different probes with different 
separations placed on various parts of the liver.  
 
Oxygenation 
The hemoglobin oxygenation index (HbD) tracks hemoglobin oxygen 
saturation. In the early studies with the bench-top system, we did not have a continuous 
oxygenation monitoring system and blood gas analysis was used as the gold standard to 
verify oxygenation measurements. Data from the bench top system was still collected in 
intervals of at least one minute length and averaged to be compared to the blood gas 
analysis data. Since the filters of that system could not block the respiratory signal that 
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caused saturation of the AC channels, data were collected during breath hold intervals 
with intermittent intervals of mechanical ventilation. Thereby we were not able to 
maintain the oxygenation levels constant during data collection and quick drops in 
oxygen saturation levels were seen during data collection on the peripheral pulse 
oximeters used for monitoring the animals. The data in panel (a) of Figure 60 shows the 
hemoglobin oxygenation index measured by the HA probe and the blood gas analysis of 
the arterial blood samples.  Panel (b) is a close up look at the data of one of the 
experiments showing the drop in HbD. 
 
 
Fig. 60. Hemoglobin oxygenation index and blood gas analysis results during a hypoxia 
study using the bench-top system. The full duration of the study is shown in panel (a) and 
a zoom in on one segment during a breath hold is shown in panel (b).  
 
To perform the quantitative analysis, the data from each interval (60-120 s) were 
averaged to one data point. The resulting hemoglobin oxygenation index is shown in 
Figure 61 below. Panel (b) shows the scatter plot of the blood gas analysis data (SaO2) 
versus the hemoglobin oxygenation index HbD. The resultant coefficient of 
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determination (R
2
) is 0.886 and the root mean square error (RMSE) is 5.1%. Part of this 
error is due to the point measurements for the blood gas analysis used as a reference and 
the comparison to the average measured by the bench-top system. This adds a significant 
error especially since the oxygenation levels are not stable during data collection as 
described earlier. Note that in this study, the venous catheter was clogged and we could 
not get venous oxygenation measurements.  
 
 
Fig. 61. Hemoglobin oxygenation index during hypoxia after 1 minute data averaging.  
 
In the following experiment, venous and arterial samples were collected and 
analyzed for blood gases. The bench-top system had 2 vascular probes (HA and PV) and 
two parenchymal probes on the left and right lobes of the liver. The data shown in the 
graphs below correspond to the parenchymal probes. The modulation ratio was 
computed as described earlier and used to predict the arterial oxygen saturation. The 
same data was used for calibration and prediction. No significant differences were seen 
between the left and right lobe. Data from both probes and the blood gas analysis are 
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shown in panel (a) of Figure 62. The predicted arterial oxygen saturation correlated with 
the blood gas analysis data with a coefficient of determination (R
2
) of 0.74. As discussed 
earlier, part of this error is due to comparing a minute average data to a single time point. 
In addition, the modulation ratio, computed from the parenchymal probes, measures the 
oxygenation of the pulsatile blood that is supplying the liver. The hepatic supply 
comprises blood from the HA and PV. Thereby, the hepatic oxygen supply can not be 
measured by the saturation of the arterial blood but instead it is the weighted average of 
the hepatic artery oxygen saturation and portal vein oxygen saturation. The weighting 
coefficients in measuring the hepatic oxygen supply are proportional to the flow levels 
of each vessel (HA and PV). The hepatic oxygen supply can be computed as defined by 
the mixed oxygen saturation (MOS) formula described in the Materials and Methods 
section of this chapter (equation V.3). For this study, we could not get vascular flow data 
from the ultrasonic transit time flowmeters to compute the MOS. 
 
Fig. 62. (Left) Arterial hemoglobin oxygen saturation as measured by the parenchymal 
probes and the blood gas analysis on arterial blood samples. (Right) Scatter plot of 
parenchymal probes vs. blood gas analysis.  
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The venous oxygen saturation was computed from the DC data as described in 
the Materials and Methods section.  Data were obtained from both parenchymal probes 
and displayed in Figure 63. The coefficient of determination for the venous oxygen 
saturation is 0.98. The RMSE for the arterial and venous oxygen saturation for this study 
was found to be 6.73% and 3.47% respectively. 
 
Fig. 63. (Left) Venous oxygen saturation as measured by the parenchymal probes and 
blood gas analysis. (Right) Scatter plot comparing the predicted SvO2 to the blood gas 
analysis results.  
 
Telemetry 
The telemetry system was tested in two porcine studies. Two different data 
collection procedures were used on the two animals. For the first study, we induced 
hypoxia without imposing any change to the hepatic flow to test the ability of the sensor 
to track oxygenation changes. The second study began with four consecutive hepatic 
artery occlusions, followed by three portal vein occlusions. These occlusions were 
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performed at normal systemic oxygenation levels. Hypoxia was induced afterwards, and 
vascular occlusions (HA and PV) were performed again at low systemic oxygenation 
levels. All occlusions were brief (less than 1 minute for full occlusion) and were 
performed in gradual steps. Although the inhaled oxygen level was not changed during 
occlusions, the hepatic oxygen saturation is expected to be altered due to an increased 
hepatic oxygen extraction ratio and a change in the relative flow (see the MOS equation 
above V.3) of the HA (high oxygen content) and PV (low oxygen content). In the 
following figures, hypoxia periods are indicated by a dark grey box on the upper 
horizontal axis. Note that the recovery period from hypoxia is also included in the grey 
boxed region.  Vertical white lines indicate segments where one or more hepatic artery 
occlusions were performed while horizontal white lines indicate where one or more 
portal vein occlusions were performed. The occlusion periods include multiple 
occlusions and baseline readings in between. 
To verify that the pulsatile signal collected with the wireless sensor is tracking 
the cardiac cycle, we looked at the cardiac cycle peak detected by our system and 
compared it to the heart rate measured by the arterial pressure catheter. This was 
performed on data from two animals and the detected heart rate was accurate with an 
RMSE of 3.9 bpm (0.065Hz). Some of this error is due to the difference in the 
integration time between the telemetry sensor (25 s) and the pressure catheter (2 s). 
Figure 64 shows the heart rate throughout the study as measured from the arterial 
pressure catheter and the FFT of the PPG signal measured with the telemetry sensor. 
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Fig. 64. Heart rate changes as measured by the arterial pressure catheter (grey) and the 
telemetry sensor (black).  
 
Perfusion 
One of the important features of the presented sensor is the ability to track 
perfusion and oxygenation changes simultaneously. To track perfusion changes, we 
measured the change in tissue total hemoglobin concentration (HbT) as described in 
the Materials and Methods section. After analyzing the laser Doppler flowmetry (LDF) 
data from the commercial system, we found that the LDF signal correlated with changes 
in HA flow but not PV nor total flow (R-square= 0.8, 0.1, and 0.5 respectively) 
measured by vascular transit-time ultrasonic flowmeters. These data are shown in detail 
in Appendix G (Figures S3 & S4). We believe that the LDF was probing a branch of the 
HA and was not tracking tissue perfusion. Because the LDF measurements reflected the 
HA flow and not tissue perfusion, they were not used as a reference for parenchymal 
perfusion. Instead, the total hepatic flow measured by the addition of the signal from two 
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transit-time ultrasound flowmeters (HA & PV) was used as the reference for 
parenchymal perfusion measurements.  
Figure 65 (left panel) shows the changes in hemoglobin concentration measured 
by the optical telemetry sensor and the total hepatic flow measured by the transit-time 
ultrasonic flowmeters. The two quantities correlate with high accuracy in the first 70 
minutes of the study (t= 150-220 min) during which four HA occlusions were 
performed. After the first PV occlusion (t=220 min), the signal from the optical 
telemetry sensor showed a slow decreasing trend in perfusion while the transit-time 
flowmeter showed an increase. This is due to the fact that the telemetry sensor is 
measuring tissue perfusion directly by looking at the tissue hemoglobin content while 
the ultrasonic transit-time flowmeter is measuring vascular flow changes. This 
discrepancy between the two can be due to a systemic response causing vasoconstriction 
that results in a decrease in microvasculature perfusion while increasing the blood flow 
in the central vasculature. Such a response can be triggered by a decrease in blood 
pressure. To verify this theory, we looked at the change in the Mean Arterial Pressure 
(MAP) shown in the right panel of Figure 65. During the period of increase in the 
Transit-Time flowmeter signal, the MAP increased from 52 mmHg to more than 70 
mmHg. We believe this event was triggered by the first portal venous occlusion that 
caused a decrease in venous return to the heart thereby causing a decrease in blood 
pressure to around 30 mmHg. This decrease in pressure is not seen during the first four 
occlusion events (HA occlusions) since the HA flow (350 mL/min in humans) is much 
lower than the PV flow (1100 mL/min, ~22% of total cardiac output) [67]. In general, 
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vasoconstriction is associated with an increase in MAP which supports our proposed 
explanation [67]. In addition, we looked at the telemetry sensor data from the hepatic 
artery probe, and they showed a similar increasing trend as measured by the transit-time 
flowmeter. This is an advantage of the employed technique since perfusion 
measurements are desired. Flow readings are usually used as an estimate of perfusion 
trends; however, in addition to perfusion, these measurements are affected by changes in 
blood pressure. Spectroscopy based techniques measure the real hemoglobin content in 
tissue which is essential to know the availability of nutrients and oxygen to cells. 
 
 
Fig. 65. (Left) Total hemoglobin concentration (HbT, black dots) in hepatic tissue 
versus total hepatic flow measured by the addition of the HA and PV transit-time 
flowmeters’ measurements (grey line). (Right) Total hepatic flow (grey) and mean 
arterial pressure (black) trends show that the increase in flow after t=200 min is 
accompanied by an increase in the arterial pressure suggesting that a systemic response 
is responsible for that increase. 
 
 
 
To assess the accuracy of the perfusion measurements, we compared the readings 
from the telemetry sensor and the transit-time flowmeter prior to the increase in blood 
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pressure (first 4 occlusions). The telemetry sensor was able to resolve perfusion changes 
with a RMSE of 0.135 mL/min/g of tissue (70.87 mL/min) as shown in Figure 66. Note 
that the standard deviation of the transit-time flowmeter measurements (0.09 mL/min/g 
of tissue  47.6 mL/min) during the first baseline collection (t=148 - 155 min) is on the 
same order as the RMSE of the telemetry sensor. 
 
 
Fig. 66. (Left) Total hemoglobin concentration (HbT) and flow changes. (Right) 
Scatter plot of measured hemoglobin concentration change (HbT) vs. tissue perfusion 
(flow normalized by liver weight).  
 
Oxygenation 
To track oxygenation changes, the hemoglobin oxygenation index (HbD) was 
computed, as obtained from the measured DC levels, which, as discussed in the 
Materials and Methods section, is a measure of tissue oxygenation affected by both 
arterial and venous oxygen saturation levels. This level is compared to both oxygen 
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supply (MOS) and venous oxygenation (SvO2) from the two different studies as shown 
in Figure 67. As described earlier, for the first study (Figure 67-a) we induced hypoxia 
and we did not alter perfusion. However, in the second study (Figure 67-b) we had 
multiple occlusions of the HA and PV at various levels of oxygen saturation during 
hypoxia. Vascular occlusions have been shown to alter tissue perfusion and oxygenation 
in liver tissue [115].  
 
 
Fig. 67. Hemoglobin oxygenation index (right axis) measured by the optical telemetry 
system versus venous and mixed oxygen saturation (left axis) for study 1 (a) and 2 (b). 
Venous oxygenation is measured by the oximetry catheter placed in the vena cava while 
the supply oxygenation is the weighted average of the HA and PV oxygenation described 
by equation V.3.  
 
Figure 67 indicates that the measured hemoglobin oxygenation index is tracking 
oxygenation changes. This measure was obtained from the collected DC signal that is 
probing both the HA/PV supply and the post-hepatic venous components. To verify that 
this measure contains oxygenation information about both supply and hepatic venous 
blood we correlated the measurements to the reference data obtained from the 
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oxygenation catheters and flow meters. Although HbD correlated well with both 
supply and venous oxygenation (data shown in supplementary information), it correlated 
best with a combination of the two using multiple linear regression (MLR) analysis 
described by equation V.5. The coefficient of determination (R
2
) was 0.99 for study 1 
(no vascular occlusions) and 0.80 for study 2 (vascular occlusions at multiple levels of 
oxygenation) respectively. This corresponds to a root mean square error (RMSE) of 
1.39% and 3.93% respectively. 
c 2b.SvOa.MOSHbD  (V.5) 
Having the calibration coefficients (a, b, and c) from the MLR, the mixed oxygen 
saturation (MOS) measured by the gold standards, and the hemoglobin oxygenation 
index (HbD) measured by the telemetry system, equation V.5 was used to compute 
venous oxygen saturation (SvO2). Figure 68 shows the predicted venous oxygenation 
and the measured oxygenation by the venous catheter as a function of time. Note that in 
study 2, occlusions are performed on the hepatic artery and are always seen as a decrease 
in the measured venous oxygenation by our probe. However, this decrease is not 
detected by the venous catheter during the first three occlusions because the catheter was 
measuring hemoglobin oxygen saturation in the vena cava rather than the hepatic veins. 
Thus, the first three occlusions performed on the hepatic artery caused a decrease in the 
hepatic venous oxygen saturation as shown by our probe but did not have a substantial 
effect on the systemic venous oxygenation, where the venous catheter is measuring, 
since the HA flow is relatively low (7% of total cardiac output) compared to the portal 
vein flow (22% of total cardiac output). 
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Fig. 68. Venous oxygen saturation as measured by the telemetry sensor (black dots) and 
the central venous catheter (grey line) for study 1 (left) and 2 (right).  
 
The data from both experiments are shown on the scatter plot of Figure 69. Note 
that the data from study 2 have a higher RMSE (3.93%) compared to study 1 (1.39%). 
This increase is mainly due to the occlusions performed in that study, and part of this 
perceived error is from the reference measurements, and not our system, because it was 
probing central venous oxygenation and not the hepatic vein. 
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Fig. 69. Scatter plot of the predicted (telemetry) versus measured (catheter) venous 
oxygen saturation for both studies (1: black & 2: grey).  
 
The data shown in Figures 68 and 69 use the supply oxygen saturation levels 
obtained from the catheters to extract the venous oxygenation from the DC levels. 
However, as described earlier, we wanted to determine the supply oxygenation levels 
from the pulsatile signal and avoid using any additional reference measurements. To do 
so, the modulation ratio (R) was calculated, and measurements were calibrated as 
discussed in the Materials and Methods section. The data from each experiment were 
calibrated separately. These measurements were compared to the Mixed Oxygen 
Saturation (MOS) described earlier. Figure 70 shows the measured MOS and the 
reference data from the catheters and the flowmeters computed using equation V.3. The 
modulation ratio was able to predict the MOS except when the oxygen saturation 
dropped below 75%. This is a known problem of pulse oximeters and is mainly due to 
the high attenuation of the red wavelength (735 nm) for low oxygenation levels. If 
needed, this issue can be resolved by optimizing the sensor design (illumination 
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wavelength, amplification, etc.) to operate for low oxygen saturation levels [58]. During 
study 2, the oxygen saturation during vascular occlusions dropped to as low as 56%, and 
the sensor was still able to measure it accurately. We believe this is due to the decreased 
absorbance as a result of the perfusion decrease that allowed the red wavelength (735 
nm) to still be measured accurately.  
 
 
Fig. 70. Mixed oxygen supply (MOS) measured by the telemetry sensor (black dots) and 
the reference equipment (grey line) for both studies (1: left, & 2: right).  
 
For oxygenation levels above 72% (for normal perfusion levels) and 55% (for 
low perfusion levels) the calculated modulation ratio from the pulsatile signal was able 
to predict oxygenation changes with an RMSE of 2.19% and 2.82% for study 1 and 2 
respectively. Figure 71 shows the corresponding scatter plot. 
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Fig. 71. Scatter plot of the predicted vs. measured MOS for study 1 (black) and 2 (grey).  
 
These predicted MOS levels can be used with equation V.5 to predict venous 
oxygenation SvO2 without the need for a reference measurement. Because the pulsatile 
signal could not predict data for very low oxygen saturations, we tested this concept on 
all other parts of the data, and we obtained the measurements shown in Figure 72.  For 
study 1, we were able to measure venous oxygen saturation with an RMSE of 1.17% 
(R
2
=0.986) while for study 2 the RMSE was higher at 3.44% (R
2
=0.1). This increased 
prediction error is mainly due to the changes measured during HA occlusions that are 
not reflected in the central venous oximetry catheter measurements. However, we 
believe that these changes likely reflect variations in the hepatic venous oxygenation. 
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Fig. 72. Predicted venous oxygen saturation by combining the DC NIRS measurements 
with the AC pulse oximetry measurements. Note that the missing values correspond to 
the periods where MOS dropped below 72% and, because of the previously reported 
problem with signal from the red wavelength, could not get reliable pulse oximetry 
measurements. Study 1 & 2 are shown in left & right panel respectively.  
 
Discussion 
The oxygenation measurements obtained by the telemetry sensor agreed for the 
most part with the reference oxygen saturation measurements acquired by the vascular 
catheters. Specifically, the pulse oximetry signal was shown to track the defined quantity 
MOS which is a function of the flow and oxygenation of the HA and PV. The hepatic 
tissue supply oxygenation was measured with an RMSE of 2.82% for the range 72-
100%. We were able to resolve venous oxygenation changes with an RMSE of 1.39%. 
This resolution went up to 3.93% when vascular occlusions were performed 
simultaneously with the hypoxia. Finally, we were able to measure perfusion changes 
with a resolution of 0.135 mL/min/g of tissue in the range of 1.5 to 3.0 mL/min/g. This 
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resolution was similar to the variation of the baseline measurements by the reference 
flowmeters.  
The main discrepancy between the oxygenation measurements obtained by the 
telemetry sensor and the reference oxygen saturation measurements acquired by the 
vascular catheters occurred during HA occlusions where the telemetry sensor showed a 
decrease in the venous oxygen saturation while the central venous catheter did not show 
any change. We believe that the short duration of occlusions on the HA caused a local 
drop in the intrahepatic venous oxygenation which was not reflected in the systemic data 
measured by the oximetry catheters. 
During vascular occlusions, the measured hemoglobin concentration changes 
correlated with the hepatic flow (R
2
~0.78). During these occlusions, HbO2 levels 
decreased while Hb levels increased, thereby resulting in a net decrease of total 
hemoglobin concentration (HbT). This agrees with previously reported findings by El-
Desoky et al. that measured hemoglobin changes in porcine hepatic tissue using a 
commercial NIRS system [115]. The RMSE in tracking tissue perfusion was found to be 
0.13 mL/min/g. We believe that part of this error is caused by the comparison of direct 
perfusion measurements from the telemetry system to flow levels measured by the 
reference vascular flowmeters. Soft tissue acts as a capacitor and quick changes seen in 
the vascular flow can sometimes be delayed and filtered by the tissue. 
Chapter Conclusions 
In this chapter, a bench-top and a wireless sensor were tested in a series of in vivo 
porcine studies. Perfusion heterogeneity studies showed that there are no significant 
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differences in perfusion changes among the different parts of the hepatic parenchyma. 
Five different locations were tested and all probes detected similar trends of perfusion 
during vascular occlusions. 
In addition, the resolution of the sensors was tested and the bench-top system 
was able to resolve arterial and venous oxygenation changes with an RMSE of be 6.73% 
and 3.47% respectively. In this study, reference vascular flowmeters were not able to 
detect flow signals. Thus, we were not able to correct the supply oxygenation to include 
the contribution of the portal vein. This contributed partially to the high error in 
measuring arterial oxygenation. In addition, reference perfusion measurements were not 
available to quantify the performance of the sensor; however, the measured perfusion 
trends detected all induced vascular occlusions. 
The wireless system resolved perfusion changes with an RMSE of 0.13 
mL/min/g of tissue. This was on the same order as the fluctuations measured from the 
baseline data collected with the reference flow meters. Oxygen supply changes were 
detected with a resolution (RMSE) of 2.19 %, when perfusion levels were not altered, 
and 2.82 % when vascular occlusions were induced. The sensor could not detect changes 
in supply oxygenation when oxygen saturation went below 72% for normal perfusion 
levels. Similarly, venous oxygen saturation was measured with an RMSE of 1.39%. This 
resolution went up to 3.93% when vascular occlusions were induced. 
As mentioned earlier, the described sensor can be applied to a wide variety of 
applications that can benefit from continuous monitoring of perfusion and oxygenation. 
In the following chapter, we demonstrate the use of this sensor to monitor intestinal 
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perfusion for abdominal trauma patients and the required modification to the sensor 
design. 
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CHAPTER VI 
OTHER APPLICATIONS: MONITORING INTESTINAL PERFUSION
*
 
 
Introduction 
The sensor described in this dissertation is designed to measure perfusion and 
oxygenation in tissue. Although the focus of the work described herein is hepatic tissue, 
the same principle can be applied to any type of tissue where vasculature can be probed 
by light. Depending on the properties of the tissue under investigation, some of the 
sensor parameters might need to be adjusted. In this chapter, we demonstrate the 
possibility of applying the same sensing principle for monitoring severe trauma patients 
during resuscitation. Monitoring intestinal perfusion and oxygen consumption in 
abdominal trauma patients is essential during the resuscitation period. 
Photoplethysmography is capable of monitoring these changes in real-time to provide 
the medical staff with a timely and quantitative measure of the adequacy of resuscitation. 
In this chapter, the challenges of using optical techniques in monitoring hemodynamics 
in intestinal tissue are discussed and solutions to these challenges are presented using a 
combination of Monte Carlo modeling and theoretical analysis of light propagation in 
tissue. In particular, it is shown that by using visible wavelengths (i.e. 470 and 525 nm) 
the perfusion signal is enhanced and the background contribution is decreased compared 
                                                 
*
 Part of this chapter is reprinted from T. J. Akl, M. A. Wilson, M. N. Ericson et al., “Intestinal 
perfusion monitoring using photoplethysmography,” J Biomed Opt, 18(8), 87005 (2013), with 
kind permission of SPIE, Copyright 2013 by Society of Photo Optical Instrumentation 
Engineers. 
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to using traditional near infrared wavelengths leading to an order of magnitude 
enhancement in the signal to background ratio. It was further shown that, using the 
visible wavelengths, similar sensitivity to oxygenation changes could be obtained (over 
50% compared to that of NIR wavelengths). This is mainly due to the increased contrast 
between tissue and blood in that spectral region and the confinement of the photons to 
the thickness of the small intestine. Moreover, the modeling results show that the source 
to detector separation should be limited to roughly 6 mm while using traditional near 
infrared light, with a few centimeters source to detector separation, leads to poor signal 
to background ratio. Finally, a visible wavelength system was tested in an in vivo 
porcine study and showed the possibility of monitoring intestinal perfusion changes. 
Injury is the leading cause of death for people aged 1-44 year(s) in the United 
States. It results in 31 million Emergency Department (ED) visits each year and accounts 
for approximately a third of all ED visits and 8% of all hospital stays [120]. Injury is a 
worldwide problem, and it results in 5.8 million deaths annually, many of which can be 
prevented [121]. When a patient loses a large volume of blood due to an injury, their 
blood pressure drops causing poor perfusion and oxygen delivery to tissue. This lack in 
perfusion results in anaerobic metabolism that causes tissue acidosis which can lead to 
the failure of multiple vital organs, known as multiple organ dysfunction syndrome 
(MODS). To avoid MODS, treatment usually starts by controlling the bleeding and 
volume resuscitation before operating on any of the primary injuries [122, 123]. The 
oxygen deprivation period is commonly known as shock. Longer shock periods result in 
a higher tissue oxygen debt, which usually requires longer resuscitation time even after 
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some of the vital signals (i.e. heart rate, blood pressure, etc.) of the patient are back to 
normal levels. During that period, the tissue oxygen uptake/consumption and perfusion 
are elevated to accommodate for tissue needs. Consequently, normal oxygen 
consumption has been proposed as the safe end-point of resuscitation [124]. The current 
standard of care for the resuscitation end-point relies on systemic indicators such as 
blood pressure, urine output and heart rate. After these parameters are normalized, up to 
85% of patients are still in “compensated shock” and still have tissue acidosis [122]. 
Monitoring tissue perfusion and oxygen consumption in real time can provide clinicians 
with a more clear and safe end-point of resuscitation [124]. 
Some functional imaging modalities, such as magnetic resonance imaging (MRI), 
can provide information about perfusion and oxygen consumption; however they are not 
cost-efficient and have a low throughput, thus they are not appropriate for continuous 
monitoring [125]. Optical techniques can potentially provide a real-time, cost-efficient 
and minimally invasive way for monitoring perfusion and oxygenation changes in tissue 
[9, 14, 22, 38, 77, 107, 126]. Currently, the gold standards for tissue perfusion and flow 
monitoring in operating rooms are thermal diffusion, laser Doppler and transit-time 
ultrasound flowmetry [14-17]. Although these techniques can provide continuous, real-
time reading of microcirculation perfusion changes and/or vascular flow levels, they do 
not provide any data on the oxygen uptake which is critical to assess the adequacy of 
perfusion and tissue stress.  
Traditional oxygenation measurement techniques, such as catheterization and 
blood draws, are invasive and not suitable for long-term, continuous monitoring of 
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oxygenation changes. Optical techniques remain the gold standard for non-invasive 
monitoring of tissue oxygen saturation because of hemoglobin’s optical properties that 
change depending on its oxygenation state [30, 31]. Near Infrared Spectroscopy (NIRS) 
is perhaps the most common of these techniques [32, 126, 127].  
Optical oximetry sensors commonly employ long visible and NIR wavelengths 
(660 nm to 940 nm) due to the relative transparency of biological tissue in that range 
[58, 59].  Compared to visible light, this allows a higher penetration depth (several 
millimeters) and a larger probing volume that is typically desired to increase the 
hemoglobin signal. For that same reason, large source to detector separations (~10 - 50 
mm) are typically used to probe deep tissue and avoid superficial poorly vascularized 
regions [60, 128-130]. However, in the case of monitoring trauma patients during 
resuscitation, particularly abdominal trauma, it is of paramount importance to monitor 
perfusion and oxygen uptake in the intestines which are relatively thin and transparent to 
light [131, 132]. The human jejunum is 3.5 to 4 mm in thickness and probing it with 
conventional NIR probes leads to high background signals and causes strong motion 
artifact from the lumen of the intestine and/or other tissue surrounding it [133]. This is 
problematic for any optical technique and in particular to PPG sensors that measure the 
inherently weak arterial pulsatile signal (0.2-5.2%), which can sometimes be overridden 
by these motion artifacts [48]. In addition, because of the small volume of probed tissue, 
the hemoglobin signal is usually weak. Previous studies by Hickey et al. showed that 
using shorter source to detector separations can lead to better PPG signals from the 
splanchnic organs such as the bowel and stomach [39, 134]. However, wavelength 
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selection was not discussed which is essential to maximize the signal to background ratio 
from the small probed volume. Moving to the visible wavelengths range where 
hemoglobin absorption is an order of magnitude higher than its NIR counterpart, 
increases the sensitivity to hemoglobin changes. In this paper, a thorough theoretical 
analysis of the problems of monitoring perfusion and oxygenation using NIR light in the 
intestine are presented. Monte Carlo simulations to support the findings as well as 
potential solutions are also proposed and tested. Finally, the results are verified with 
preliminary in vivo porcine studies with a sensor based on the PPG technique.  
Materials and Methods 
In order for an optical sensor to succeed in monitoring perfusion and oxygenation 
changes in the intestine it has to satisfy a few conditions: 1- High sensitivity to 
hemoglobin concentration changes, 2- Optical contrast between the two oxygenation 
states of hemoglobin at the selected wavelength(s) and 3- Penetration depth that is 
sufficient to satisfy conditions 1 and 2 but that does not exceed the thickness of the 
probed tissue (< 3 mm). In the following paragraphs of this section, the methods used to 
adjust these parameters to conform to the proposed criteria are presented. The two main 
independent variables are: illumination wavelengths and source to detector separation. 
Perfusion and Oxygenation Signal 
Hemoglobin absorption is the main source of contrast in monitoring perfusion 
and oxygenation changes. To study the strength of the signal at different wavelengths, 
we look at the absorption coefficient dynamic range due to perfusion and oxygenation 
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changes. This is followed by Monte Carlo simulations that consider the contribution of 
both the absorption and scattering of light in tissue. 
The oxygenation signal is mainly a result of the change in the absorption 
properties of hemoglobin when it switches between its oxygenated and deoxygenated 
state (HbO2 and Hb respectively). A typical pulse oximeter would operate two Red-NIR 
wavelengths of light: one that is more sensitive to oxy-hemoglobin and the other more 
sensitive to deoxy-hemoglobin. Most sensors employ a third wavelength at an isobestic 
point that has optical properties independent of the oxygenation state. This wavelength is 
typically used to measure and/or separate the contribution of other hemoglobin forms 
(met-hemoglobin and carboxy-hemoglobin) as well as other confounder chromophores 
and dyes in the selected spectral region [34, 135]. A common method of studying the 
oxygenation signal as a function of wavelength is to look at the differences between the 
optical properties of oxy- and deoxy-hemoglobin. These differences are mainly due to 
the absorption coefficient since the scattering properties of blood have been shown to be 
relatively independent of its oxygen content [30]. Equation (VI.1) was used to look at 
the oxygenation signal at each wavelength. Note that the zero crossings of that equation 
correspond to isobestic points.  
  ,, 2HbOHbS   (VI.1) 
 In equation (VI.1) S is the difference signal and εHb,λ and εHbO2,λ are the absorption 
coefficient of deoxy- and oxy-hemoglobin respectively. 
The perfusion signal is a result of the change in blood volume in the tissue. To 
simulate that signal, the full dynamic range due to changes in blood volume is examined. 
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This is quantified by the difference in absorption coefficient between normally perfused 
tissue and unperfused (ischemic) tissue (eq. (VI.2)). This quantity, designated SBR, has 
the same trend as the signal to background ratio (blood to total signal). Further details on 
equations VI.1 and VI.2 are described in the supplementary information.  
 

 

,,
,,
tissueperfused
tissueperfused
SBR


  (VI.2) 
These simplified equations served as a guide for the simulations.  Specifically, 
they provided information regarding which wavelengths are viable candidates for 
determining appropriate oxygenation and perfusion signals and which ones are less 
sensitive to hemodynamic changes. The performance of the wavelengths of interest 
guided by the above 2 equations was modeled using Monte Carlo simulations as 
described in a later section (Monte Carlo Model). 
Penetration Depth 
The penetration depth properties were assessed using the equations derived by 
Weiss et al. based on a random walk model [73]. The first quantity of interest is the 
mean penetration depth (Z). This symbolizes the average penetration depth of a group of 
photons launched into a medium. This quantity is a function of the optical properties (µa 
and µs’) of the medium, which in turn depend on the wavelength of light and the distance 
from the source to detector (r) used to collect these photons (eq. (VI.3)).  
  4
1,
2
1
476.0
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r
r
Z



  (VI.3) 
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In equation (VI.3), µa and µ’s are the absorption coefficient and the reduced 
scattering coefficient of the medium (perfused tissue) respectively. In addition, r is the 
source to detector separation. Although important in describing how deep photons 
propagate in the medium, the mean penetration depth (Z) described above does not 
provide the full picture needed to understand the probing volume nor what percentage of 
photons are probing the intestine lumen and/or surrounding tissue. To obtain that 
information, the probability density function (p) of the penetration depth is calculated as 
described in equation (VI.4) [73]. The equation describes the distribution of the collected 
photons over depth for which z represents the depth in tissue which is different from the 
mean penetration depth Z. 
    





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z
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2
2
1
2
1
, .48exp..38   (VI.4) 
Note that equations 3 and 4 assume a homogeneous infinite medium of perfused 
tissue. The optical properties are also considered to be the weighted average of tissue 
and fully oxygenated blood (SO2=100%) and all of these equations (VI.1 – VI.4) are 
evaluated in MATLAB (Mathworks inc, MA). 
Monte Carlo Model 
For the Monte Carlo (MC) simulations, the MCML program developed by Wang 
et al. was employed [66]. The medium was considered a single layer of homogeneous 
tissue. The optical properties were varied to model changes in the perfusion and 
oxygenation state as shown in Table 4. Eight commercially available LED wavelengths 
were selected for the simulations. The optical properties used for the intestine tissue 
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were reported by Chan et al. [132]. The tissue refractive index and anisotropy factor 
were assumed to be 1.4 and 0.9 respectively. There are numerous references for the 
optical properties of blood but the ones used in this work were based on the data 
reported by Scott Prahl [31] and Friebel et al. [30]. The refractive index of blood was 
assumed to be constant at 1.4. Previous work has shown that changes in whole blood 
refractive index are minimal and that the refractive index ranges between 1.375 and 1.4 
for the wavelength range of interest [136]. Every MC simulation consisted of 10 million 
photon packets. 
 
Table 4. Optical properties of the human jejunum and oxygenated & deoxygenated 
blood. The absorption and scattering coefficients in the table are all in cm
-1
. 
 
Wavelength 
(nm) 
Tissue  Oxygenated Blood  Deoxygenated 
blood 
µa µs g  µa µs g  µa µs g 
470 3.98 129.2 0.9  177.8 400.8 0.996  86.5 400.8 0.996 
525 2.65 107.5 0.9  165.4 392.0 0.995  188.3 392.0 0.995 
590 3.08 129.2 0.9  77.12 329.5 0.992  151.7 329.5 0.992 
630 1.5 81.6 0.9  3.26 316.0 0.992  27.57 316.0 0.992 
660 1.32 76.8 0.9  1.71 315.0 0.991  17.28 315.0 0.991 
735 1.47 69.2 0.9  2.21 304.2 0.992  5.90 304.2 0.992 
805 1.73 65.8 0.9  4.49 292.5 0.991  3.93 292.5 0.991 
850 2 64 0.9  5.67 282.5 0.991  3.70 282.5 0.991 
 
 
In the case of perfused tissue, the medium was considered homogeneous and the 
optical properties were set to the weighted average of the two (tissue and blood). Skinner 
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et al. reported that the percentage of vasculature within the mucosa of the colon tissue 
varies between 7.7 and 13.4 %v/v depending on the exact location (proximal, mid and 
distal colon) [137]. This number should be a fair estimate of the percentage of 
vasculature in the small intestine. In the model 12% was used as the percentage of 
vasculature. 
Instrumentation 
To verify the results of the model, data was collected using a PPG sensor system 
developed by our group. The instrumentation has been previously described in detail and 
the performance of the system has been validated on phantoms and liver tissue [38, 63, 
104, 105, 138]. In brief, the sensor system interface board has four channels each that 
can drive a three wavelength PPG probe. The wavelengths are time multiplexed and the 
reflected light is collected using a single photodetector. The collected signal from each 
sensor, after passing through a pre-amp, is split into two channels. The first channel, the 
AC channel, has a band-pass filter with cutoff frequencies (f3dB) at 0.15 and 15 Hz. It 
should be noted that the high-pass cutoff frequency in the band-pass filter was set at 0.15 
Hz to separate the DC level from the AC signal. The pulsatile AC signal is known to be 
around 0.2 to 5.2% of the total collected signal [48] and requires high gain amplification; 
however, it is essential that the DC signal be eliminated from the amplification channel 
to avoid saturation and that is the role of the 0.15 Hz cutoff filters. In the new generation 
of this device, the cutoff frequency is set at 0.55 Hz to also eliminate the respiratory 
motion. The filtered AC signal passes through a variable gain amplifier that allows for 8 
gain settings in the range of 1- to 400-V/V. In the second channel, the DC channel, the 
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signal passes through a low pass filter with a 3 dB cutoff frequency at 0.15Hz. The same 
process is applied to all three wavelengths of each sensor resulting in a total of 24 
channels (4 sensors, 3 wavelengths each, AC and DC signals). All channels are digitized 
and sent to a computer for processing via a USB-6529 (National Instruments 
Corporation, TX).  
Two types of probes were used in the in vivo porcine study. The NIR probes, 
which our group has used in the past to measure perfusion and oxygenation in liver 
tissue, consist of three wavelengths 735, 805 and 940 nm (L660/735/805/940-40B42, 
Epitex Inc., Japan) [38, 104, 105]. All three wavelengths are packaged in the same lens 
to probe the same location and avoid problems associated with tissue perfusion 
heterogeneity. The second set of probes was fabricated for the sole purpose of this study 
and consists of visible wavelengths bands centered at 465, 525 and 639 nm (part number 
LED528EHP, LED465E, LED630E respectively, Thorlabs Inc., MD, USA). Each of the 
wavelengths is a separate LED with a separate lens. The three LEDs were placed at three 
of the corners of the photodetector to insure the source to detector spacing is the same 
for all wavelengths. Both probes used the same silicon photodetector (S2833-01, 
Hamamatsu, Japan). The edge to edge separation on all probes used in this work was 
approximately 2 mm (equivalent to 6-7 mm center to center separation). The visible 
probes were coated with polydimethylsiloxane (PDMS) to protect the circuitry from the 
wet tissue. Figure 73 shows the sensor interface and the probes. 
 
  
140 
 
 
Fig. 73. The benchtop PPG sensor (on left) including the laptop, data acquisition card 
and sensor interface electronics (from left to right). The right panels show the visible 
(upper) and NIR LEDs (lower) used in this study.  
 
In Vivo Porcine Study 
All animal studies were performed under an animal use protocol (AUP #2010-
257) approved by the Institutional Animal Care and Use Committee at Texas A&M 
University. The study was performed on a pig (body weight 27.5 kg). The pig was 
premedicated with Telazol 5-10 mg/kg. Buprenorphine 0.01-0.05 mg/kg was used as an 
analgesic.  Both drugs were introduced intramuscularly 10 to 15 minutes prior to 
anesthesia induction. Initial anesthesia was induced via inhalation of 3-4% Isoflurane in 
Oxygen at 3 L/min. An endotracheal tube was placed and connected to a breathing 
circuit. Anesthesia was maintained by inhalation of Isoflurane (0.5-4%) in Oxygen (15 
mL/lb). Once the animal was anesthetized, a laparotomy was performed to get access to 
the intestine. The two PPG probes (NIR and VIS) were placed in adjacent spots on the 
serosal surface of the jejunum and sutured in place. Throughout the operation, the 
animal’s vital signals (SpO2, pressure, heart rate, temperature and respiratory rate) were 
monitored and recorded. To alter the perfusion levels, the intestine was clamped for 
short durations (<1min) throughout the study. The PPG signals on both probes were 
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recorded continuously before, during and after the occlusions. At the end of the data 
collection, while still anesthetized, the animal was euthanized with a barbiturate 
derivative solution administered intravenously (80-120 mg/kg). 
Results and Discussion 
Perfusion and Oxygenation Signals 
Using equation (VI.2), the changes in signal to background ratio as a function of 
wavelength (Fig. 74) were investigated. The visible wavelengths were shown to carry a 
higher signal from blood relative to tissue.  The results of this equation (solid line in Fig. 
74) were compared to the ratio of reflectance from the perfused and unperfused cases 
from a MC simulation (dots in Fig. 74). The two methods show the same trend 
indicating a higher perfusion signal from the visible wavelengths. The signal (reflectance 
ratio) is over an order of magnitude higher at 470 nm compared to the NIR wavelengths 
(735, 805 and 940 nm). Note that the three wavelengths of 470, 525 and 590 nm have 
similar levels of perfusion signal. This quantity was calculated for the case of 
oxygenated and deoxygenated blood and the results are similar in both cases (data shown 
in the supplementary information). In summary, at 470 nm the signal is higher in the 
oxygenated case while for the 590 nm wavelength the signals are flipped and the 
deoxygenated case shows a higher level of signal. The 525 nm showed the same levels 
of signal independent from the oxygenation level and can be used as an isobestic 
wavelength.  
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Fig. 74. Perfusion signal as a function of wavelength when the intestine is perfused with 
oxygenated blood. The solid lines show the SBR calculated from the change in the 
optical properties between perfused and ischemic tissue (eqn. VI.2). The dots are the 
Monte Carlo simulation results at the wavelengths of interest. The data show over an 
order of magnitude enhancement when moving from the NIR to VIS wavelengths.  
 
Equation (VI.1) was used to better quantify the oxygenation signal. The zero 
crossings in that equation indicate isobestic points in the hemoglobin spectrum (Fig. 75 
– solid line). Since this equation is simplified and does not take into account the effects 
of scattering, tissue optical properties and geometry, we compared the results to the 
change in reflectance measured from MC simulations (|ROxy - RDeoxy|) as reflected by the 
red dots in Fig. 75. The results show that the level of the oxygenation signal is similar 
for both the visible and NIR wavelengths. Moreover, there are multiple wavelengths in 
the visible range that can be used as isobestic points. Note that the oxygenation signal 
defined in equation VI.1 and shown in Figure 75, describes the sensitivity of the sensor 
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to oxygenation changes since it measures the total change in signal over the full range of 
oxygenation (from 0 to 100% saturation). 
 
 
Fig. 75. Oxygenation signal as calculated by equation VI.1 (solid line) and through 
Monte Carlo simulations (red dots). Note the multiple isobestic points in the visible 
range and the bands of oxygenation sensitive wavelengths.  
 
One possible issue in using the visible wavelengths is the narrowness of the 
oxygen sensitive bands which might pose a problem when using LEDs. To test for that, 
the extinction coefficient of hemoglobin over the wavelength band of commercially 
available LEDs was integrated and the ratio of extinction coefficient of oxy- and deoxy- 
hemoglobin over these bands for both the NIR and visible wavelengths were explored. 
This ratio shows the change in hemoglobin absorption coefficient with the change in its 
oxygenation state indicating whether or not a wavelength is sensitive to hemoglobin’s 
oxygen saturation levels. The specifications of the LEDs are based on the datasheets of 
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Epitex LEDs (part # L470-30M32, L525-30T52, L590-35D32 and L660/735/805/940-
40B42) and the full width half max ranged between 14 and 45 nm. The results shown in 
Figure 76 indicate that the 525 and 805 nm LEDs can both be considered as isobestic 
points and their absorption coefficients are independent of the oxygenation level (ratio 
close to 1). The other wavelengths showed similar levels of change (40 to 80% change in 
optical properties) depending on the oxygenation state. The 470 and 940 nm wavelength 
bands are more sensitive to oxy-hemoglobin while the 590 and 735 nm wavelength 
bands are more absorbed by deoxy-hemoglobin. 
 
 
Fig. 76. Ratio of the average absorption coefficient of oxy- to deoxy-hemoglobin over the 
band of commercially available LEDs in the visible and NIR range. The data show that 
the change in the hemoglobin absorption coefficient with oxygenation changes is similar 
for NIR and VIS wavelengths.  
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Penetration Depth 
The simulation results presented in the previous section show that some visible 
wavelength bands (i.e. 470, 525 and 590 nm) carry enough perfusion and oxygenation 
information to be used in a PPG sensor. However, the simulation results do not answer 
the concerns about motion artifacts from the lumen of the intestine and adjacent tissue. 
To study the effects of motion, the mean penetration depth described in equation (VI.3) 
was explored. As shown in Figure 77, the mean penetration depth depends on the 
illumination wavelength and the source to detector separation (A plot of mean 
penetration depth vs. source to detector separation is provided in the supplementary 
information). There is a clear increase in the penetration depth when moving from 
visible to NIR wavelengths and that is why this region of NIR is sometimes referred to 
as the therapeutic window. Note that even for a 16 mm separation, the mean penetration 
depth of NIR wavelength is still under 3 mm. However, different photons penetrate to 
different depths in tissue and the mean penetration depth is only the average and does 
not represent the maximum penetration of photons.  
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Fig. 77. Mean penetration depth for different source to detector separations as a 
function of wavelength. The legend shows the corresponding source to detector 
separation for each line (In case colors are not available, note that the legend is in the 
same order as the lines appear on the graph).  
 
Although the mean penetration depth provides insight into the relationship 
between the penetration depth and the wavelengths and source to detector separation, it 
does not tell the full story. To assess the amount of light probing the background, the 
probability distribution of the penetration depth given by equation (VI.4) is investigated. 
Below is an example of the probability distribution for the two studied isobestic points 
(525 and 805 nm). The mean wall-thickness used for the human small intestine is 4 mm 
[133]. This number varies across patients and even across different areas of the intestine 
of the same patient, however, the serosal side of the intestine is where perfusion should 
be monitored and the penetration depth there should be limited to around 3 mm. 
Anything past that limit is assumed to contribute to the background signal. The data in 
Figure 78 show that approximately 25.25% of photons probe the background when using 
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NIR wavelengths and a 16 mm separation. This can be reduced by either limiting the 
source to detector separation to less than 6 mm for the NIR wavelengths or using visible 
wavelengths with separations up to 20 mm. As mentioned earlier, most NIR based 
sensors utilize separations that are greater than 10 mm. Furthermore, if the sensor is 
utilizing regular LEDs and photodiodes, the average diameter of each is approximately 5 
mm which constrains the source to detector separation, measured from center to center, 
to 5 mm or more. Moving to the visible wavelengths gives more flexibility in the 
geometry of the probe.  
 
 
Fig. 78. Probability density function of the photon penetration depth for the visible and 
NIR isobestic wavelengths (525 and 805 nm) for multiple source to detector separations.  
 
Figure 79 shows the transmittance and reflectance data from the MC simulation.  
Transmittance is the amount of light that was transmitted through the wall relative to the 
light that was incident on the tissue. It is three to seven orders of magnitude lower for 
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visible wavelengths compared to their NIR counterparts. Furthermore, this decrease in 
the transmittance does not reduce the reflectance substantially. The reflectance is the 
light intensity collected at the surface of the tissue relative to the intensity coming from 
the source.  
 
 
Fig. 79. Transmittance (squares) and reflectance (dots) as a function of wavelength as 
calculated by MC simulations. Note that the y-data is shown on a log scale.  
 
In summary, the modeling indicates that the visible wavelengths (470, 525 and 
590 nm) have a better perfusion signal with similar oxygenation signal compared to their 
NIR counterparts. The green (525 nm) wavelength can be used as an isobestic point if 
needed. Moreover, all three visible wavelengths have similar perfusion signal levels and 
similar penetration depths. This is imperative to insure similar probing volumes and 
avoid problems associated with perfusion heterogeneity that can lead to erroneous 
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oxygenation results [58]. In addition, at typical separation distances, NIR wavelengths 
penetrate through the wall of the intestine to probe its lumen, and sometimes 
neighboring tissue. This results in high background signals that can vary tremendously 
with motion artifact. In the following section, preliminary in vivo results are presented 
that validate and fortify these theoretical findings. 
In Vivo Porcine Study 
Data was collected from the jejunum using two probes simultaneously. One of 
the probes had three NIR wavelengths (735, 805 and 940 nm) while the second probe 
had three visible wavelengths (470, 525 and 630 nm). As shown in the modeling results 
in the previous section, the red LED (630 nm) used in the visible probe for these 
experimental results was not optimal since it would pick up a strong background. 
However, at the time of the study the 590 nm LED was not available so the 630 nm LED 
was used as a reference since it uses the same photodetector as the other visible 
wavelengths and is probing the same tissue. Figure 80 shows the time domain PPG 
waveform collected on each of the wavelengths (on right) and the corresponding Fast 
Fourier Transform (on left). Three peaks can be seen in the spectra: 1) 0.25 Hz which 
corresponds to the respiratory rate (15 breaths/min); 2) 2.18 Hz corresponding to the 
cardiac cycle peak (130.8 beats/min); and 3) 3.95 Hz that corresponds to a non-
thermoregulatory shivering motion. Note that the body temperature was closely 
monitored and controlled throughout the study. Multiple reports discuss the non-
thermoregulatory shivering that is common in an anesthetized animal but still not 
completely understood [139, 140]. This high frequency motion peak was slightly shifted 
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on the NIR probe (4.61 Hz) compared to the VIS probe (3.95 Hz) which might be due to 
the different wavelengths probing different locations or different depths. 
 
Fig. 80. The time domain (right column) PPG signal collected in vivo and the 
corresponding FFT spectrum (left column) for VIS and NIR wavelengths. In Figure 96 in 
Appendix H the 1-5 Hz region is zoomed in showing the cardiac cycle and high 
frequency motion peaks.  
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In Figure 80 it was shown that the NIR wavelengths have a much greater 
background at low-frequency. In addition, the cardiac cycle peak, which carries 
information about arterial blood, is higher for the visible wavelengths (see zoomed in 1 
to 5 Hz range in Figure 96 in Appendix H). These findings indicate that the visible 
wavelengths have higher blood signal and lower background levels and verify the 
modeling from the previous section. To quantify the signal to background enhancement, 
the ratio from these spectra is plotted as shown in Figure 81. The signal to background 
ratio is defined as the ratio of the cardiac cycle peak to the highest background frequency 
component above 0.15 Hz (DC excluded). Compared to the signal to background ratio 
from the Monte Carlo simulations (red dots) it can be seen that both quantities follow the 
same trend and show a better performance for the visible wavelength range compared to 
the traditional NIR wavelength range. Note that the Monte Carlo simulations assumed 
monochromatic sources while the in vivo data were collected with LEDs that had a 
bandwidth (FWHM~14-45 nm). This accounts for some of the discrepancy in the results 
for the 630 nm wavelength that falls on the tail of the decaying SBR graph. The LED 
data show a higher SBR for that wavelength compared to the model in part, because it is 
integrating over that tail. 
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Fig. 81. The signal to background ratio from the in vivo porcine data (black squares) 
compared to the Monte Carlo simulations results (red dots).  
 
To verify that the cardiac cycle peak is not motion artifact and is in fact probing 
the microvasculature, the part of the small intestine that had the optical probes was 
occluded for short periods of time (~30s). The probes recorded data continuously 
throughout the process (4 occlusions and 4 baselines). The Fast Fourier Transform (FFT) 
was applied to a sliding window (25 seconds in width and shifted 10 seconds for every 
data point) and the cardiac cycle peak was detected using an automated program 
implemented in MATLAB (Mathworks, Inc.). The cardiac cycle peak was monitored 
during baseline and occlusion periods (Figure 95, Appendix H).  Figure 82 shows the 
change in the peak amplitude due to the drop in perfusion during occlusions at the two 
visible wavelengths (470 and 525 nm). The data show that the peaks correlate well with 
perfusion changes and can discriminate the baseline and occlusion state (p<0.05, two 
pair student t-test). The goal of these studies was to assure that the detected signal was 
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due to the microvasculature perfusion. In the future, the sensor will be optimized and 
quantitative studies comparing its performance to other monitors (i.e. Laser Doppler) 
will be conducted to assess the accuracy, sensitivity and resolution of the sensor to 
perfusion and oxygenation changes. The inspired oxygen level was maintained constant 
during these studies. The modulation ratio (R) was calculated using the data from the 
two visible wavelengths (470 and 525 nm) as shown in figure 95 in the Appendix H. 
 
 
Fig. 82. In vivo porcine occlusion study data. The left panel shows the change in time of 
the FFT peak on the two wavelengths of interest. The grey areas correspond to the 
occlusion periods. The right panel shows the average of the FFT peaks during baseline 
and occlusion periods.  
 
The findings presented in this chapter can be applied to other cases where limited 
penetration depth is desired. One example is monitoring skin oxygenation and perfusion 
which is of interest in cases such as wound healing and critical limb ischemia [141, 142]. 
As discussed earlier, current perfusion and oxygenation systems are optimized to probe 
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relatively deep tissue and when sensors are applied to the skin, the collected signal is 
mainly probing muscle vasculature and reflects muscle rather than skin hemodynamics 
which is a desired property when studying muscle physiology [128, 143, 144]. The 
reported findings can be applied to measure skin perfusion and oxygenation changes for 
the aforementioned applications or coupled with NIRS measurements of muscle 
hemodynamics to correct for small variations in the muscle signal due to skin perfusion. 
Chapter Conclusions 
In this chapter, we investigated the use of the sensor described in this thesis for 
other applications provided some minor changes. In particular, we investigated the 
challenging application of monitoring intestinal tissue that presents challenges in high 
background signals and low hemoglobin signature due to weak perfusion.  The use of the 
bench-top photoplethysmography sensing system with visible and NIR wavelengths was 
modeled and tested in vivo for use as an intestinal perfusion and oxygenation sensor. 
This type of sensing system, once optimized and reduced in size, could be a critical 
improvement for monitoring trauma patients during resuscitation. By modeling the 
signal in the visible wavelength range (i.e. 470, 525 and 590 nm), it was shown that the 
perfusion signal could be increased and the background signal reduced while keeping the 
same levels of oxygenation sensitivity as traditional NIR sensors. In addition, it was 
shown that by using small source to detector separations (6 mm or less) the background 
signals collected from the lumen of the intestine and/or surrounding tissue can be 
decreased by limiting the probing depth. These findings were confirmed in an in vivo 
porcine study by comparing NIR and VIS LED based probes. VIS wavelengths had a 
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higher signal to background ratio than NIR wavelengths. In addition, we used the sensor 
to monitor perfusion changes during in vivo occlusion studies and showed that the signal 
correlates with the perfusion state. 
These results show the possibility of employing the technology described in this 
dissertation in a variety of applications provided minor adjustments. 
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CHAPTER VII 
CONCLUSIONS AND FUTURE WORK 
 
Every year, over 6,000 patients receive a liver transplant in the United States 
alone [5] and we still don’t have a continuous sensor to monitor the graft in real-time 
and alert the medical staff of any complications. Such a device could have a great impact 
on patient survival and retransplantation rates. In this thesis, a perfusion and oxygenation 
sensor is described. The sensor is designed to operate on batteries and transmit data 
wirelessly with the goal of building an implantable sensor that can monitor hepatic 
hemodynamics in the first two weeks post-surgery. Nearly 60% of graft failures take 
place during that period [7]. 
The first part of this thesis (Chapters I-III) focused on describing the theory of 
the used optical techniques and the instrumentation of the sensor. The sensor combines 
the principles of pulse oximetry and near infrared spectroscopy. This allows for 
measuring and separating the hemoglobin oxygen saturation of the supply and venous 
vasculature and subsequently providing a measure of oxygen consumption to assess 
oxidative stress. In addition, the sensor tracks perfusion changes. The relative measure of 
perfusion, coupled with the oxygenation readings gives an assessment of the sufficiency 
of nutrients supply to the tissue. The sensor uses three wavelengths of light in the tissue 
optical window (also known as therapeutic window) where light can penetrate deeper in 
tissue. The three light emitting diodes are time multiplexed allowing for the use of a 
single photo-detector to collect the signal from the three sources. Band-pass filters were 
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designed to separate the DC component from the weak pulsatile signal for amplification. 
The separation between the source and the detector is an important factor in determining 
the performance of an optical sensor based on diffuse reflectance. Simulations and in 
vitro studies showed that higher intensities can be collected at short separations while 
long separations showed a higher signal to background ratio. Separations in the 2-6 mm 
range provided sufficient SBR while maintaining high levels of reflectance which allows 
the use of less power on the light sources to save battery power. In addition, the effect of 
wavelengths selection was studied and the 735, 805, and 940 nm wavelengths were 
found to have a good oxygenation signal, penetration, and performance consistency over 
a wide range of oxygen saturation levels. In addition, LEDs are commercially available 
at these wavelengths.   
The latter part (Chapters IV-VI) described the testing of the sensor in vitro, ex 
vivo, and in vivo. Phantoms were designed to mimic the anatomy of the liver vasculature 
and the optical and mechanical properties of hepatic tissue. These phantoms were used 
in fluidic circuits that simulate hepatic blood flow. Dye mixtures were designed to 
mimic the optical properties of blood in the desired wavelength range and eliminate the 
use of blood in the in vitro testing. The sensor detected oxygen saturation changes with a 
prediction error of 1.3% within a study and 4.6% across studies. These errors are on the 
same order as the preparation error of the different dye solutions used in the study. In 
addition, perfusion changes were resolved with a resolution of 0.07 mL/min/g. Similar 
results were obtained with the ex vivo rat liver perfusion studies where the RMSE in 
detecting perfusion changes was found to be 0.08 mL/min/g of tissue. Finally, the sensor 
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was tested in a series of in vivo porcine studies. In these studies we were able to measure 
venous oxygenation, arterial oxygenation, and perfusion with an RMSE of 3.93%, 
2.82%, and 0.13 mL/min/g respectively. 
Future work should focus on miniaturizing the electronics to make the sensor 
implantable. Different coating and fixation strategies should also be investigated. In 
particular, photonic textiles can be used to design a probe that is flexible and easy to fix 
on tissue [145]. Some groups have shown the possibility to fabricate an “electronic 
patch” that coats the sensor electronics and adheres to skin [146]. In the design of the 
sensor, the addition of a second detector at a different distance from the source provides 
a measure of the differential pathlength factor which is needed to calibrate the 
measurements of the sensor. This feature will be most valuable for long term studies 
where the calibration factor might change over time due to sensor encapsulation and/or 
movement. In addition, the use of multiple detectors will increase the collected light 
intensity and different processing methods can be used to benefit from that. The use of 
custom made photodetectors can increase the active area of detection without increasing 
the probe size leading to higher signal levels [61]. 
In addition, the preliminary results from the PPG waveform analysis are very 
promising. This part of the signal is very rich in information that is still to be studied and 
understood. Investigating and quantifying tissue mechanical properties non-invasively 
has many other potential applications ranging from monitoring wound healing, to 
fibrosis of various types of tissue. 
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APPENDIX A 
MONTE CARLO SIMULATION SOFTWARE  
 
%%%%%%%%%%%%%%%%%%%%%%%monte_carlo_6.m%%%%%%%%%%%%%%%%%%%% 
%This program was last updated on July 22,2010 
%V6 has the added feature of specifying the numerical aperture of the  
%light source 
%V5 It includes the extra output of penetration depth at different  
%detector positions 
%The diffuse reflectance is calculated as a function of r and z where r  
%is the radial distance from the source and z is the penetration depth 
%In previous versions the diffuse reflectance was calculated as a  
%function of x and y 
clear all 
tic 
nb_of_photons=1000000; 
step_size=0.01; 
%size_limit=2; 
threshold=0.001; 
NA=0.4;     %numerical aperture of the source 
nb_of_layers=3; 
  
%%%%%%%%%%Define the optical properties%%%%%%%%%%% 
%medium 
nf(1)=1; 
nf(nb_of_layers+2)=1; 
%layer1 
mua(1)=1.1594; 
mus(1)=63.014; 
g(1)=0.925; 
g2(1)=g(1)^2; 
nf(2)=1.33; 
%layer2 
%OXY 7400nm 
mua(2)=2.4084; 
mus(2)=3050; 
g(2)=0.9941; 
g2(2)=g(2)^2; 
nf(3)=1.392; 
%layer3 
mua(3)=1.1594; 
mus(3)=63.014; 
g(3)=0.925; 
g2(3)=g(1)^2; 
nf(4)=1.33; 
%%%%%%%%%%Define the boundaries%%%%%%%%%%%%%%%%%%% 
bnd(1)=0; 
bnd(2)=0.3; 
bnd(3)=1.0; 
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bnd(4)=1.5; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
size_limit=max(bnd); 
r=sqrt(2*(size_limit/2)^2); 
% refl_r=zeros(ceil(r/step_size),size_limit/step_size); 
% absorbed=zeros(ceil(r/step_size)+1,size_limit/step_size); 
refl_r=zeros(5/step_size,size_limit/step_size); 
absorbed=zeros(5/step_size,size_limit/step_size); 
b=0; 
for i=1:(nb_of_layers+1) 
alpha_c(i)=asin(min(nf(i:i+1))/max(nf(i:i+1))); 
end 
for j1=1:100 
for i=1:nb_of_photons/100 
    pos.x=0; 
    pos.y=0; 
    pos.z=0; 
    max_depth=0; 
    alpha_i=asin(NA*rand/nf(1));  % Angle with the z axis, this is 
limited by the NA of the source 
    alpha_t=asin(nf(1)*sin(alpha_i)/nf(2)); 
    muz=cos(alpha_t); 
    Rxy=muz*tan(alpha_t); 
    theta_x=acos(2*(rand-0.5));     %launching angle relative to the x 
axis, the ray has an equal opportunity to be launched at any direction 
relative to X 
    mux=Rxy*cos(theta_x); 
    muy=Rxy*sin(theta_x); 
   
    
    Refl=0.5*((sin(alpha_i-alpha_t)/sin(alpha_i+alpha_t))^2+… 
(tan(alpha_i-alpha_t)/tan(alpha_i+alpha_t))^2); 
     
    weight=1-Refl; 
    layer=1;    %photon enters the first layer 
    while (1) 
    S=-log(rand)/(mua(layer)+mus(layer)); 
     
    if muz<0 
        dS=(bnd(layer)-pos.z)/muz; 
    else 
        dS=-(pos.z-bnd(layer+1))/muz; 
    end 
     
    sg=sign(muz); 
    %%%%%%%%%%%%%%%%%%Surface reflections%%%%%%%%%%%%%%%%%% 
    %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
        while (S>=dS) 
            pos.x=pos.x+dS*mux; 
            pos.y=pos.y+dS*muy; 
            pos.z=pos.z+dS*muz; 
            alpha_i=acos(abs(muz)); 
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            S=S-dS; 
            if 
nf(layer+1)>=nf(layer+1+sg)&&(alpha_i>alpha_c(layer+(sg>0))) 
                Refl=1; 
            else 
                alpha_t=asin(nf(layer+1)*sin(alpha_i)/nf(layer+1+sg)); 
                Refl=0.5*((sin(alpha_i-alpha_t)/sin(alpha_i+alpha_t))^2 
+(tan(alpha_i-alpha_t)/tan(alpha_i+alpha_t))^2); 
            end 
            
            if (rand<=Refl) 
                muz=-muz; 
            else 
                if (muz<0) 
                    if layer==1 
                        r=sqrt(pos.x^2+pos.y^2); 
                        
refl_r(floor(r/step_size+1),floor(max_depth/step_size+1))=… 
refl_r(floor(r/step_size+1),floor(max_depth/step_size+1))+weight; 
                        b=1; 
                        break 
                    else 
                        layer=layer-1; 
                    end 
                else 
                    if layer==nb_of_layers 
                        b=1; 
                        break 
                    else 
                        layer=layer+1; 
                    end 
                end 
                muz=sg*cos(alpha_t); 
                mux=mux*nf(layer+1-sg)/nf(layer+1); 
                muy=muy*nf(layer+1-sg)/nf(layer+1); 
                S=S*(mua(layer-sg)+mus(layer-sg))/… 
(mua(layer)+mus(layer));                 
            end 
            if muz<0 
                    dS=(bnd(layer)-pos.z)/muz; 
            else 
                    dS=-(pos.z-bnd(layer+1))/muz; 
            end 
        end 
        if (b==1) 
            b=0; 
            break 
        end 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%      
         
    pos.x=pos.x+mux*S; 
    pos.y=pos.y+muy*S; 
    pos.z=pos.z+muz*S; 
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    max_depth=max(max_depth,pos.z); 
    theta=acos((1+g2(layer)-((1-g2(layer))/… 
(1-g(layer)+2*g(layer)*rand))^2)/(2*g(layer))); 
    phi=2*pi*rand; 
    albedo=mus(layer)/(mus(layer)+mua(layer)); 
    %r=ceil(sqrt(pos.x^2+pos.y^2+pos.z^2)/step_size); 
     
%     rx=ceil((size_limit/2+pos.x)/step_size+1); %size_limit/2+1 is an 
offset since X and Y can be either negative or positive, the start of 
the array corresponds to -size_limit/2 
%     ry=ceil((size_limit/2+pos.y)/step_size+1); 
    r=floor(sqrt(pos.x^2+pos.y^2)/step_size + 1); 
    rz=ceil((pos.z)/step_size); 
%     if 
(rx<=0)||(rx>size_limit/step_size)||(ry<=0)||(ry>size_limit/step_size) 
%         break 
%     end 
  
  
    %if r>size_limit/step_size 
     %   break 
    %end 
    absorbed(r,rz)=absorbed(r,rz)+weight*(1-albedo); 
    weight=weight*albedo; 
    if (muz>0.9999) 
        mux=sin(theta)*cos(phi); 
        muy=sin(theta)*sin(phi); 
        muz=sign(muz)*cos(theta); 
    else 
        mux_n=sin(theta)*(mux*muz*cos(phi)-muy*sin(phi))/… 
(sqrt(1-muz^2))+mux*cos(theta); 
        muy_n=sin(theta)*(muy*muz*cos(phi)+mux*sin(phi))/… 
(sqrt(1-muz^2))+muy*cos(theta); 
        muz_n=-sin(theta)*cos(phi)*sqrt(1-muz^2)+muz*cos(theta); 
        mux=mux_n; 
        muy=muy_n; 
        muz=muz_n; 
    end 
    if (weight<threshold) 
       roulette=rand; 
        if roulette>0.9 
            weight=weight*10; 
        else 
            break 
        end 
    end 
    end 
     
end 
j1 
end 
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toc 
figure,plot([0.05:0.1:0.05+149*0.1],refl_r(2,:)/nb_of_photons) 
hold on 
plot([0.05:0.1:0.05+149*0.1],refl_r(6,:)/nb_of_photons,'--r') 
plot([0.05:0.1:0.05+149*0.1],refl_r(11,:)/nb_of_photons,'-.m') 
plot([0.05:0.1:0.05+149*0.1],refl_r(21,:)/nb_of_photons,'.-.g') 
legend('d=0.15mm','d=0.55mm','d=1.05mm','d=2.05mm') 
axis([0 5 0 max(max(refl_r(2,:)))/nb_of_photons]) 
xlabel('Penetration Depth(mm)') 
ylabel('Energy(a.u.)') 
title('Point detector at d_(_m_m_) from source') 
hold off 
% figure,imagesc([-size_limit/2:step_size:size_limit/2-step_size],[-
size_limit/2:step_size:size_limit/2-step_size],refl); 
% xlabel('X(cm)') 
% ylabel('Y(cm)') 
%  
% for i=1:size_limit/step_size 
% a(i,:)=absorbed(i,ceil(size(absorbed,2)/2),:); 
% end 
% z=[0:step_size:size_limit-step_size]; 
% figure,imagesc(z-size_limit/2,z,a') 
% xlabel('X(cm)') 
% ylabel('Z(cm)') 
% axis([-size_limit/2 size_limit/2 0 size_limit]) 
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%%%%%%%%%%%%%%%%%%%conv_gauss%%%%%%%%%%%%%%%%%% 
%This program modifies the output of the monte carlo code to take into  
%account the spatial distribution of the source. This is done by  
%convolving the output with the spacial distribution of the source 
  
%%%%%%%%%%%%%%%%%%INPUT%%%%%%%%%%%%%%%%%%%% 
FWHM=2.4;             %Full width half max of the source spatial 
ditsribution in mm 
source_position=0;  % Source position in mm 
s=0.1;              %step size in mm, this should be the same as the 
step size used in the MC code 
size_limit=100; 
  
x=[s/2:s:(size_limit/s-1)*s+s/2]; 
sigma=FWHM/(2*sqrt(2*log(2))); 
source_dist=gaussmf(x,[sigma source_position]); 
figure,plot(x,source_dist) 
axis([0 3*sigma 0 1]) 
xlabel('r(mm)') 
ylabel('Normalized Source Intensity(a.u.)') 
  
for i=1:size(refl_r,2) 
    refl_r_conv(:,i)=conv(refl_r(:,i),source_dist); 
end 
  
figure,plot(x,sum(refl_r_conv(1:size(x,2),:)')) 
title('Diffuse Reflectance from a Gaussian distributed source') 
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%%%%%%%%%%%%%%%%%%%%detector_size.m%%%%%%%%%%%%%%%%%%%% 
%Last modified on June 22, 2011 
%Tony Akl 
%tja161@gmail.com 
%Optical BioSensing Lab (OBSL) 
  
clc, clear Fxy 
x=[0.05:0.05:max(r)]; 
y=[-2.8:0.05:2.8]; 
rmax=max(r); 
%correction_factor=pi*4*0.05*r;%correction_factor=pi*0.1*(2*r+0.1); 
%Fr=sum(refl_r(1:500,:)')./(1000000*correction_factor); 
Fr=C; 
for i=1:size(x,2) 
    for j=1:size(y,2) 
        rij=round(sqrt(x(i)^2+y(j)^2)/0.1); 
        Fxy(i,j)=Fr(rij); 
    end 
end 
refl_xy=Fxy;%*0.0001; %The 0.0001 factor was used to normalize by the 
number of photons and convert from mm2 to cm2 
  
% x2=[2:4:ceil(max(r)/4)*4]; 
% k=1; 
% refl_x4mm=zeros(1,size(x2,2)); 
for i=25:length(x)-28 
    refl_4_5X5_5mm(i-24)=mean(mean(refl_xy(i-
24:i+23,round(size(refl_xy,2)/2)-28:round(size(refl_xy,2)/2)+27))); 
end 
refl_4_5X5_5mm=refl_4_5X5_5mm*2.5*2.4;  %Multiply by the area of the 
detector since we used the average to calculate this quantity 
display('End') 
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APPENDIX B 
DYES PREPARATION  
 
Figure 83 shows the extinction coefficient of the dye mixture mimicking 
oxygenated hemoglobin on different pH levels. The mixture was found to be pH 
sensitive and that is why we started preparing the dyes in a high concentration buffer 
solution. 
 
 
Fig. 83. Absorbance of the oxygenated hemoglobin dye mixture for different pH levels.  
 
The changes in optical properties with pH led to problems with the dyes stability 
as shown in Figure 84. All these problems were resolved when using a high 
concentration PBS buffer (100 mM, pH 7.4). 
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Fig. 84. The change in optical properties of the oxy-hemoglobin dye mixture over 24 
hours when prepared in a 10 mM PBS buffer solution.  
 
Another problem that was encountered with the dyes was the clogging of the 
microfluidic channels. The dye mixtures were forming large aggregates over time and 
causing the microchannels to clog and eventually rupture under pressure. Figure 85 
shows the aggregation of dyes. The use of 100 mM PBS buffer eliminated this problem.  
 
 
Fig. 85. Picture of the oxy-hemoglobin dye mixture aggregation. 
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APPENDIX C 
PUMP CONTROL SYSTEM  
 
This appendix shows the virtual instrument (VI) designed in LabVIEW to control the 
pumping circuit and read the values of a thermistor to provide a measure of temperature 
when needed. This VI was used in the in vitro and ex vivo studies to control flow and/or 
monitor temperature. 
Fig. 86. Block diagram of the LabVIEW virtual instrument (VI) used for the in vitro 
studies. 
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Fig. 87. Pictures of the front panel of the LabVIEW virtual instrument (VI) that controls 
the pumps and reads data from the thermistor to provide a measure of the temperature. 
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APPENDIX D 
STRESS STRAIN TESTING  
 
% This program calculates the Young's Modulus from the stress-strain 
data 
% obtained by the instron machine 
% It was created on 9/18/2011 
% Tony Akl 
% tja161@gmail.com 
% Optical Biosensing laboratory 
% Texas A&M University 
% 
clc 
[fname, fpath]=uigetfile({'*.csv','Comma Separated Values 
(*.csv)';'*.txt','Text Document (*.txt)';'*.xls','Excel 2003 Worksheet 
(*.xls)';'*.xlsx','Excel 2007 Worksheet (*.xslx)';'*.*','All files 
(*.*)'}); ; 
prompt = {'Length (mm)','Thickness (mm):','Width (mm):'}; 
dlg_title = 'Input Young''s Modulus calculations'; 
num_lines = 1; 
def = {'15','4.1','3.03'}; 
answer = inputdlg(prompt,dlg_title,num_lines,def); 
len=str2num(char(answer(1))); 
thickness=str2num(char(answer(2)));width=str2num(char(answer(3))); 
data=importdata(strcat(fpath,fname)); 
time_s=data.data(:,1);extension_mm=data.data(:,2); 
load_N=data.data(:,3); 
fig = figure; 
plot(extension_mm,load_N) 
ylabel('Load (N)'),xlabel('Extension (mm)') 
dcm_obj = datacursormode(fig); 
set(dcm_obj,'DisplayStyle','datatip',... 
'SnapToDataVertex','off','Enable','on') 
[X1 Y1]=input_selection(dcm_obj); 
[X2 Y2]=input_selection(dcm_obj); 
A=width*thickness; 
P=(Y2-Y1)/A; 
slope=(Y2-Y1)/(X2-X1); 
display(strcat('The calculated slope is:  ', num2str(slope),' N/mm')); 
YM=P/((X2-X1)/len); 
display(strcat('The calculated Young''s Modulus is:  ', num2str(YM),' 
MPa')); 
msgbox(strcat('The calculated Young''s Modulus is:  ', num2str(YM),' 
MPa')); 
close(fig) 
 
 
function [X Y]=input_selection(dcm_obj) 
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uiwait(msgbox('Select one point on the linear part of the curve then 
press Enter')) 
k=0; 
while(k==0) 
    k=waitforbuttonpress; 
end 
  
btn=questdlg('Are you satisfied with your selection?'); 
while btn(1)=='N' 
    uiwait(msgbox('Select one point on the linear part of the curve 
then press OK')) 
    waitforbuttonpress 
    btn=questdlg('Are you satisfied with your selection?'); 
end 
if btn(1)=='C' 
    X=0;Y=0; 
    return 
end 
pt = getCursorInfo(dcm_obj); 
X=pt.Position(1); 
Y=pt.Position(2); 
end 
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APPENDIX E 
FAST FOURIER TRANSFORM PROCESSING  
 
This section shows two examples of MATLAB code for processing the PPG 
signals using an FFT based algorithm. The first example processes all data as one 
segment while the second example splits the data in multiple time windows and the 
results show the temporal trends. 
%Last updated 06-26-2012 
%Latest updates: Input dialog box and time limits  
%                Figures saved automatically 
%Tony Akl 
%tja161@gmail.com 
%% 
%%%%%%%%%%%%%%%%%%%%%%%%Data Input%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
data_dir=uigetdir(strcat(dropbox_path,'Research\Perfusion sensor 
project\Perfusion Sensor documents\Animal Studies\Porcine\EXP 06-29-
2011(Oxygenation studies)\TAMU 6-28-2011\Exp10\'),'Pick a directory'); 
base_filename='Run6_Probe'; 
nb_of_files=1; 
first_file=0; 
Fs=300;     %sampling frequency in Hz 
minf=1.3; 
maxf=5; 
cut_off=0.2; 
nb=1; 
start_time=0;   %starting time in seconds 
end_time=-1;    %ending time, if set to an invalid number (negative or 
bigger than limit) it will read until the end of the data file. 
probes=[1,2,3,4]; 
default_answer={'',num2str(nb_of_files),num2str(first_file),num2str(Fs)
,num2str(minf),num2str(maxf),num2str(cut_off),num2str(start_time),num2s
tr(end_time),num2str(probes)}; 
answer=inputdlg({'Comments:','Number of files to read:','First file 
index:', 'Sampling frequency (Hz):',... 
    'Minimum expected frequency (Hz):','Maximum expected frequency 
(Hz):', 'Threshold (For peak power calculations,0-1):',... 
   'Start time (Set to 0 for invalid answers):','End time (Set to the 
end of data file for invalid answers):','Probes to be 
processed:'},'Inputs',1,default_answer); 
a_num=str2num(char(answer(2:9))); 
nb_of_files=a_num(1); first_file=a_num(2); Fs=a_num(3); minf=a_num(4); 
maxf=a_num(5); cut_off=a_num(6);start_time=a_num(7);end_time=a_num(8); 
probes=str2num(char(answer(10)));comm=answer(1); 
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gain=[(3+1)*440/8 (1+1)*440/8 440 440]; 
%% 
%%%%%%%%%%%%%%%%%%%%%%%%%Main Program%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Reading data 
cd(data_dir) 
if data_dir(length(data_dir)) ~= '\' 
    data_dir=strcat(data_dir,'\'); 
end 
start_time=start_time*Fs+1-first_file*60*Fs; 
end_time=end_time*Fs+1-first_file*60*Fs; 
for p1=1:length(probes) 
p=probes(p1); 
fname=strcat(data_dir,base_filename,num2str(p),'_'); 
data_all=importdata(strcat(fname,num2str(first_file),'.txt')); 
%data_all=importdata(strcat(base_filename,'.txt')); 
file1=first_file; 
    for i=1:nb_of_files-1 
        if i>nb_of_files-1 
            break 
        end 
        file1=file1+1; 
        temp=importdata(strcat(fname,num2str(file1),'.txt')); 
        data_all=[data_all; temp]; 
    end 
  
if (start_time>=length(data_all))||(start_time<=0) 
    start_time=1; 
    msgbox(strcat('Invalid input. End time set to ', 
num2str(data_all(length(data_all),1)),'s'),'Invalid input') 
end 
if (end_time>length(data_all))||(end_time<=0)||(end_time<=start_time) 
    end_time=length(data_all); 
    msgbox(strcat('Invalid input. End time set to ', 
num2str(data_all(length(data_all),1)),'s'),'Invalid input') 
end 
data_all=data_all(start_time:end_time,:); 
  
  
time=data_all(:,1); 
%AC 
AC735=data_all(:,2); 
AC805=data_all(:,3); 
AC940=data_all(:,4); 
%DC 
DC735=data_all(:,5); 
DC805=data_all(:,6); 
DC940=data_all(:,7); 
%Sum 
total735=AC735+DC735; 
total805=AC805+DC805; 
total940=AC940+DC940; 
%% Fourrier transforms 
n=length(AC735); 
  
195 
 
NFFT=n;%2^nextpow2(n);      % If the NFFT is set at 2^next 
FFT735=fft(AC735,NFFT)/n; 
power735=abs(FFT735).^2; 
FFT805=fft(AC805,NFFT)/n; 
power805=abs(FFT805).^2; 
FFT940=fft(AC940,NFFT)/n; 
power940=abs(FFT940).^2; 
  
% Detecting HR 
f=Fs/2*linspace(0,1,NFFT/2); 
[l kmin]=max(f>=minf); 
[l kmax]=max(f>=maxf); 
[maxFFT735 l]=max(abs(FFT735(kmin:kmax))); 
HR735=f((kmin+l-1)) 
i=kmin+l-2; 
while(abs(FFT735(i))>cut_off*maxFFT735)&&(i>1) 
    i=i-1; 
end 
imin735=i; 
fmin735=f(imin735); 
  
i=kmin+l; 
while(abs(FFT735(i))>cut_off*maxFFT735) 
    i=i+1; 
end 
imax735=i; 
fmax735=f(imax735); 
  
power735=sum(abs(FFT735(imin735:imax735))); 
  
[maxFFT805 l]=max(abs(FFT805(kmin:kmax))); 
HR805=f((kmin+l-1)) 
  
i=kmin+l-2; 
while(abs(FFT805(i))>cut_off*maxFFT805)&&(i>1) 
    i=i-1; 
end 
imin805=i; 
fmin805=f(imin805); 
i=kmin+l; 
while(abs(FFT805(i))>cut_off*maxFFT805) 
    i=i+1; 
end 
imax805=i; 
fmax805=f(imax805); 
power805=sum(abs(FFT805(imin805:imax805))); 
  
[maxFFT940 l]=max(abs(FFT940(kmin:kmax))); 
HR940=f((kmin+l-1)) 
i=kmin+l-2; 
while(abs(FFT940(i))>cut_off*maxFFT940)&&(i>1) 
    i=i-1; 
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end 
imin940=i; 
fmin940=f(imin940); 
  
i=kmin+l; 
while(abs(FFT940(i))>cut_off*maxFFT940) 
    i=i+1; 
end 
imax940=i; 
fmax940=f(imax940); 
power940=sum(abs(FFT940(imin940:imax940))); 
  
%% Plotting and data output 
figure(p),subplot(3,2,1), plot(f,2*abs(FFT735(1:NFFT/2))) 
axis([0 10 0 1.1*max(2*abs(FFT735(kmin:kmax)))]),title(['735 nm';comm]) 
subplot(3,2,3), plot(f,2*abs(FFT805(1:NFFT/2))) 
axis([0 10 0 1.1*max(2*abs(FFT805(kmin:kmax)))]),title(['805 nm';comm]) 
subplot(3,2,5), plot(f,2*abs(FFT940(1:NFFT/2))) 
axis([0 10 0 1.1*max(2*abs(FFT940(kmin:kmax)))]),title(['940 nm';comm]) 
  
h(p)=figure(p); 
subplot(3,2,1), hold on, plot([fmin735 fmin735],[0 4*maxFFT735],'--r') 
plot([fmax735 fmax735],[0 4*maxFFT735],'--r'),hold off 
ylabel('|FFT|'),xlabel('f(Hz)') 
subplot(3,2,3); 
hold on, plot([fmin805 fmin805],[0 4*maxFFT805],'--r') 
plot([fmax805 fmax805],[0 4*maxFFT805],'--r'),hold off 
ylabel('|FFT|'),xlabel('f(Hz)') 
subplot(3,2,5) 
hold on, plot([fmin940 fmin940],[0 4*maxFFT940],'--r') 
plot([fmax940 fmax940],[0 4*maxFFT940],'--r'),hold off 
ylabel('|FFT|'),xlabel('f(Hz)') 
set(h(p),'Units','Normalized') 
set(h(p),'Position',[0 0 1 1]) 
  
flow(nb,1:3)=[abs(maxFFT735) abs(maxFFT805) abs(maxFFT940)]; 
meanDC(nb,1:3)=[mean(DC735) mean(DC805) mean(DC940)]; 
FFT_peak=[maxFFT735 maxFFT805 maxFFT940] 
FFT_power=[power735 power805 power940]*Fs/(NFFT-2) 
DC=[mean(DC735) mean(DC805) mean(DC940)] 
R(p)=(flow(:,1)./meanDC(:,1))./(flow(:,3)./meanDC(:,3)) 
  
HR(p,:)=[HR735 HR805 HR940]*60, AC=[AC735 AC805 AC940];DCt=[DC735 DC805 
DC940];ACDC=AC./DCt; 
ch1_ch3=ACDC(:,1)./ACDC(:,3); 
  
R2(p)= 
log((((maxFFT735/gain(p))+DC(1))./DC(1)))./log((((maxFFT940/gain(p))+DC
(3))./DC(3))); 
PI(p,:)= 100*[maxFFT735/(gain(p)*DC(1)) maxFFT805/(gain(p)*DC(2)) 
maxFFT940/(gain(p)*DC(3))]; 
%% Filter and plot waveforms 
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maxf1=6; 
[b,a]=butter(4,[minf maxf1]/150); 
AC7351=filter(b,a,AC735);AC8051=filter(b,a,AC805);AC9401=filter(b,a,AC9
40); 
t1=strcat(base_filename,num2str(p)); 
t1=replace_char(t1,'_','-'); 
subplot(3,2,2);plot(time,AC7351),xlabel('Time (s)'),ylabel('AC 
(V)'),title([t1;comm]) 
subplot(3,2,4);plot(time,AC8051),xlabel('Time (s)'),ylabel('AC 
(V)'),title([t1;comm]) 
subplot(3,2,6);plot(time,AC9401),xlabel('Time (s)'),ylabel('AC 
(V)'),title([t1;comm]) 
  
end 
%% Saving figures 
figure(probes(1)) 
%data_dir=save_dir; 
ButtonName = questdlg('Would you like to save the 
images?','Save','Yes','No','Yes'); 
switch ButtonName, 
    case 'Yes', 
        save_dir=uigetdir(data_dir,'Save directory'); 
        cd(save_dir) 
        for i=1:length(probes) 
            
saveas(h(probes(i)),strcat('Probe',num2str(probes(i)),'.fig')); 
        end 
            msgbox('Figures saved successfully','Data saved') 
    case 'No', 
        msgbox('Figures not saved, you can still save them 
manually','Data not saved') 
end 
excel_out=[R2 PI(1,:) PI(2,:) PI(3,:) PI(4,:) HR(1,:) HR(2,:) HR(3,:) 
HR(4,:)]; 
%excel_out=[flow meanDC flow./meanDC R]; 
display('END') 
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%% Thefollowing program processes the data similar to the previous  
%% example with the added feature of splitting the data in multiple  
%% segments to look at temporal trends within a dataset. 
 
clear all 
dropbox_path=getdropbox; 
%% Inputs 
  
processing_interval=25; %processing interval duration in seconds 
time_step=10;            %time step in seconds 
start_time=0; 
t0=0;    %The time stamp on the first file of the experiment 
                        %All data will be referenced to this time point 
Fs=300;     %sampling frequency in Hz 
minf=1.5; 
maxf=2.5; 
cut_off=0.2; 
nb_of_files=21; 
first_file=210; 
start_index=1; 
end_index=18000*nb_of_files; 
sheet_name=strcat(num2str(floor(start_index/Fs)),'s-
',num2str(floor(end_index/Fs)),'s'); 
probes=[2 3]; 
gain=[20.39849 70.17787 33.66493]; 
  
data_dir=uigetdir(strcat(dropbox_path,'Research\Perfusion sensor 
project\Perfusion Sensor documents\Animal Studies\Porcine\EXP 06-29-
2011(Oxygenation studies)\TAMU 6-28-2011\Exp10\'),'Pick a directory'); 
base_filename='Run1_Probe'; 
  
%% 
dt=processing_interval; 
  
np=length(probes); 
%%%%%%%%%%%%%%%%%%%%%%%%%Main Program%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% 
  
for i1=1:length(probes) 
p=probes(i1); 
fname=fullfile(data_dir,strcat(base_filename,num2str(p),'_')); 
  
probes_data=importdata(strcat(fname,num2str(first_file),'.txt')); 
%data_all=importdata(strcat(base_filename,'.txt')); 
file1=first_file; 
    for i=1:nb_of_files-1 
        if i>nb_of_files-1 
            break 
        end 
        file1=file1+1; 
        temp=importdata(strcat(fname,num2str(file1),'.txt')); 
        probes_data=[probes_data; temp]; 
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    end 
     
end_index=min(end_index,length(probes_data));     
data_all2=probes_data(start_index:end_index,:); 
ts=1; 
nmax=end_index-start_index; 
jmax=floor((nmax-dt*Fs/2)/(time_step*Fs)); 
if jmax==0 
    jmax=1; 
end 
  
for j=1:jmax 
tf=min(ts+dt*Fs,nmax); 
  
data_temp=data_all2(ts:tf,:); 
  
% time=[0:1/Fs:(end_index-start_index)/Fs]; 
%AC 
AC735=data_temp(:,2); 
AC805=data_temp(:,3); 
AC940=data_temp(:,4); 
%DC 
DC735=data_temp(:,5); 
DC805=data_temp(:,6); 
DC940=data_temp(:,7); 
  
%% Fourrier transforms 
n=length(AC735); 
NFFT=n;%2^nextpow2(n);      % If the NFFT is set at 2^next 
FFT735=fft(AC735,NFFT)/n; 
power735=abs(FFT735).^2; 
FFT805=fft(AC805,NFFT)/n; 
power805=abs(FFT805).^2; 
FFT940=fft(AC940,NFFT)/n; 
power940=abs(FFT940).^2; 
  
% Detecting HR 
f=Fs/2*linspace(0,1,NFFT/2); 
[l kmin]=max(f>=minf); 
[l kmax]=max(f>=maxf); 
[maxFFT735 l]=max(abs(FFT735(kmin:kmax))); 
HR735=f((kmin+l-1)); 
i=kmin+l-2; 
while(abs(FFT735(i))>cut_off*maxFFT735)&&(i>1) 
    i=i-1; 
end 
imin735=i; 
fmin735=f(imin735); 
  
i=kmin+l; 
while(abs(FFT735(i))>cut_off*maxFFT735) 
    i=i+1; 
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end 
imax735=i; 
fmax735=f(imax735); 
  
power735=sum(abs(FFT735(imin735:imax735))); 
  
[maxFFT805 l]=max(abs(FFT805(kmin:kmax))); 
HR805=f((kmin+l-1)); 
  
i=kmin+l-2; 
while(abs(FFT805(i))>cut_off*maxFFT805)&&(i>1) 
    i=i-1; 
end 
imin805=i; 
fmin805=f(imin805); 
i=kmin+l; 
while(abs(FFT805(i))>cut_off*maxFFT805) 
    i=i+1; 
end 
imax805=i; 
fmax805=f(imax805); 
power805=sum(abs(FFT805(imin805:imax805))); 
  
[maxFFT940 l]=max(abs(FFT940(kmin:kmax))); 
HR940=f((kmin+l-1)); 
i=kmin+l-2; 
while(abs(FFT940(i))>cut_off*maxFFT940)&&(i>1) 
    i=i-1; 
end 
imin940=i; 
fmin940=f(imin940); 
  
i=kmin+l; 
while(abs(FFT940(i))>cut_off*maxFFT940) 
    i=i+1; 
end 
imax940=i; 
fmax940=f(imax940); 
power940=sum(abs(FFT940(imin940:imax940))); 
  
%% Data output 
flow(j,i1,1:3)=[abs(maxFFT735) abs(maxFFT805) abs(maxFFT940)]; 
meanDC(j,i1,1:3)=[mean(DC735) mean(DC805) mean(DC940)]; 
% FFT_peak=[maxFFT735 maxFFT805 maxFFT940] 
% FFT_power=[power735 power805 power940]*Fs/(NFFT-2) 
DC=[mean(DC735) mean(DC805) mean(DC940)]; 
R(j,i1)=(flow(j,i1,1)./meanDC(j,i1,1))./(flow(j,i1,3)./meanDC(j,i1,3)); 
  
HR(j,i1,:)=[HR735 HR805 HR940]*60; %AC=[AC735 AC805 AC940];DCt=[DC735 
DC805 DC940];ACDC=AC./DCt; 
%ch1_ch3=ACDC(:,1)./ACDC(:,3); 
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R2(j,i1)= 
log((((maxFFT735/gain(i1))+DC(1))./DC(1)))./log((((maxFFT940/gain(i1))+
DC(3))./DC(3))); 
PI(j,i1,:)= 100*[maxFFT735/(gain(i1)*DC(1)) maxFFT805/(gain(i1)*DC(2)) 
maxFFT940/(gain(i1)*DC(3))]; 
  
t(j)=start_time-t0+mean(data_temp(:,1)); 
ts=ts+time_step*Fs; 
end 
end 
%% 
output1=zeros(length(t),length(probes)*12+3); 
output1=[t' t'/60 (t'-t(1))]; 
for i=1:length(probes) 
    for j=1:3 
        output1(:,3+(i-1)*12+j) = flow(:,i,j); 
        output1(:,6+(i-1)*12+j) = meanDC(:,i,j); 
        output1(:,9+(i-1)*12+j) = flow(:,i,j)./meanDC(:,i,j); 
        output1(:,12+(i-1)*12+j) = HR(:,i,j); 
    end 
end 
  
%% Initializing headers 
header2={' ' ' ' ' ' 'Probe2' 'Probe2' 'Probe2' 'Probe2' 'Probe2'... 
    'Probe2' 'Probe2' 'Probe2' 'Probe2' 'Probe2' 'Probe2' 'Probe2'... 
    'Probe3' 'Probe3' 'Probe3' 'Probe3' 'Probe3' 'Probe3' 'Probe3'... 
    'Probe3' 'Probe3' 'Probe3' 'Probe3' 'Probe3'...    
    }; 
  
  
header1={'Time(s)' 'Time(min)' 'Relative time(s)' ... 
 'FFT peak' 'FFT peak' 'FFT peak' 'DC' 'DC' 'DC' 'PI' 'PI' 'PI' 'HR' 
'HR' 'HR'... 
 'FFT peak' 'FFT peak' 'FFT peak' 'DC' 'DC' 'DC' 'PI' 'PI' 'PI' 'HR' 
'HR' 'HR'... 
 %'FFT peak' 'FFT peak' 'FFT peak' 'DC' 'DC' 'DC' 'PI' 'PI' 'PI' 'HR' 
'HR' 'HR' 
 }; 
  
header3={' ' ' ' ' '  'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    %'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    %'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    }; 
  
%% Saving data 
excel_out=[header1;header2;header3;num2cell(output1)]; 
ButtonName = questdlg('Would you like to save the 
data?','Save','Yes','No','Yes'); 
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switch ButtonName, 
    case 'Yes', 
        [save_name,pname]=uiputfile({'*.xls', 'Excel Worksheet 
(*.xls)'},'Saving data'); 
        save_name=fullfile(pname,save_name); 
        [status msg]=xlswrite(save_name,excel_out,sheet_name); 
        if status==1 
            msgbox('Data saved successfully','Data saved') 
        else 
            msgbox(msg.message,'Data not saved') 
        end 
    case 'No', 
        msgbox('Data not saved! You can still save them 
manually.','Data not saved') 
end 
%% 
display('END') 
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APPENDIX F 
PULSE ANALYSIS  
 
% This program computes the pulse amplitude and quantifies the rise and 
% fall time and slopes for a PPG signal. 
% 
% V2 added the following features: 
%   -The ability to process data from multiple probes at the same time 
%   -The ability to save processed data into an excel file 
% 
% V2.1 Minor update: added a 4th order band-pass butterworth filter 
% 
% Last updated: 08/14/2013 
% Tony J. Akl 
% tja161@gmail.com 
  
%%%%%%%%%%%%%%%%%%%%%%%%Data Input%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
data_dir=uigetdir; 
% data_dir='F:\Research\Perfusion sensor\BRP data\Porcine 
studies\2011\TAMU 6-28-2011\EXP6'; 
base_fname='occlusion3_Probe'; 
nb_of_files=-1; 
first_file=0; 
Fs=300;     %data sampling frequency in Hz 
minf=0.8; 
maxf=3.0; 
probes=[1 2 3 4]; 
start_index=2100; 
%% 
%% Saving data dialog 
ButtonName = questdlg('Would you like to save the 
data?','Save','Yes','No','Yes'); 
  
switch ButtonName 
    case 'Yes', 
        [save_name,pname]=uiputfile({'*.xls', 'Excel Worksheet 
(*.xls)'},'Saving data'); 
        save_name=fullfile(pname,save_name);    
end 
%% Constructing filter 
[b_filt,a_filt] = butter(4,[minf maxf]/(Fs/2)); 
%% 
%%%%%%%%%%%%%%%%%%%%%%%%%Main Program%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% Finding the start date from the log file 
cd(data_dir); 
try 
    fn=dir('*.log'); 
    temp=importdata(fn.name,',','8'); 
catch 
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    msgbox('No log file found, start time is set to the current 
timing!') 
    temp=datevec(now); 
end 
start_time=datevec(strcat(temp(2),',',temp(3))); 
time_offset=start_time(4)*3600+start_time(5)*60+start_time(6); 
%% 
for p=1:length(probes) 
base_filename = strcat(base_fname,num2str(probes(p))); 
data_all = file_read(data_dir, base_filename, nb_of_files, first_file); 
% data_all=data_all(start_index:end,:); 
time = data_all(start_index:end,1); 
%AC 
AC735_raw = data_all(:,3); AC805_raw = data_all(:,3); AC940_raw = 
data_all(:,4); 
% %DC 
DC735 = data_all(start_index:end,5); DC805 = 
data_all(start_index:end,6); DC940 = data_all(start_index:end,7); 
% %Sum 
% total735=AC735+DC735; total805=AC805+DC805; total940=AC940+DC940; 
%% Filtering signal 
AC735 = filter(b_filt,a_filt,AC735_raw); 
AC805 = filter(b_filt,a_filt,AC805_raw); 
AC940 = filter(b_filt,a_filt,AC940_raw); 
AC735 = AC735(start_index:end); 
AC805 = AC805(start_index:end); 
AC940 = AC940(start_index:end); 
%% Fourrier transforms 
n=length(AC735); 
NFFT=2^nextpow2(n); 
NFFT=n; 
FFT735=fft(AC735,NFFT)/n; 
power735=abs(FFT735).^2; 
FFT805=fft(AC805,NFFT)/n; 
power805=abs(FFT805).^2; 
FFT940=fft(AC940,NFFT)/n; 
power940=abs(FFT940).^2; 
  
%% Detecting average HR 
f=Fs/2*linspace(0,1,NFFT/2); 
[l kmin]=max(f>=minf); 
[l kmax]=max(f>=maxf); 
  
[maxFFT735 l]=max(abs(FFT735(kmin:kmax))); 
HR735=f((kmin+l-1)); 
T735=1/HR735; 
  
%% Detecting local maxima and minima and pulse rate 
cpt=1;nb=0; 
clear maxa mina maxt mint 
while cpt<(n-2.0*T735*Fs) 
    nb=nb+1; 
    [maxa(nb) kmax] = max(AC735(cpt:ceil(cpt+T735*Fs))); 
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    maxt(nb)=cpt+kmax-1; 
    [mina(nb) kmin] = min(AC735(maxt(nb):maxt(nb)+ceil(T735*Fs))); 
    mint(nb)=maxt(nb)+kmin-1; 
%     cpt=maxt(nb)+T735*Fs; 
    cpt=mint(nb); 
end 
%% Temporal heart rate/period and pulse amplitude 
Tmax=diff(maxt)/Fs; 
Tmin=diff(mint)/Fs; 
Amp=maxa-mina; 
clear DC_average 
for i=1:length(maxt)-1 
DC_average(i)=mean(DC735(maxt(i):maxt(i+1))); 
end 
DC_average(end+1)=mean(DC735(maxt(end):end)); 
%% Detecting slopes 
clear falling_slope rising_slope maxt_thresh maxa_thresh maxt_thresh2 
maxa_thresh2 
clear mint_thresh mina_thresh mint_thresh2 mina_thresh2 
min_thresh=mina+0.1*Amp;    %The slopes are calculated for the section 
10% above 
max_thresh=maxa-0.2*Amp;    %minimum and 10% below maximum 
for i=1:length(maxt) 
    temp=AC735(maxt(i):mint(i)); 
    a=find(temp>=min_thresh(i) & temp<=max_thresh(i)); 
    dt=time(maxt(i)+a(end)-1)-time(maxt(i)+a(1)-1); 
    maxt_thresh(i)=maxt(i)+a(1)-1;  mint_thresh(i)=maxt(i)+a(end)-1; 
    maxa_thresh(i)=temp(a(1));mina_thresh(i)=temp(a(end)); 
    da=mina_thresh(i)-maxa_thresh(i); 
    falling_slope(i)=da/dt; 
end 
Amp2=maxa(2:end)-mina(1:end-1); 
min_thresh2=mina(1:end-1)+0.1*Amp2; %The slopes are calculated for the 
section 10% above 
max_thresh2=maxa(2:end)-0.3*Amp2;   %minimum and 10% below maximum 
for i=2:length(maxt) 
     temp=AC735(mint(i-1):maxt(i)); 
     a=find(temp>=min_thresh2(i-1) & temp<=max_thresh2(i-1)); 
     dt=time(mint(i-1)+a(end)-1)-time(mint(i-1)+a(1)-1); 
     maxt_thresh2(i-1)=mint(i-1)+a(end)-1;mint_thresh2(i-1)=mint(i-
1)+a(1)-1; 
     maxa_thresh2(i-1)=temp(a(end));mina_thresh2(i-1)=temp(a(1));      
     da=maxa_thresh2(i-1)-mina_thresh2(i-1); 
     rising_slope(i-1)=da/dt; 
end 
%% Rise and fall times 
rise_time=maxt_thresh2-mint_thresh2; 
fall_time=mint_thresh-maxt_thresh; 
%% Saving results 
temp1=[(time(mint)+time_offset) time(mint) time(maxt) min_thresh' mint' 
mint_thresh' maxt' maxt_thresh'... 
    maxa_thresh' maxa' mina_thresh' mina' fall_time' Amp' 
DC_average'... 
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    fall_time' falling_slope']; 
temp2=[Tmax' Tmin' min_thresh2' mint_thresh2' maxt_thresh2' 
maxa_thresh2' ... 
    rise_time' rising_slope' Amp2']; 
header1={'time(mint) offset' 'time(mint)' 'time(maxt)' 'min_thresh' 
'mint' 'mint_thresh' ... 
    'maxt' 'maxt_thresh' 'maxa_thresh' 'maxa' 'mina_thresh' 'mina' ... 
    'fall_time' 'Amp' 'DC_average' 'fall_time' 'falling_slope' 
'Tmax'... 
    'Tmin' 'min_thresh2' 'mint_thresh2' 'maxt_thresh2' 
'maxa_thresh2'... 
    'rise_time' 'rising_slope' 'Amp2'}; 
  
switch ButtonName 
    case 'Yes' 
        excel_out=[num2cell(temp1) [num2cell(temp2); {' ' ' ' ' ' ' ' ' 
' ' ' ' ' ' ' ' '}]]; 
        excel_out=[header1;excel_out]; 
        sheet_name=['Probe ' num2str(probes(p))]; 
        [status msg]=xlswrite(save_name,excel_out,sheet_name); 
        if status==0 
            if msg.message=='Excel returned: Error: Object returned 
error code: 0x800A03EC.' 
                for f_nb=1:ceil(length(excel_out)/50000) 
                    [status, msg]=xlswrite(save_name,excel_out((f_nb-
1)*50000+1:min(f_nb*50000,length(excel_out)),:),... 
                        [sheet_name '-' num2str(f_nb)]);%, ['A' 
num2str((f_nb-1)*10000+1) ':AD' 
num2str(min(f_nb*10000,length(excel_out)))]); 
                end 
            end    
            msgbox(msg.message,'Saving Data'); 
        end 
end 
 
 
 
 
 
 
 
 
  
207 
 
%FILE_READ reads a sequence of data files 
% This function takes three inputs and returns two outputs 
% Inputs: 
%     data_dir: directory where the file is located 
%     base_filename: the base filename without the numbering at the  
%   end  
%  nb_of_files: number of files in the sequence, if a negative  
%   number  is given in that field, the function will read all 
%  files that start with the base_filename in the specified 
%  folder 
%    first_file: the numbder/id of the first file 
% For example to read the files "C:\Tony_1.txt" until "C:\Tony_4.txt"  
% the inputs would be: file_read('C:\','Tony',4,1); 
%  
% Last updated on 10/06/2011 
% Tony J. Akl 
% tja161@gmail.com 
 
function [data_all] = file_read(data_dir, base_filename, nb_of_files, 
first_file) 
if nargin < 2 
   error('Not enough input arguments.'); 
   return 
end 
if (nargin==2) 
    nb_of_files=1; 
    first_file=0; 
elseif (nargin==3) 
    first_file=0; 
end 
if nb_of_files<0 
    myFiles=dir(strcat(fullfile(data_dir,base_filename),'*')); 
    nb_of_files=length(myFiles); 
end 
if nb_of_files==0 
    return 
end 
cd(data_dir) 
if data_dir(length(data_dir)) ~= '\' 
    data_dir=strcat(data_dir,'\'); 
end 
fname=strcat(data_dir,base_filename,'_'); 
data_all=importdata(strcat(fname,num2str(first_file),'.txt')); 
     
    for i=1:nb_of_files-1 
        if i>nb_of_files-1 
            break 
        end 
        first_file=first_file+1; 
        temp=importdata(strcat(fname,num2str(first_file),'.txt')); 
        data_all=[data_all; temp]; 
    end 
end 
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% This program combines different excel files from the same experiment  
% into a single excel file to make data analysis easier. The user the 
% inputs name of the sheet in the excel files that he wants to combine  
% and selects all the files to merge and the saving location. 
%  
% V1.1 works for files that has the extra column for adjusted timing 
% 
% Tony J. Akl 
% tja161@gmail.com 
  
%% 
[fname1, pname] = uigetfile({'*.xls','Excel files (*.xls)'},'Pick all 
data file','MultiSelect','on'); 
prompt={'Sheet name:'}; 
name='User Input'; 
numlines=1; 
defaultanswer={'Probe 1'}; 
sheet_name = char(inputdlg(prompt,name,numlines,defaultanswer)); 
  
%% Initializing headers 
header1={'time(mint) offset' 'time(mint)' 'time(maxt)' 'min_thresh' 
'mint' 'mint_thresh' ... 
    'maxt' 'maxt_thresh' 'maxa_thresh' 'maxa' 'mina_thresh' 'mina' ... 
    'fall_time' 'Amp' 'DC_average' 'fall_time' 'falling_slope' 
'Tmax'... 
    'Tmin' 'min_thresh2' 'mint_thresh2' 'maxt_thresh2' 
'maxa_thresh2'... 
    'rise_time' 'rising_slope' 'Amp2'}; 
%% 
nb_files=0; 
fname1=sort(fname1); 
excel_out=[header1]; 
for nf=1:length(fname1) 
    fname=char(fname1(nf)); 
    filename=fullfile(pname,fname); 
    [status,sheets1]= xlsfinfo(filename); 
     
    if max(strcmp(sheets1,sheet_name))~=1 
        nb_files=nb_files+1; 
        files(nb_files)={fname}; 
        continue 
    end 
     a=xlsread(filename,sheet_name); 
     excel_out=[excel_out; num2cell(a)]; 
end 
[fname, pname]=uiputfile({'*.xls', 'Excel Worksheet (*.xls)'},'Saving 
data','Summary.xls'); 
  
xlswrite(fullfile(pname,fname),excel_out,sheet_name); 
display([num2str(length(fname1)-nb_files) ' files added to ' fname ... 
    ' and ' num2str(nb_files) ' files could not be added']); 
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APPENDIX G 
TELEMETRY SYSTEM SUPPLEMENTARY DATA  
 
I. Probe fabrication & sensor encapsulation: 
All sensor probes were coated with Polydimethylsiloxane (PDMS) to avoid water 
leakage into the electronics. To do that, the Printed Circuit Board (PCB) with the Light 
Emitting Diodes (LEDs) and photodetector was secured in a 3D printed mold and PDMS 
was poured on it. The mold was then placed in an oven for roughly 1 hour at 65C to 
cure the PDMS. The PDMS coated electronics were placed in a different mold 
containing one of three 3D printed suture-holders designed to secure the probes in place 
(Figure 88). PDMS was poured into this mold and placed again in the oven for an extra 
hour at 65C. The probes were left overnight at room temperature before any testing was 
performed. All PDMS was mixed with a curing agent at a volumetric ration of 10:1 and 
degassed for 60 minutes to avoid air pockets. The PDMS was degassed again after being 
poured in the mold to make sure no air bubbles were introduced in the process. The 
probes were coated with an additional thin layer of electronic grade silicone to avoid any 
leakage. Prior to the animal studies, all probes were placed in a water bath overnight to 
test for leakage. 
Figure 88-a shows CAD models of the three different suture holders used in the 
parenchymal (left) and vascular probes (middle and right). The vascular probes were 
made in two different sizes to be secured around the hepatic artery and portal vein that 
differ in diameter (HA ~ 5 mm and PV ~ 8-10 mm). 
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Fig. 88. a-Suture holders for the parenchymal, HA, and PV probes (left to right). b & c- 
CAD drawing of a parenchymal and a vascular probe respectively.  
 
All sensor electronics were enclosed in a 3D printed box (Figure 89). The box 
was coated with a thin layer of electronic grade silicone. 
 
 
 
   
Fig. 89. (Left) CAD drawing of the electronics box showing the PCBs inside. (Right) 
Picture of the telemetry system showing the sensor, probes, and data acquisition 
software. 
 
 
LEDs 
Photodetector Suture 
holders 
a) b) c) 
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II. Reference Measurements: 
The data from the Laser Doppler (LD) Perfusion monitor did not correlate well 
with tissue perfusion changes. In both studies we had two LD monitors placed on the 
hepatic tissue: a surface probe and a needle probe. The probes were adjusted and moved 
to various spots on the tissue to be able to pick up a Doppler signal. We were not able to 
get a signal with the needle probe. The surface probe gave a good Doppler signal. 
However, further analysis showed that the signal by that probe correlated well with the 
hepatic artery flow but not with the portal venous flow. We believe that the LD was 
probing a branch of the hepatic artery embedded in tissue. The data from the LD was not 
used as a reference, and instead we used the total hepatic flow obtained by the two 
Transit-Time Ultrasound flowmeters. Figure 90 shows the correlation between the LD 
output and the HA and PV flow measured by the Transit-Time flowmeters. As 
mentioned, the LD signal correlates with the HA flow with a coefficient of 
determination (R
2
) of 0.8 while the correlation with PV flow showed an R
2
 of 0.1. The 
time pattern of the measured signals is shown in Figure 91. Note that during the PV 
occlusion studies (Figure 91, blue segments), the HA occluders were open (not inflated). 
All changes in HA flow during these segments are due to a systemic response.  
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Fig. 90.  Scatter plots of the Laser Doppler data versus HA flow (left), PV flow (middle), 
and total hepatic flow (right). The data shows that the LD data correlates best with the 
HA flow suggesting that the system was probing a branch of the HA. 
 
 
 
 
 
Fig. 91. Reference flow measurements by the transit time flowmeters (left axis) and 
Laser Doppler flowmeter (right axis). The time segments highlighted in red correspond 
to HA occlusion studies while the blue segments correspond to PV occlusion studies.  
 
Figure 92 shows the raw data from the arterial and venous oxygenation catheters 
from both studies described in the manuscript. The catheters used do not measure 
oxygenation levels above 97.5% and that is why some data for the arterial catheter is 
missing from the graph below. 
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Fig. 92.  Data from the arterial and venous oxygenation catheters collected from 
experiment 1 (left) and 2 (right)  
 
III. Data processing: 
Figure 93 shows the correlation between the measured hemoglobin oxygenation 
index and the different reference oxygenation measurements (MOS and SvO2). The data 
show that HbD correlates best with a combination of the two which is expected since 
the collected light probe both the venous and arterial blood. 
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Fig. 93. (Left) Correlation between the measured hemoglobin oxygenation index 
(HbD) and the measured oxygenation levels. (Right) Calibrated HbD can predict 
SvO2 with a higher degree of confidence (R
2
=0.99) when using a multiple linear 
regression taking account for both supply and venous oxygenation. 
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APPENDIX H 
INTESTINAL PERFUSION: SUPPLEMENTARY DATA  
 
According to the Beer-Lambert law, the collected intensity on the surface of the 
tissue can be expressed in a simplified case by the following equation. 
)..exp(.0 CII   
Diffuse reflectance is the ratio of the collected light at the surface of the tissue (I) 
to the light from the light source (I0): 
)..exp(
0
CR II    
In which    tissuetissuetissuebloodbloodblood CCC  ......    
 
A. Oxygenation Signal: 
To look at the oxygenation signal, the ratio of the diffuse reflectance is 
considered in the cases where tissue is perfused with oxygenated and deoxygenated 
blood. These two cases represent the extreme in oxygenation changes and can be used to 
study the dynamic range to oxygenation changes which correlates to the sensitivity of 
the sensor. 
bloodbloodHbObloodbloodHb
Hb
HbO
CC
R
R
S  ....log
2
2  





  
  ,, 2HbOHbS   
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This quantity can be positive or negative depending on the wavelength used. The 
oxygenation signal is defined as the absolute value of this quantity in order to have a 
comparison of the sensitivity across the spectrum without being affected by the direction 
of change in the signal. 
  ,, 2HbOHbS     (This corresponds to equation (VI.1)) 
This equation makes the assumption that the optical pathlength does not change 
between the cases of oxygenated and deoxygenated blood perfusion. Although this is not 
exactly true, it can be used as a simplified theory to guide the more accurate Monte 
Carlo models. 
B. Perfusion Signal: 
Similar to the derivation of the oxygenation signal, the diffuse reflectance ratio of 
the ischemic tissue (Cblood = 0) to the normally perfused tissue can be defined. 
In ischemic tissue, there is no blood and CIschemic = Ctissue 
In normally perfused tissue, blood constitutes 12% of the total volume and thus,  
CPerfused= 0.12 Cblood + 0.88 Ctissue and the signal to background is, 
 ....log IschemicIschemicPerfusedPerfused
Perfused
Ischemic CC
R
R
SBR  








  
Assuming that the product of the chromophores concentration and the pathlength 
stays the same, the SBR can be reduced to: 
  ..88.012.0 CSBR tissuetissueblood    
 tissuebloodSBR   12.0  
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Although these equations have many assumptions, for this paper they were 
adequate to build hypotheses that were verified through the more accurate Monte Carlo 
simulations and in vivo data. 
C. Mean Penetration Depth: 
In Chapter VI, the change in the mean penetration depth was shown as a function 
of wavelength for multiple source to detector separations (Figure 77). Below (Fig. 94) 
the mean penetration depth versus source to detector separation for multiple wavelengths 
is shown. Data in this figure were generated using equation (VI.3) based on the work of 
Weiss et al. [73]. 
 
 
Fig. 94. Mean penetration depth as a function of source to detector separation for 
multiple wavelengths of interest.  
 
D. In Vivo Data: 
The modulation ratio (R) was calculated using the equation below. This ratio is 
typically used in pulse oximetry to measure oxygen saturation changes. In this study, the 
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inhaled oxygen levels were maintained constant and we did not expect any significant 
changes in oxygen saturation levels. The modulation ratio was measured to see how 
stable the signal was. Figure 95 shows the modulation ratio as a function of time and the 
detected heart rate for the two wavelengths (470, and 525 nm). The modulation ratio 
shows a stable level during baseline indicating stable oxygenation levels. During the 
occlusions, the modulation ratio shows an increase which can indicate an increase in 
oxygenation. However, the pulse almost disappeared during these occlusions which 
sometimes leads to erroneous oxygenation and heart rate data. 












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470
470
525
525
DC
AC
DC
AC
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Fig. 95. Heart rate (left panel) and modulation ratio (right panel) measured from the 
visible wavelengths data. The grey segments indicate the occlusion periods during which 
the monitored section of the intestine was clamped.  
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Due to the high amplitude of the noise peak on the NIR wavelengths, it is difficult to 
visualize the cardiac cycle peak and the high frequency motion in the spectra of Figure 
80. Figure 96 shows the 1 to 5 Hz range of the spectra for comparison of the signal 
peaks. It can be seen that the cardiac cycle peak is 4 to 5 times higher on the visible 
wavelengths (470 and 525 nm) compared to the NIR wavelengths. 
 
 
Fig. 96. Zoom-in for the 1 to 5 Hz range in the FFT of the AC signal for all six 
wavelengths. The cardiac cycle peak is 4 to 5 times higher for the 470 and 525 nm 
wavelengths compared to the NIR wavelengths. 
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APPENDIX I 
TELEMETRY SENSOR PROCESSING SOFTWARE  
 
This appendix has all the data processing software used with the telemetry sensor. 
This first program is used for the FFT processing of the telemetry data: 
 
 
clear all 
dropbox_path=getdropbox; 
%% Inputs 
  
processing_interval=25; %processing interval duration in seconds 
time_step=10;            %time step in seconds 
start_time=0; 
t0=0;    %The time stamp on the first file of the experiment 
                        %All data will be referenced to this time point 
Fs=300;     %sampling frequency in Hz 
minf=1.5; 
maxf=2.5; 
cut_off=0.2; 
nb_of_files=21; 
first_file=210; 
start_index=1; 
end_index=18000*nb_of_files; 
sheet_name=strcat(num2str(floor(start_index/Fs)),'s-
',num2str(floor(end_index/Fs)),'s'); 
probes=[2 3]; 
gain=[20.39849 70.17787 33.66493]; 
  
data_dir=uigetdir(strcat(dropbox_path,'Research\Perfusion sensor 
project\Perfusion Sensor documents\Animal Studies\Porcine\EXP 06-29-
2011(Oxygenation studies)\TAMU 6-28-2011\Exp10\'),'Pick a directory'); 
base_filename='Run1_Probe'; 
  
%% 
dt=processing_interval; 
np=length(probes); 
%%%%%%%%%%%%%%%%%%%%%%%%%Main Program%%%%%%%%%%%%%%%%%%%%%%%%%% 
%% 
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for i1=1:length(probes) 
p=probes(i1); 
fname=fullfile(data_dir,strcat(base_filename,num2str(p),'_')); 
  
probes_data=importdata(strcat(fname,num2str(first_file),'.txt')); 
%data_all=importdata(strcat(base_filename,'.txt')); 
file1=first_file; 
    for i=1:nb_of_files-1 
        if i>nb_of_files-1 
            break 
        end 
        file1=file1+1; 
        temp=importdata(strcat(fname,num2str(file1),'.txt')); 
        probes_data=[probes_data; temp]; 
    end 
     
end_index=min(end_index,length(probes_data));     
data_all2=probes_data(start_index:end_index,:); 
ts=1; 
nmax=end_index-start_index; 
jmax=floor((nmax-dt*Fs/2)/(time_step*Fs)); 
if jmax==0 
    jmax=1; 
end 
  
for j=1:jmax 
tf=min(ts+dt*Fs,nmax); 
  
data_temp=data_all2(ts:tf,:); 
  
% time=[0:1/Fs:(end_index-start_index)/Fs]; 
%AC 
AC735=data_temp(:,2); 
AC805=data_temp(:,3); 
AC940=data_temp(:,4); 
%DC 
DC735=data_temp(:,5); 
DC805=data_temp(:,6); 
DC940=data_temp(:,7); 
  
%% Fourrier transforms 
n=length(AC735); 
NFFT=n;%2^nextpow2(n);      % If the NFFT is set at 2^next 
FFT735=fft(AC735,NFFT)/n; 
power735=abs(FFT735).^2; 
FFT805=fft(AC805,NFFT)/n; 
power805=abs(FFT805).^2; 
FFT940=fft(AC940,NFFT)/n; 
power940=abs(FFT940).^2; 
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% Detecting HR 
f=Fs/2*linspace(0,1,NFFT/2); 
[l kmin]=max(f>=minf); 
[l kmax]=max(f>=maxf); 
[maxFFT735 l]=max(abs(FFT735(kmin:kmax))); 
HR735=f((kmin+l-1)); 
i=kmin+l-2; 
while(abs(FFT735(i))>cut_off*maxFFT735)&&(i>1) 
    i=i-1; 
end 
imin735=i; 
fmin735=f(imin735); 
  
i=kmin+l; 
while(abs(FFT735(i))>cut_off*maxFFT735) 
    i=i+1; 
end 
imax735=i; 
fmax735=f(imax735); 
  
power735=sum(abs(FFT735(imin735:imax735))); 
  
[maxFFT805 l]=max(abs(FFT805(kmin:kmax))); 
HR805=f((kmin+l-1)); 
  
i=kmin+l-2; 
while(abs(FFT805(i))>cut_off*maxFFT805)&&(i>1) 
    i=i-1; 
end 
imin805=i; 
fmin805=f(imin805); 
i=kmin+l; 
while(abs(FFT805(i))>cut_off*maxFFT805) 
    i=i+1; 
end 
imax805=i; 
fmax805=f(imax805); 
power805=sum(abs(FFT805(imin805:imax805))); 
  
[maxFFT940 l]=max(abs(FFT940(kmin:kmax))); 
HR940=f((kmin+l-1)); 
i=kmin+l-2; 
while(abs(FFT940(i))>cut_off*maxFFT940)&&(i>1) 
    i=i-1; 
end 
imin940=i; 
fmin940=f(imin940); 
  
i=kmin+l; 
while(abs(FFT940(i))>cut_off*maxFFT940) 
    i=i+1; 
end 
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imax940=i; 
fmax940=f(imax940); 
power940=sum(abs(FFT940(imin940:imax940))); 
 
  
%% Data output 
flow(j,i1,1:3)=[abs(maxFFT735) abs(maxFFT805) abs(maxFFT940)]; 
meanDC(j,i1,1:3)=[mean(DC735) mean(DC805) mean(DC940)]; 
% FFT_peak=[maxFFT735 maxFFT805 maxFFT940] 
% FFT_power=[power735 power805 power940]*Fs/(NFFT-2) 
DC=[mean(DC735) mean(DC805) mean(DC940)]; 
R(j,i1)=(flow(j,i1,1)./meanDC(j,i1,1))./(flow(j,i1,3)./meanDC(j,i1,3)); 
  
HR(j,i1,:)=[HR735 HR805 HR940]*60; %AC=[AC735 AC805 AC940];DCt=[DC735 
DC805 DC940];ACDC=AC./DCt; 
%ch1_ch3=ACDC(:,1)./ACDC(:,3); 
  
R2(j,i1)= 
log((((maxFFT735/gain(i1))+DC(1))./DC(1)))./log((((maxFFT940/gain(i1))+
DC(3))./DC(3))); 
PI(j,i1,:)= 100*[maxFFT735/(gain(i1)*DC(1)) maxFFT805/(gain(i1)*DC(2)) 
maxFFT940/(gain(i1)*DC(3))]; 
  
t(j)=start_time-t0+mean(data_temp(:,1)); 
ts=ts+time_step*Fs; 
end 
end 
%% 
 
output1=zeros(length(t),length(probes)*12+3); 
output1=[t' t'/60 (t'-t(1))]; 
for i=1:length(probes) 
    for j=1:3 
        output1(:,3+(i-1)*12+j) = flow(:,i,j); 
        output1(:,6+(i-1)*12+j) = meanDC(:,i,j); 
        output1(:,9+(i-1)*12+j) = flow(:,i,j)./meanDC(:,i,j); 
        output1(:,12+(i-1)*12+j) = HR(:,i,j); 
    end 
end 
 
 
  
%% Initializing headers 
header2={' ' ' ' ' ' 'Probe2' 'Probe2' 'Probe2' 'Probe2' 'Probe2'... 
    'Probe2' 'Probe2' 'Probe2' 'Probe2' 'Probe2' 'Probe2' 'Probe2'... 
    'Probe3' 'Probe3' 'Probe3' 'Probe3' 'Probe3' 'Probe3' 'Probe3'... 
    'Probe3' 'Probe3' 'Probe3' 'Probe3' 'Probe3'...    
    }; 
  
  
header1={'Time(s)' 'Time(min)' 'Relative time(s)' ... 
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 'FFT peak' 'FFT peak' 'FFT peak' 'DC' 'DC' 'DC' 'PI' 'PI' 'PI' 'HR' 
'HR' 'HR'... 
 'FFT peak' 'FFT peak' 'FFT peak' 'DC' 'DC' 'DC' 'PI' 'PI' 'PI' 'HR' 
'HR' 'HR'... 
 %'FFT peak' 'FFT peak' 'FFT peak' 'DC' 'DC' 'DC' 'PI' 'PI' 'PI' 'HR' 
'HR' 'HR' 
 }; 
  
header3={' ' ' ' ' '  'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    %'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    %'Ch1' 'Ch2' 'Ch3' 'Ch1' 'Ch2' 'Ch3'... 
    }; 
  
%% Saving data 
excel_out=[header1;header2;header3;num2cell(output1)]; 
ButtonName = questdlg('Would you like to save the 
data?','Save','Yes','No','Yes'); 
  
switch ButtonName, 
    case 'Yes', 
        [save_name,pname]=uiputfile({'*.xls', 'Excel Worksheet 
(*.xls)'},'Saving data'); 
        save_name=fullfile(pname,save_name); 
        [status msg]=xlswrite(save_name,excel_out,sheet_name); 
        if status==1 
            msgbox('Data saved successfully','Data saved') 
        else 
            msgbox(msg.message,'Data not saved') 
        end 
    case 'No', 
        msgbox('Data not saved! You can still save them 
manually.','Data not saved') 
end 
%% 
display('END') 
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The following programs are used for the NIRS processing of the telemetry data: 
% NIRS_v2_1.m 
% This program reads and process data from the telemetry system 
% The data is processed using NIRS algorithm 
% The data is first truncated and the first few seconds are eliminated 
% All data is saved in excel files and plotted at the end 
% 
% v2 (Major update) allows the processing of previously saved matlab  
% files which is faster than reading the raw data. The matlab file  
% should contain the parameters probes_data, start_time, status_data,  
% and comments. 
% However, only the probes_data and start_time are required, the rest  
% is optional. 
%  
% This program also runs the updated automated_NIRS_v2 (Major update)  
% which fixed some formulas from previous version that caused  
% miscalculation of DHbO2 on some wavelengths combinations 
% 
% v2_1 (Minor changes) allows for selecting multiple preprocessed  
% matlab files for processing 
% 
% Tony J. Akl 
% tja161@gmail.com 
% Last updated 7/25/2013 
  
%% 
FileTypeButton = questdlg('Where is the data?', 'Select Data', ... 
    'Raw data file', 'Preprocessed matlab file','Raw data file'); 
switch FileTypeButton, 
    case 'Raw data file' 
        process_data; nb_files=1; 
    case 'Preprocessed matlab file' 
        [fname1 pname1]=uigetfile('*.mat','Select data 
file(s)','MultiSelect','on'); 
        if ischar(fname1) 
            nb_files=1; 
            fname=fname1; 
            load(fullfile(pname1,fname)); 
            multiple_files = false; 
        else 
            nb_files=length(fname1); 
            fname=char(fname1(1)); 
            load(fullfile(pname1,fname)); 
            multiple_files = true; 
        end 
end 
%% 
for ifile=1:nb_files 
automatic_truncation; 
btn = questdlg('Are you content with your selection?','Data 
truncation','Yes','No','Yes'); 
while (1) 
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switch btn 
    case 'No', 
        automatic_truncation; 
        btn = questdlg('Are you content with your selection?','Data 
truncation','Yes','No','Yes'); 
    case 'Yes' 
        break; 
end 
end 
close all 
display(['Starting NIRS processing for :"' fname '"']) 
automated_NIRS_inputs_v2; 
% automated_NIRS_v2; 
%% Close all message boxes 
allHandle = allchild(0); 
allTag = get(allHandle, 'Tag'); 
isMsgbox = strncmp(allTag, 'Msgbox_', 7); 
delete(allHandle(isMsgbox)); 
  
%% Redaing next file for processing 
if multiple_files && ifile<nb_files 
    fname=char(fname1(ifile+1)); 
    load(fullfile(pname1,fname)); 
end 
end 
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% automated_NIRS_inputs_v2.m 
%% 
clear DHb* C* 
 
ext_deoxy_l1=1.29559;    %Extinction coefficient of deoxy hemoglobin 
for wavelength 1 
ext_oxy_l1=0.46448;        %Extinction coefficient of oxy hemoglobin 
for wavelength 1 
ext_cyt_l1=1.80054;%1.624; 
ext_deoxy_l2=0.81439;    %Extinction coefficient of deoxy hemoglobin 
for wavelength 2 
ext_oxy_l2=0.89708;        %Extinction coefficient of oxy hemoglobin 
for wavelength 2 
ext_cyt_l2=2.28643;%4.633; 
ext_deoxy_l3=0.7872;     %Extinction coefficient of deoxy hemoglobin 
for wavelength 3 
ext_oxy_l3=1.35165;         %Extinction coefficient of oxy hemoglobin 
for wavelength 3 
ext_cyt_l3=1.28616;%0.93; 
  
t0=(17-6)*3600+46*60+05;        %Start time for experiment 1-30-13 
data_all2=probes_data; 
probes=[1 2 3]; 
np=length(probes); 
% DHbO2=zeros(1,length(probes)); 
% DHb=zeros(1,length(probes)); 
Ib1=[2.52212524414063,2.63717651367188,2.73635864257813]; 
Ib2=[3.31726074218750,2.51586914062500,2.43194580078125]; 
Ib3=[1.79542541503906,1.76239013671875,1.85424804687500]; 
%% 
prompt={'Averaging period (s):'; 'Interoptode separation (cm):'}; 
name='User Input'; 
numlines=1; 
defaultanswer={'1';'0.7'}; 
user_inputs=str2num(char(inputdlg(prompt,name,numlines,defaultanswer)))
; 
averaging_period =user_inputs(1); 
L=user_inputs(2); 
averaging_samples=averaging_period*Fs; 
averaging_samples=floor(averaging_samples/2); 
%%%%%%%%%%%%%%%%%%%%%%%%%Main Program%%%%%%%%%%%%%%%%%%%%%%%%%% 
ButtonName = questdlg('Would you like to save the 
data?','Save','Yes','No','Yes'); 
  
switch ButtonName 
    case 'Yes', 
        [save_name,pname]=uiputfile({'*.xls', 'Excel Worksheet 
(*.xls)'},'Saving data'); 
        save_name=fullfile(pname,save_name);    
end 
clear tf DHbf DHbO2f 
for kk=1:length(mx) 
    start_index=mx(kk); 
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    end_index=mn(kk); 
    automated_NIRS_v2; 
    display([num2str(kk), ' done and ',num2str(length(mx)-kk),' left']) 
end 
  
%% Saving data 
trf=tf+start_time-t0; 
output1=[tf' tf'/60 trf' DHbf_l12 DHbO2f_l12 DHbf_l12+DHbO2f_l12 
DHbf_l13 DHbO2f_l13 DHbf_l13+DHbO2f_l13 DHbf_l23 DHbO2f_l23 
DHbf_l23+DHbO2f_l23 Cdeoxyf Coxyf Coxyf+Cdeoxyf Ccytf]; 
output1=output1(2:end,:); 
excel_out=[header1;header2;header3;num2cell(output1)]; 
  
switch ButtonName 
    case 'Yes' 
        [status msg]=xlswrite(save_name,excel_out,['Combined ' 
num2str(averaging_period) 's']); 
        if status==0 
            if msg.message == 'Excel returned: Error: Object returned 
error code: 0x800A03EC.' 
                sname=['Combined ' num2str(averaging_period) 's']; 
                for f_nb=1:ceil(length(excel_out)/50000) 
                [status, msg]=xlswrite(save_name,... 
                  excel_out((f_nb-
1)*50000+1:min(f_nb*50000,length(excel_out)),:),... 
                  [sname '-' num2str(f_nb)]); 
                end 
            end     
         
            msgbox(msg.message,'Saving Data') 
        end 
end 
  
%% Plotting data 
figure,set(gcf, 'Position', get(0,'Screensize')); % Maximize figure. 
for i=1:np 
    subplot(np,1,i);plot(tf(2:end),DHbf_l13(2:end,i)) 
    hold on, plot(tf(2:end),DHbO2f_l13(2:end,i),'r') 
    plot(tf(2:end),DHbO2f_l13(2:end,i)+DHbf_l13(2:end,i),'g') 
    hold off 
end 
xlabel('Time (s)') 
subplot(np,1,1),legend('Hb','HbO_2','tHb',... 
    'Location','Best','Orientation','Horizontal') 
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% automated_NIRS_v2.m 
% V2 includes corrections of the DHbO2 equations 
% This program measures changes in Oxy and Deoxy hemoglobin 
concentrations 
% using the DC levels of a PPG sensor. 
%% 
sheet_name=strcat(num2str(floor(start_index/Fs)),'s-
',num2str(floor(end_index/Fs)),'s'); 
data_temp=data_all2(start_index:end_index,:); 
clear DHbO2_l* DHb_l* C_* 
t=[0:1/Fs:(end_index-start_index)/Fs]+data_temp(1,1); 
tr=t+start_time-t0; 
for p1=1:np 
p=probes(p1); 
% time=[0:1/Fs:(end_index-start_index)/Fs]; 
  
%DC 
DC735=data_temp(:,7*(p-1)+3)*5/2^16; 
DC805=data_temp(:,7*(p-1)+5)*5/2^16; 
DC940=data_temp(:,7*(p-1)+7)*5/2^16; 
  
Is1=DC735;          %Signal intesity for wavelength 1 
Is2=DC805;          %Signal intesity for wavelength 2 
Is3=DC940;          %Signal intesity for wavelength 3 
  
mups=[0.3*2.53+0.7*4.76 0.3*2.54+0.7*4.11 0.3*2.71+0.7*3.41]; 
mua0=[0.3*2.21+0.7*1.19 0.3*4.50+0.7*0.81 0.3*6.5+0.7*0.57]; 
PF=pathlength_factor(L,mups,mua0,mups); 
DA_l1=log(Ib1(p1)./Is1)/PF(1); 
DA_l2=log(Ib2(p1)./Is2)/PF(2); 
DA_l3=log(Ib3(p1)./Is3)/PF(3); 
%Change in oxy hemoglobin concentration 
DHbO2_l12(:,p1)=(ext_deoxy_l2*DA_l1-
ext_deoxy_l1*DA_l2)/((ext_oxy_l1*ext_deoxy_l2-
ext_oxy_l2*ext_deoxy_l1)*L); 
DHbO2_l13(:,p1)=(ext_deoxy_l3*DA_l1-
ext_deoxy_l1*DA_l3)/((ext_oxy_l1*ext_deoxy_l3-
ext_oxy_l3*ext_deoxy_l1)*L); 
DHbO2_l23(:,p1)=(ext_deoxy_l3*DA_l2-
ext_deoxy_l2*DA_l3)/((ext_oxy_l2*ext_deoxy_l3-
ext_oxy_l3*ext_deoxy_l2)*L); 
%Change in deoxy hemoglobin concentration 
DHb_l12(:,p1)=(ext_oxy_l2*DA_l1-
ext_oxy_l1*DA_l2)/((ext_deoxy_l1*ext_oxy_l2-
ext_deoxy_l2*ext_oxy_l1)*L); 
DHb_l13(:,p1)=(ext_oxy_l3*DA_l1-
ext_oxy_l1*DA_l3)/((ext_deoxy_l1*ext_oxy_l3-
ext_deoxy_l3*ext_oxy_l1)*L); 
DHb_l23(:,p1)=(ext_oxy_l3*DA_l2-
ext_oxy_l2*DA_l3)/((ext_deoxy_l2*ext_oxy_l3-
ext_deoxy_l3*ext_oxy_l2)*L); 
%Change in total hemoglobin concentration 
%DHbt(p1,:)=DHbO2(p1,:)+DHb(p1,:); 
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% Multi wavelengths processing 
multi_wavelength_NIRS; 
%% Averaging dta 
[ta DHbO2_l12a(:,p1)]=smoothing(t,DHbO2_l12(:,p1),averaging_samples); 
[ta DHbO2_l13a(:,p1)]=smoothing(t,DHbO2_l13(:,p1),averaging_samples); 
[ta DHbO2_l23a(:,p1)]=smoothing(t,DHbO2_l23(:,p1),averaging_samples); 
[ta DHb_l12a(:,p1)]=smoothing(t,DHb_l12(:,p1),averaging_samples); 
[ta DHb_l13a(:,p1)]=smoothing(t,DHb_l13(:,p1),averaging_samples); 
[ta DHb_l23a(:,p1)]=smoothing(t,DHb_l23(:,p1),averaging_samples); 
%% 
end 
try 
    tt=length(tf); 
catch 
    tt=0; 
end 
l_ta=length(ta); 
tf(tt+1:tt+l_ta) = ta; 
DHbf_l12(tt+1:tt+l_ta,:) = DHb_l12a; 
DHbf_l13(tt+1:tt+l_ta,:) = DHb_l13a; 
DHbf_l23(tt+1:tt+l_ta,:) = DHb_l23a; 
DHbO2f_l12(tt+1:tt+l_ta,:) = DHbO2_l12a; 
DHbO2f_l13(tt+1:tt+l_ta,:) = DHbO2_l13a; 
DHbO2f_l23(tt+1:tt+l_ta,:) = DHbO2_l23a; 
Coxyf(tt+1:tt+l_ta,:) = C_oxya; 
Cdeoxyf(tt+1:tt+l_ta,:) = C_deoxya; 
Ccytf(tt+1:tt+l_ta,:) = C_cyta; 
%% 
output1=[t' t'/60 tr' DHb_l12 DHbO2_l12 DHb_l12+DHbO2_l12 DHb_l13 
DHbO2_l13 DHb_l13+DHbO2_l13 DHb_l23 DHbO2_l23 DHb_l23+DHbO2_l23 C_deoxy 
C_oxy C_oxy+C_deoxy C_cyt]; 
  
%% Initializing headers 
header1={' ' ' ' ' ' 'Wavelengths 1-2' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' 
'... 
   'Wavelengths 1-3' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '... 
   'Wavelengths 2-3' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '... 
   'All wavelengths' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '}; 
header2={' ' ' ' ' ' 'Probe1' 'Probe2' 'Probe3' 'Probe1' 'Probe2' 
'Probe3'... 
    'Probe1' 'Probe2' 'Probe3' 'Probe1' 'Probe2' 'Probe3' 'Probe1' 
'Probe2' 'Probe3'... 
    'Probe1' 'Probe2' 'Probe3' 'Probe1' 'Probe2' 'Probe3' 'Probe1' 
'Probe2' 'Probe3'... 
    'Probe1' 'Probe2' 'Probe3' 'Probe1' 'Probe2' 'Probe3' 'Probe1' 
'Probe2' 'Probe3'... 
    'Probe1' 'Probe2' 'Probe3' 'Probe1' 'Probe2' 'Probe3'}; 
header3={'Time(s)' 'Time(min)' 'Relative time(s)' ... 
    'DHb' 'DHb' 'DHb' 'DHbO2' 'DHbO2' 'DHbO2' 'DHbt' 'DHbt' 'DHbt'... 
    'DHb' 'DHb' 'DHb' 'DHbO2' 'DHbO2' 'DHbO2' 'DHbt' 'DHbt' 'DHbt'... 
    'DHb' 'DHb' 'DHb' 'DHbO2' 'DHbO2' 'DHbO2' 'DHbt' 'DHbt' 'DHbt'... 
    'DHb' 'DHb' 'DHb' 'DHbO2' 'DHbO2' 'DHbO2' 'DHbt' 'DHbt' 'DHbt' 
'Cytaa3' 'Cytaa3' 'Cytaa3'}; 
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%% Saving data 
excel_out=[header1;header2;header3;num2cell(output1)]; 
  
switch ButtonName 
    case 'Yes' 
        [status msg]=xlswrite(save_name,excel_out,sheet_name); 
        if status==0 
            if msg.message=='Excel returned: Error: Object returned 
error code: 0x800A03EC.' 
                for f_nb=1:ceil(length(excel_out)/50000) 
                    [status, msg]=xlswrite(save_name,excel_out((f_nb-
1)*50000+1:min(f_nb*50000,length(excel_out)),:),... 
                        [sheet_name '-' num2str(f_nb)]);%, ['A' 
num2str((f_nb-1)*10000+1) ':AD' 
num2str(min(f_nb*10000,length(excel_out)))]); 
                end 
            end    
            msgbox(msg.message,'Saving Data'); 
        end 
end 
%% 
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% multi_wavelength_NIRS.m 
A=[DA_l1';DA_l2';DA_l3']; 
E=[ext_oxy_l1 ext_deoxy_l1 ext_cyt_l1;ext_oxy_l2 ext_deoxy_l2 
ext_cyt_l2;ext_oxy_l3 ext_deoxy_l3 ext_cyt_l3]; 
C=inv(E)*A/L; 
  
C_oxy(:,p1)=C(1,:)'; 
C_deoxy(:,p1)=C(2,:)'; 
C_cyt(:,p1)=C(3,:)'; 
  
%Data averaging 
[ta C_oxya(:,p1)]=smoothing(t,C_oxy(:,p1),averaging_samples); 
[ta C_deoxya(:,p1)]=smoothing(t,C_deoxy(:,p1),averaging_samples); 
[ta C_cyta(:,p1)]=smoothing(t,C_cyt(:,p1),averaging_samples); 
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% process_data.m 
%%  
%%%%%%%%%%%%%%%%%%%%%%%%Data Input%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%data_dir='C:\Tony\Dropbox\Research\Perfusion sensor project\Perfusion 
Sensor documents\in vitro data\Implantable system\PV phantom'; 
clear probes_data status_data comments 
[fname,pname]=uigetfile({'*.dat','Data files (*.dat)';'*.*',  'All 
Files (*.*)'},'Pick a data file'); 
full_name=fullfile(pname,fname); 
cd(pname) 
header_length=58; 
  
%% 
%%%%%%%%%%%%%%%%%%%%%%%%%Main Program%%%%%%%%%%%%%%%%%%%%%%%%%% 
data_all=importdata(full_name,','); 
%% 
s=1;d=1;c=1; 
for i=header_length+1:length(data_all) 
    A=cell2mat(data_all(i)); 
    [l k]=max((A=='>')); 
    data_type=char(A(2:k-1)); 
    num_data=str2num(A(k+1:length(A)-k-1)); 
    switch data_type 
        case 'Status' 
            status_data(s,:)=num_data;s=s+1; 
        case 'Data' 
            probes_data(d,:)=num_data;d=d+1; 
        case 'Comment' 
            comments(c)=cellstr(A(k+1:end));c=c+1; 
        otherwise 
            comments(c-1)=cellstr(strcat(comments(c-1), '___',A)); 
    end 
end 
t=char(data_all(4)); 
t=datevec(t(8:end-7)); 
start_time=(t(4)-6)*3600+t(5)*60+t(6); %convert time to CT and then to 
seconds 
clear data_all 
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% automatic_truncation.m 
%% 
clear y mx mn 
response_time=2;    %response time in seconds. 
dt=1;               %Time to cut out at the deginning of the dataset 
Fs=300; 
test_data=probes_data(:,2)-mean(probes_data(:,2)); 
figure,plot(test_data) 
uiwait(msgbox('Select the threshold for cutoff and press enter when you 
are satisfied with your selection','Threshold')) 
[x,y,k]=ginput; 
threshold=y(length(y)); 
y=abs(test_data)<threshold; 
response_time=response_time*Fs-1; 
for i=1:length(y)-response_time 
    y(i)=min(y(i:i+response_time)); 
end 
diffy=diff(y); 
hold on,plot(10000*diffy,'r') 
data_length=length(test_data); 
mx=find(diffy>0); 
mn=find(diffy<0); 
mx=mx+dt*Fs; 
mn=mn+response_time-50; 
mn(length(mn)+1)=data_length; 
if length(mx)==length(mn) 
    msgbox(strcat(num2str(length(mx)),' datasets found.'),'Data 
truncation'); 
else 
    msgbox('Error! Retry by selecting a different threshold.','Error!') 
end 
  
hold on,plot(mx,test_data(mx),'xg') 
plot(mn,test_data(mn),'og') 
  
  
235 
 
% summary_file_v2.m 
% This program combines different excel files from the same experiment  
% into a single excel file to make data analysis easier. The user the 
% inputs name of the sheet in the excel files that he wants to combine 
% and selects all the files to merge and the saving location. 
%  
% Tony J. Akl 
% tja161@gmail.com 
  
%% 
[fname1, pname] = uigetfile({'*.xls','Excel files (*.xls)'},'Pick all 
data file','MultiSelect','on'); 
prompt={'Sheet name:'}; 
name='User Input'; 
numlines=1; 
defaultanswer={'Combined 5s'}; 
sheet_name = char(inputdlg(prompt,name,numlines,defaultanswer)); 
  
%% Initializing headers 
header1={' ' ' ' ' ' 'Wavelengths 1-2' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' 
'... 
   'Wavelengths 1-3' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '... 
   'Wavelengths 2-3' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '... 
   'All wavelengths' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '}; 
header2={' ' ' ' ' ' 'Probe1' 'Probe2' 'Probe3' 'Probe1' 'Probe2' 
'Probe3'... 
    'Probe1' 'Probe2' 'Probe3' 'Probe1' 'Probe2' 'Probe3' 'Probe1' 
'Probe2' 'Probe3'... 
    'Probe1' 'Probe2' 'Probe3' 'Probe1' 'Probe2' 'Probe3' 'Probe1' 
'Probe2' 'Probe3'... 
    'Probe1' 'Probe2' 'Probe3' 'Probe1' 'Probe2' 'Probe3' 'Probe1' 
'Probe2' 'Probe3'... 
    'Probe1' 'Probe2' 'Probe3' 'Probe1' 'Probe2' 'Probe3'}; 
header3={'Time(s)' 'Time(min)' 'Relative time(s)' ... 
    'DHb' 'DHb' 'DHb' 'DHbO2' 'DHbO2' 'DHbO2' 'DHbt' 'DHbt' 'DHbt'... 
    'DHb' 'DHb' 'DHb' 'DHbO2' 'DHbO2' 'DHbO2' 'DHbt' 'DHbt' 'DHbt'... 
    'DHb' 'DHb' 'DHb' 'DHbO2' 'DHbO2' 'DHbO2' 'DHbt' 'DHbt' 'DHbt'... 
    'DHb' 'DHb' 'DHb' 'DHbO2' 'DHbO2' 'DHbO2' 'DHbt' 'DHbt' 'DHbt' 
'Cytaa3' 'Cytaa3' 'Cytaa3'}; 
%% 
nb_files=0; 
fname1=sort(fname1); 
excel_out=[header1;header2;header3]; 
for nf=1:length(fname1) 
    fname=char(fname1(nf)); 
    filename=fullfile(pname,fname); 
    [status,sheets1]= xlsfinfo(filename); 
     
    if max(strcmp(sheets1,sheet_name))~=1 
        nb_files=nb_files+1; 
        files(nb_files)={fname}; 
        continue 
    end 
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     a=xlsread(filename,sheet_name); 
     excel_out=[excel_out; num2cell(a)]; 
end 
[fname, pname]=uiputfile({'*.xls', 'Excel Worksheet (*.xls)'},'Saving 
data','Summary.xls'); 
  
xlswrite(fullfile(pname,fname),excel_out,sheet_name); 
display([num2str(length(fname1)-nb_files) ' files added to ' fname ... 
    ' and ' num2str(nb_files) ' files could not be added']); 
%% 
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% process_fft.m 
clear PI R2 HR 
Fs=300;     %sampling frequency in Hz 
minf=1.1; 
maxf=2.7; 
cut_off=0.2; 
start_index=294000; 
end_index=312700; 
probes=[1 2 3]; 
  
gain=[20.39849 38.69856 96.28571]; 
%% 
%%%%%%%%%%%%%%%%%%%%%%%%%Main Program%%%%%%%%%%%%%%%%%%%%%%%%%% 
for i=1:length(probes) 
p=probes(i); 
%% Input 
time=[0:1/Fs:(end_index-start_index)/Fs]; 
%AC 
AC735=probes_data(start_index:end_index,7*(p-1)+2)*5/2^16; 
AC805=probes_data(start_index:end_index,7*(p-1)+4)*5/2^16; 
AC940=probes_data(start_index:end_index,7*(p-1)+6)*5/2^16; 
%DC 
DC735=probes_data(start_index:end_index,7*(p-1)+3)*5/2^16; 
DC805=probes_data(start_index:end_index,7*(p-1)+5)*5/2^16; 
DC940=probes_data(start_index:end_index,7*(p-1)+7)*5/2^16; 
%Sum 
total735=AC735+DC735; 
total805=AC805+DC805; 
total940=AC940+DC940; 
%% Fourrier transforms 
n=length(AC735); 
NFFT=n;%2^nextpow2(n);      % If the NFFT is set at 2^next 
FFT735=fft(AC735,NFFT)/n; 
power735=abs(FFT735).^2; 
FFT805=fft(AC805,NFFT)/n; 
power805=abs(FFT805).^2; 
FFT940=fft(AC940,NFFT)/n; 
power940=abs(FFT940).^2; 
  
% Detecting HR 
f=Fs/2*linspace(0,1,NFFT/2); 
[l kmin]=max(f>=minf); 
[l kmax]=max(f>=maxf); 
[maxFFT735 l]=max(abs(FFT735(kmin:kmax))); 
HR735=f((kmin+l-1)) 
i=kmin+l-2; 
while(abs(FFT735(i))>cut_off*maxFFT735)&&(i>1) 
    i=i-1; 
end 
imin735=i; 
fmin735=f(imin735); 
  
i=kmin+l; 
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while(abs(FFT735(i))>cut_off*maxFFT735) 
    i=i+1; 
end 
imax735=i; 
fmax735=f(imax735); 
  
power735=sum(abs(FFT735(imin735:imax735))); 
  
[maxFFT805 l]=max(abs(FFT805(kmin:kmax))); 
HR805=f((kmin+l-1)) 
  
i=kmin+l-2; 
while(abs(FFT805(i))>cut_off*maxFFT805)&&(i>1) 
    i=i-1; 
end 
imin805=i; 
fmin805=f(imin805); 
i=kmin+l; 
while(abs(FFT805(i))>cut_off*maxFFT805) 
    i=i+1; 
end 
imax805=i; 
fmax805=f(imax805); 
power805=sum(abs(FFT805(imin805:imax805))); 
  
[maxFFT940 l]=max(abs(FFT940(kmin:kmax))); 
HR940=f((kmin+l-1)) 
i=kmin+l-2; 
while(abs(FFT940(i))>cut_off*maxFFT940)&&(i>1) 
    i=i-1; 
end 
imin940=i; 
fmin940=f(imin940); 
  
i=kmin+l; 
while(abs(FFT940(i))>cut_off*maxFFT940) 
    i=i+1; 
end 
imax940=i; 
fmax940=f(imax940); 
power940=sum(abs(FFT940(imin940:imax940))); 
  
%% Plotting and data output 
figure(p),subplot(3,2,1), plot(f,2*abs(FFT735(1:NFFT/2))) 
axis([0 10 0 1.1*max(2*abs(FFT735(kmin:kmax)))]),title('735 nm') 
subplot(3,2,3), plot(f,2*abs(FFT805(1:NFFT/2))) 
axis([0 10 0 1.1*max(2*abs(FFT805(kmin:kmax)))]),title('805 nm') 
subplot(3,2,5), plot(f,2*abs(FFT940(1:NFFT/2))) 
axis([0 10 0 1.1*max(2*abs(FFT940(kmin:kmax)))]),title('940 nm') 
  
h(p)=figure(p); 
subplot(3,2,1), hold on, plot([fmin735 fmin735],[0 4*maxFFT735],'--r') 
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plot([fmax735 fmax735],[0 4*maxFFT735],'--r'),hold off 
ylabel('|FFT|'),xlabel('f(Hz)') 
subplot(3,2,3); 
hold on, plot([fmin805 fmin805],[0 4*maxFFT805],'--r') 
plot([fmax805 fmax805],[0 4*maxFFT805],'--r'),hold off 
ylabel('|FFT|'),xlabel('f(Hz)') 
subplot(3,2,5) 
hold on, plot([fmin940 fmin940],[0 4*maxFFT940],'--r') 
plot([fmax940 fmax940],[0 4*maxFFT940],'--r'),hold off 
ylabel('|FFT|'),xlabel('f(Hz)') 
set(h(p),'Units','Normalized') 
set(h(p),'Position',[0 0 1 1]) 
  
flow(p,1:3)=[abs(maxFFT735) abs(maxFFT805) abs(maxFFT940)]; 
meanDC(p,1:3)=[mean(DC735) mean(DC805) mean(DC940)]; 
FFT_peak=[maxFFT735 maxFFT805 maxFFT940] 
FFT_power=[power735 power805 power940]*Fs/(NFFT-2) 
DC=[mean(DC735) mean(DC805) mean(DC940)] 
R(p)=(flow(p,1)./meanDC(p,1))./(flow(p,3)./meanDC(p,3)) 
  
HR(p,:)=[HR735 HR805 HR940]*60, AC=[AC735 AC805 AC940];DCt=[DC735 DC805 
DC940];ACDC=AC./DCt; 
ch1_ch3=ACDC(:,1)./ACDC(:,3); 
  
R2(p)= 
log((((maxFFT735/gain(p))+DC(1))./DC(1)))./log((((maxFFT940/gain(p))+DC
(3))./DC(3))); 
PI(p,:)= 100*[maxFFT735/(gain(p)*DC(1)) maxFFT805/(gain(p)*DC(2)) 
maxFFT940/(gain(p)*DC(3))]; 
%% Filter and plot waveforms 
maxf1=10; 
[b,a]=butter(4,[minf maxf1]/150); 
AC7351=filter(b,a,AC735);AC8051=filter(b,a,AC805);AC9401=filter(b,a,AC9
40); 
subplot(3,2,2);plot(time,AC7351),xlabel('Time (s)'),ylabel('AC (V)') 
title(strcat( strrep(fname, '_', '-'), 'from 
:',num2str(probes_data(start_index)),' s 
to',num2str(probes_data(end_index)),' s')); 
subplot(3,2,4);plot(time,AC8051),xlabel('Time (s)'),ylabel('AC (V)') 
subplot(3,2,6);plot(time,AC9401),xlabel('Time (s)'),ylabel('AC (V)') 
  
end 
%% Saving figures 
figure(probes(1)) 
%data_dir=save_dir; 
ButtonName = questdlg('Would you like to save the 
images?','Save','Yes','No','Yes'); 
switch ButtonName, 
    case 'Yes', 
        save_dir=uigetdir(pname,'Save directory'); 
        cd(save_dir) 
        for i=1:length(probes) 
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saveas(h(probes(i)),strcat('Probe',num2str(probes(i)),'.fig')); 
        end 
            msgbox('Figures saved successfully','Data saved') 
    case 'No', 
        msgbox('Figures not saved, you can still save them 
manually','Data not saved') 
end 
PI=PI';HR=HR';meanDC=meanDC';flow=flow'; 
excel_out=[cellstr(fname) num2cell([probes_data(start_index,1) 
probes_data(end_index,1) R2 flow(1:end) meanDC(1:end) PI(1:end)  
HR(1:end)])]; 
% excel_out=[flow meanDC flow./meanDC]; 
display('END') 
 
 
